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ABSTRACT 
Thymoquinone is a major active ingredient of black seeds which are produced by the plant, 
Nigella sativa. Thymoquinone exhibits various chemotherapeutic and chemo preventative 
activities including immunostimulation, antimicrobial, anticancer and chemoprotection activities 
(reviewed by (Darakhshan et al., 2015). Despite available data on thymoquinone’s anticancer 
mechanism of action, there is no description of its antifungal mode of action. This thesis 
presents data on thymoquinone’s effect on the redox status of C. glabrata and reveals a binding 
site of TQ on the surface of these cells. 
The data presented in chapter 2 demonstrates for the first time the growth inhibitory effect of TQ 
on the species C. krusei and C. glabrata beside other Candida species. This chapter also shows 
that in C. glabrata, thymoquinone exhibited concentration-dependent fungicidal activity on 
planktonic cells and caused necrotic death. In addition, the antifungal effect of thymoquinone 
against C. glabrata biofilms was examined. The biofilms were stabilised using a poly propylene 
biofilm reactor designed to mimic Calgary biofilm device (Almshawit et al., 2014b). The 
advantages of this novel reactor are described. 
Thymoquinone may act as       anti-oxidant or pro-oxidant depending on the milieu (Mansour et 
al., 2002). Chapter 3 demonstrated that thymoquinone causes oxidative stress in C. glabrata as a 
result of increased reactive oxygen species generation. This chapter also reports depletion of 
reduced glutathione levels and reduced mitochondrial membrane potential. In addition, this 
chapter provides experimental characterisation of the ALO1 gene and evidence of production of 
D-erythroascorbic acid by C. glabrata. 
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Chapter 4 shows that activation of CWI-MAPK in C. glabrata results following treatment with 
thymoquinone, hydrogen peroxide, doxycycline or hypo-osmotic treatment. However, CWI-
MAPK mutants were neither sensitive nor resistant to thymoquinone. In contrast the downstream 
kinase mutant (C. glabrata Δslt2) was sensitive to H2O2 (Chapter 5). Activation of CWI-MAPK 
by hypo-osmolarity was exploited to develop a hypothesis that this mechanism could be used to 
screen potential CWI-MAPK inhibitors. Survival of cells in water was used as a model to screen 
such inhibitor. The results give insights into important facts that should be considered when 
using water suspensions of C. glabrata cells.  
Finally chapter 5 describes for the first time an interaction between thymoquinone and the fungal 
cell wall. This study demonstrates that thymoquinone induced stress promotes chitin synthesis 
after induction of CWI-MAPK. Chitin was shown to bind thymoquinone and facilitate its 
transport through the cell wall inside the cell. This was supported by the observation that 
inhibition of chitin synthesis led to a decrease in thymoquinone antifungal efficacy. This finding 
is important in a reconsideration of the use of TQ together with other cell wall active antifungal 
compounds such as nikkomycin Z. 
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CHAPTER 1: 
Introduction 
 
The kingdom fungi contains yeast organisms responsible for human infections. The genus 
Candida contains species responsible for the commonest forms of these infections. Over the past 
three decades the incidence of Candida infections has considerably increased. This is attributed 
to various factors including the increased numbers of immunocompromised patients (e.g. AIDS 
and cancer patients), a growing aged population, the increased use of indwelling medical devices 
and antibiotic misuse. Candida albicans is considered the main cause of candidiasis. However, 
non-albicans Candida species such as Candida glabrata are important due to their increased 
incidence of infection. In the 1960s Candida glabrata was known as a non-pathogenic fungus 
(Fidel et al., 1999), however by the 1990s C. glabrata was reported as the 4
th
 most common 
cause of Candida blood stream infections, and in the 2000s it became one of the most common 
cause of blood stream infections in the USA (Li et al., 2007). Additionally, C. glabrata infection 
is of concern because of the organism’s ability to develop resistance towards common 
antifungals (Silva et al., 2012), which necessitates a continued search for new antifungal agents.  
Plant-derived antifungal agents (Phytochemicals) have been historically used to treat fungal 
infections (Halberstein). Thymoquinone is one of these phytochemicals which showed several 
pharmacological effects and can be extracted from Nigella sativa seeds (reviewed by 
(Forouzanfar et al., 2014). This study investigates thymoquinone’s antifungal action particularly 
towards C. glabrata. 
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1.1  Candida glabrata 
 
1.1.1 General characteristics of  Candida glabrata 
C. glabrata is a yeast that forms blastoconidia with cell sizes ranging from 1 to 4 µm in diameter 
(Bialkova et al., 2006).  It is a haploid yeast, petite-positive (can grow in the absence of oxygen 
as a reduced colony size mutant) and genetically is considered to be the Candida species most 
closely related to Saccharomyces cerevisiae (Barns et al., 1991, Marcet-Houben et al., 2009).  C. 
glabrata is an asexual yeast despite the presence of genes potentially responsible for conjugation 
and mating switching (Bialkova et al., 2006). It has a genome of 12.3 Mb with 38.8% G+C 
content, which is close to that of S. cerevisiae (38.3%). Its genome comprises 13 chromosomes 
(sizes of    .5-1.4 Mb) and encodes 5283 coding sequences (CDS), with an average CDS size of 
493 codons. Although the vast majority of S. cerevisiae genes have obvious C. glabrata 
orthologs, C. glabrata has a simplified metabolic capacity when compared to S. cerevisiae, 
probably because of its association with and adaptation to the mammalian host. For instance, the 
C. glabrata genome has lost genes involved in galactose and sucrose assimilation, phosphate, 
nitrogen and sulfur metabolism, as well as thiamine, pyridoxine and nicotinic acid biosynthesis 
(Kaur et al., 2005). C. glabrata has been considered a non-dimorphic yeast. Thus C. glabrata 
was classified historically under the genus Torulopsis. However, in 1978, it was demonstrated 
that production of pseudohyphae was not a reliable factor to distinguish members of the Candida 
genus. Consequently, T. glabrata was classified into the genus Candida (Fidel et al., 1999). In a 
subsequent study to this reclassification, C. glabrata was found to be able to form pseudohyphae 
in response to nitrogen source starvation which is commonly thought to arise from its search for 
nutrients when they are limiting (Roetzer et al., 2011a). 
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C. glabrata is a common cause of superficial and systematic infections including oral, vaginal 
and urinary tract candidiasis and candidemia. Moreover its incidence has increased worldwide. 
The International Fungal Surveillance Participant Group reported in 2004 that C. glabrata 
comprises 7.5% to 18.3% of bloodstream fungal isolates in the study period 1992 to 2001 
(Pfaller et al., 2004a). A recent Australian candidemia study reported that 32% of Candida 
isolates were identified as C. glabrata (from 2004 to 2007 it was 15%) and this species was the 
most resistant to antifungal drugs amongst other candida isolates tested (Chen et al., 2015).  
 
The increased incidence of C. glabrata infections is of concern because of the organism’s ability 
to rapidly develop resistance to antifungal compounds such as fluconazole, itraconazole, 
voriconazole and amphotericin B (Foster et al., 2007, Diekema et al., 2002, Borst et al., 2005). 
Resistance has also been found to develop after prolonged periods of azole prophylaxis such as 
that used in hematopoietic stem cell transplant recipients (Bennett et al., 2004). Moreover, 
following exposure to fluconazole C. glabrata can develop high-level resistance to other azoles 
such as voriconazole: this is called cross-resistance (Panackal et al., 2006, Hitchcock et al., 
1993). Echinocandins (e.g. caspofungin) have generally retained excellent activity against C. 
glabrata (Kauffman et al., 2014). However isolated cases of resistance have been also reported 
against this antifungal group. Overall, the broad emergence of co-resistance over time to both 
azoles and echinocandins in clinical isolates of C. glabrata has been reported (Pfaller et al., 
2012), creating a need for continued development of new antifungal drugs. 
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1.1.2 Candida glabrata virulence factors 
Virulence determinants are a subset of genes that have evolved and are primarily expressed in 
vivo to promote survival, allow replication of the fungus and facilitate disease progression in the 
mammalian host (Haynes, 2001). Compared with Candida albicans there is a limited number of 
studies examining the virulence determinants of C. glabrata (Kaur et al., 2005). The 
pathogenicity of C. glabrata has mainly been attributed to its ability to adhere, production of 
tissue damaging hydrolytic enzymes and formation of biofilms on host tissue and medical 
devices (Rodrigues et al., 2014).  
 
1.1.2.1 Adherence and biofilm formation  
Adherence of Candida glabrata cells to components of mammalian tissues has been 
hypothesized to be important in virulence (Calderone et al., 2001). Its epithelial adhesion (EPA) 
protein family is a specific family of glycosylphosphatidylinositol (GPI)-anchored cell wall 
proteins which are involved in mediating adhesion to human epithelial cells in vitro.  The 
genomes of CBS138 and the BG2 strains contain at least 17 and 23 EPA-related genes, 
respectively. However, only three of them (EPA1, EPA6 and EPA7) have been shown to be 
involved in adhesion (Kaur et al., 2005, Maestre-Reyna et al., 2012, Caudle, 2010). EPA1 is a 
lectin that binds to host-encoded N-acetyl lactosamine-containing glycol conjugates in human 
epithelial cells (HEp2) (Cormack et al., 1999). The other two adhesins EPA6 and EPA7 are more 
involved in C. glabrata biofilm formation (Iraqui et al., 2005). Deletion of EPA1 reduces 
adherence in vitro and is associated with a reduction of expression of other EPA genes. The EPA 
genes are localized to the sub-telomeric regions of chromosomes and thus their expression is 
controlled by SIR and RIF genes (termed as sub-telomeric silencing). Therefore, C. glabrata 
Chapter1 
- 5 - 
  
sir3∆ and rif1∆ strains showed increased colonization of the kidney in a murine model after 
increased expression of EPA6 and EPA7 (Castano et al., 2005). More recently it has been found 
that Cst6p also regulates expression of EPA6 and consequently biofilm formation (Riera et al., 
2012).  
Another four adhesion-like proteins, Awp1/2/3/4 have been identified by de Groot’s group 
(2008). These proteins were also implicated in C. glabrata adherence to human epithelia and 
biofilm formation. The presence of these proteins in the cell wall depended on the growth phase 
and on the genetic background that was used, and that in turn affected the adhesion capacity and 
cell surface hydrophobicity (de Groot et al., 2008). This study demonstrated that Awp2, Awp3, 
Awp4, and Epa6 were present in C. glabrata ATCC2001 but not in ATCC90876. In contrast, 
Awp1 was found only in C. glabrata ATCC90876. In addition, Awp3 was identified only in log-
phase cells while Awp4 and Epa6 were identified only in stationary-phase cells (de Groot et al. 
2008). YPS genes encoding extracellular glycosylphosphatidylinositol-linked aspartyl proteases 
were also found to be important for adherence to mammalian cells, cell wall integrity and 
survival in macrophages (Kaur et al., 2007). In addition, the chromatin remodelling Swi/Snf 
complex has been shown to regulate positively biofilm formation in C. glabrata (Riera et al., 
2012). All these facts suggest a contribution of these adhesion (-like) genes of C. glabrata to its 
adaptability and virulence in vivo. 
 
Since C. glabrata cells are able to adhere and surround themselves by an external matrix, it has 
been widely accepted that the pathogenesis of C. glabrata infections is related also to their 
ability to form biofilms. This property is a strain-dependent ability which is mediated by the 
expression of a large number of adhesins (Almshawit et al., 2014, de Groot et al., 2013, Riera et 
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al., 2012). Candida biofilms may adhere to abiotic medical device materials and subsequently 
invade human tissues and the immune system mechanism. Furthermore, biofilms are believed to 
cause elevation in antifungal treatment resistance (Seneviratne et al., 2008a) and help them 
withstand the competitive pressure from other microorganisms in comparison to their planktonic 
cells counterpart (Mohammadi et al., 2012, Nett et al., 2007b, Toulet et al., 2012).  Moreover, 
adhesion and dispersion of cells from biofilms are an important part of the biofilm development 
cycle which is associated with disseminated invasive diseases such as candidemia (Braga et al., 
2008, Uppuluri et al., 2010a). Therefore, antibiotic treatment of biofilm-related catheter infection 
is difficult and usually requires implant replacement which entails an additional cost and 
discomfort for the patient (Kucharikova et al., 2015). In talking about C. glabrata biofilm 
virulence, the role of mixed organism biofilm pathogenicity should not be ignored. For instance, 
for mixed C. albicans and C. glabrata biofilm it is thought that C. glabrata takes advantage of 
the C. albicans hyphae extension that penetrates and invades into the host tissue (Coco et al., 
2008). In contrast, mixed bacterial biofilms (e.g. Lactobacilli sp. or Pseudomonas aeruginosa) 
inhibited C. glabrata biofilm formation (Bandara et al., 2010, Chew et al., 2015).  
 
1.1.2.2 Pigment production  
Pigment production is thought to protect fungal cells from the host defence system (Wang et al., 
1995).  Indole-derived pigment was described for C. glabrata by Mayser and colleagues (2007). 
They described this pigment as similar to that produced by the skin pathogen Malassezia furfur. 
It is a by-product of tryptophan catabolism via the Ehrlich pathway when tryptophan is provided 
as a sole nitrogen source (Mayser et al., 2007). Indeed there is no direct evidence of this 
protection in vivo where systemic C. glabrata infections may originate from niches where 
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tryptophan and other nitrogen sources are readily available (Brunke et al., 2010). Nevertheless 
compared to non-pigmented cultures, in vitro pigmented C. glabrata cultures exhibited decreased 
killing by hydrogen peroxide, enhancement of protection against oxidative burst inside the 
neutrophil phagosomes and caused increased damage of human epithelial cells in a monolayer 
infection model (Brunke et al., 2010). This protection is similar to that provided by melanin in 
fungi such as Cryptococcus neoformans or Aspergillus fumigatus (Jacobson, 2000, Wang et al., 
1995). 
 
1.1.2.3 Morphology and Phenotypic switching  
C. glabrata clinical isolates have been shown to have a limited capacity to form pseudohyphae, 
indicating that the ability of this species to form true hyphae is not essential for its pathogenesis 
(Gow et al., 2002, Grubb et al., 2008).  However Roetzer and colleagues (2011a) showed that 
colonies with ability to form pseudohyphae exhibited an advantage in colonizing the liver and 
spleen in a mouse model. These colonies were isolated on CuSO4-containing agar as dark brown 
C. glabrata colonies. 
 
Defects in cell separation may also enhance the virulence of C. glabrata. In a study that 
investigated the deletion of ACE2 (part of the RAM network regulation of Ace2 activity and 
cellular morphogenesis) on budding patterns, the mutant showed a significant increase in 
virulence in a murine model of disseminated candidiasis (Kamran et al., 2004). This was thought 
to be due to a defect in cell separation and this resulted in the growth of cells in large clumps. 
Although the aggregates did not cause vascular occlusion, the virulence was related in part to an 
increase in pro-inflammatory cytokine levels including alpha tumor necrosis factor and 
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interleukin-6. However, the specific downstream targets of C. glabrata ACE2 that account for 
the proinflammatory phenotype of the ace2 mutant are not known yet (Kamran et al., 2004).  
 
1.1.2.4 Enzyme production 
Candida glabrata is not major producer of secreted enzymes in vivo, but recent studies have 
described production of hemolysins and phospholipases. The genetic expression of hemolytic 
activity in C. glabrata is however poorly understood. Candida glabrata has no known receptors 
for haem (Nevitt et al., 2011), but like many other Candida species C. glabrata can obtain 
elemental iron from host cells by degrading haemoglobin using haemolysins. Interestingly, in 
vitro production of hemolysins is strain-dependent and this might be a reason for variation in 
virulence between C. glabrata strains (Luo et al., 2004). Candida glabrata also produces 
phospholipases which hydrolyze phospholipids into fatty acids (Mohan das et al., 2008). Their 
production destroys the host mucosa and aids effective invasion of the involved tissues 
(reviewed by Rodrigues et al., 2014).  
According to Polakova et al., (2009) C. glabrata isolates can also alter their chromosome 
number by duplication of chromosome segments carrying a centromere and subsequently adding 
novel telomeric ends. This plasticity is associated with antifungal drug resistance and it seems to 
be an advantage in colonizing the human body where there is much fluctuation in the 
environmental conditions (Poláková et al., 2009). 
 
1.1.3 Host interaction  
Infection of mucosal surfaces with Candida glabrata has been reported in the mouth, 
oesophagus, intestines, and vagina. Since different Candida species can be commensals of 
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human mucosae, the origin of candidiasis is considered to be mainly endogenous. The 
establishment of Candida glabrata infection in vivo requires four essential steps: adherence, 
invasion, immune interaction and efficient nutrient acquisition (Brunke et al., 2014, Seider et al., 
2014). 
 
As described in a previous section, C. glabrata has a large family of genes called EPA which are 
essential for expressing different adhesions to different epithelial human cells. Based on in vitro 
studies it seems to be that the host environment signalling controls the expression of EPA genes. 
For example, Sir complex-mediated transcriptional silencing requires NAD
+
 as a cofactor, thus 
there is an indirect influence on the silencing activity by external nicotinic acid concentrations. 
This acid is present in low concentrations in the human urinary tract. Deficiency of nicotinic acid 
decreases SIR2 activity resulting in derepression of EPA6. This leads to an increased adherence 
of C. glabrata to host tissues and thus C. glabrata infection thrives in this niche (reviewed in 
(Brunke et al., 2013, Domergue et al., 2005). In addition, exposure to preservatives such as 
sorbic acid and parabens induces EPA6 expression via activation of the transcription factors Flo8 
and Mss11 which control weak organic acid stress. These preservatives are used often in food 
and health products including over-the-counter vaginal products. Candida glabrata cells also 
have better chance to adhere to vaginal epithelium because of the low pH which leads to 
activation of Flo8 and Mss11 transcription factors and consequently an induction of EPA6 
expression (Mundy et al., 2009, Tscherner et al., 2011).  
 
Little is known about the C. glabrata invasion mechanism. It is likely to occur accidently or 
iatrogenically in susceptible individuals. Infection can be transmitted from contaminated 
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catheters or surgically related inoculation. C. glabrata can also penetrate across the epithelial 
surfaces as an association with the absorption of other microbes, mainly C. albicans (Coco et al., 
2008, Silva et al., 2011). According to Coco et al. 2008 it is likely that C. albicans hyphae help 
to maintain the structural integrity of denture-associated biofilm, and form a sanctuary for the 
smaller C. glabrata cells. Silva and colleagues (2010) have also shown by fluorescence 
microscopy how C. glabrata is transported to deeper tissue layers through adherence to C. 
albicans. 
 
Invasion of naked epithelial surfaces via trauma or/and endocytosis is another proposed way of 
invasion (reviewed in Brunke & Hube, 2013). Once C. glabrata enters the bloodstream, it starts 
to employ immune evasion strategies (Seider et al., 2014). While strong neutrophil infiltration is 
characteristic for C. albicans infections, C. glabrata infection is associated with stimulation of 
mononuclear cells rather than neutrophil attraction (reviewed in (Brunke et al., 2013, Jacobsen et 
al., 2010, Westwater et al., 2007). This observation is attributed to the fact that C. glabrata 
induces more GM-CSF than C. albicans and less of the other inflammatory cytokines like IL-1a 
or Il-8 (reviewed by (Brunke et al., 2013). According to Keppler-Ross et al., (2010), C. glabrata 
is recognized and phagocytosed by macrophages more frequently than C. albicans. The yeast 
form is more susceptible to uptake by macrophages compared to hyphae. This selectivity seems 
to be mannan dependent, but independent of glucan or chitin (Keppler-Ross et al., 2010). 
Candida glabrata exploits the macrophage’s phagosomes as niches for replication until the 
phagosome bursts and releases the pathogen. To be able to survive in the harsh environment of 
phagosomes, intracellular survival strategies have evolved. One of these strategies is to repress 
and detoxify reactive oxygen species that can be produced by primary human macrophages. In 
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addition, intracellular persistence is an important strategy to hide from other branches of the 
immune system such as neutrophils and humoral immune components. Candida glabrata has 
been shown to modify the phagosome into a non-acidified environment and alter phagosomal 
biogenesis via arresting of phagosomal maturation in a late endosomal stage to prevent fusion 
with lysosomes. In this manner, C. glabrata can multiply until the host cell finally lyses and 
releases the fungi (Kasper et al., 2014, Seider et al., 2011). 
 
Efficient nutrient acquisition is another crucial factor for survival inside the phagosomes. In 
contrast with C. albicans which escapes from the nutrient-poor environment in the phagosome, 
C. glabrata depends on autophagy to survive inside the phagosome. It remodels its chromatin to 
facilitate reprogramming of cellular energy metabolism which also provides protection against 
DNA damage (Rai et al., 2012, Seider et al., 2014). C. glabrata might obtain nitrogen from 
amino acids which are present in free form in low millimolar concentrations at different host 
sites such as urine or blood in the same way that C. albicans liberates these amino acids from 
proteins and peptides through the action of hydrolases and uptake them using permeases (Brunke 
et al., 2014). However, it is not clear yet how this microorganism can obtain enough other 
nutrients such as a carbon source, minerals and vitamins (Brunke et al., 2013). Therefore, more 
C. glabrata infection studies are required to detail events inside the cell, organ and/or organism 
(Rodrigues et al., 2014). 
 
1.1.4 Cell wall structure and cell wall integrity MAPK 
The cell wall determines the shape of the fungal cell. It is essential for the integrity, 
environmental stress response and recognition by host cells. Common to many other fungi the 
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major constituents of the cell wall in C. glabrata are mannoproteins and polysaccharides (Ueno 
et al., 2011). The polysaccharides include β-1,3-glucan and β-1,6-glucan linked to lower levels of 
chitin  (1.4–7.1% of the entire cell wall mass (Aguilar-Uscanga et al., 2003)) via β-1,4-glucan  
(Fig. 1.1). Chitin forms the innermost part close to the cell membrane and β-(1,6)-glucan 
linkages/structure are displayed outwards to link with the outer cell wall mannoproteins. Some of 
the chitin and glucan chains may extend throughout the entire depth of the cell wall structure and 
chitin is concentrated mostly in the septa ( > 90%) (Cabib et al., 2013, Molano et al., 1980). The 
cell wall forms about 20% of the cell's dry weight in C. glabrata and it appears to have 50% 
more mannoprotein and a thinner glucan layer than baker's yeast and C. albicans. Indeed, β-
glucans in the cell wall of C. glabrata may be more effectively masked from host immune 
recognition by the receptor dectin-1 than in C. albicans (Cabib et al., 2013, de Groot et al., 2008, 
Santos et al., 2000, West et al., 2013). Nevertheless, as previously mentioned C. glabrata is more 
recognizable to macrophages than C. albicans and this might be attributable to their cell wall’s 
higher content of mannan (Keppler-Ross et al., 2010). 
 
 
Figure 1.1  The cell wall structure in Candida spp. 
Adapted from Prof. Neil Gow’s profile < http://www.abdn.ac.uk/ims/profiles/n.gow> , viewed 17th August 2015 
Mannoproteins 
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Taking S. cerevisiae as model yeast, cell wall stress recognition is mediated through the response 
of a specific cell wall integrity (CWI) MAPK pathway which is known also as Pkc1-MAPK. As 
reviewed by Levin (2011) this signal transduction pathway activates an adaptive transcriptional 
response. Environmental stress is detected mainly via Wsc1 and Mid2 sensors. Then Rom1/2, the 
guanine nucleotide exchange factors, will be recruited and consequently trigger the GTPase 
Rho1. Rho1 activates Pkc1which triggers the MAPK cascade. The linear pathway consisting of 
the MAPKKKK Pkc1, MAPKKK Bck1, MAPKKs Mkk1/2 and finally the mitogen activated 
kinase, Slt2, which activates the transcription factors Rlm1 and Swi4/Swi6 (Fig. 1.2). Following 
the activation of transcription factors the expression of cell wall biosynthesis genes will be 
regulated to produce compounds that are involved in remodelling of the yeast cellular envelope 
(reviewed in Levin et al., 2011). Such genes are CHS1, MNN10 and CWH41 (Schwarzmuller et 
al., 2014). A search through the Candida Genome Data Base (CGD) reveals that all of the S. 
cerevisiae genes encoding CWI MAPK proteins have homologs in C. glabrata except for the 
Mkk1 homolog. 
 
Activation of CWI MAPK has been demonstrated to be inducible under conditions that stress the 
cell surface, mainly under hypo-osmotic shock.  However, due to the conversation between 
MAPK pathways. CWI can be activated under other stresses such as growth at high 
temperatures, hypo-osmotic shock, polarized growth, actin perturbation, oxidative stress or the 
presence of compounds or mutations that interfere with cell wall biosynthesis (Krasley et al., 
2006a, Soriano-Carot et al., 2012, Krasley et al., 2006b, Martin et al., 2015, Fuchs et al., 2009).  
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Figure 1.2 Cell wall integrity (CWI) signalling pathway in Candida glabrata. Signals are 
initiated at the stress sensors which are located at the plasma membrane. The extracellular 
domains of these proteins recruits the Rom1/2 GEFs to the plasma membrane, then the sensors 
stimulate nucleotide exchange on Rho1. The Rho1 activates the Pkc1-MAPK cascade. The 
transcription factors Rlm1 and SBF (Swi4/Swi6) are activated by the pathway. Skn7 may also 
contribute to the CWI transcriptional program (dashed line). The summary of the core elements 
of Pkc1-MAPK pathway was adapted from (Levin, 2011) except Mkk1 protein which was 
excluded from C. glabrata in this study. 
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1.2  Thymoquinone 
1.2.1 Thymoquinone in Nigella sativa 
The Nigella sativa seed (also called black cumin, or black seed) is a member of Ranunculaceae 
family (Fig. 1.3). The seed produces an annual flowering plant native to Mediterranean 
countries, Pakistan and India. The black seed has an interesting cultural history that traces back 
to the Egyptian Dynasty, having been discovered in Pharaoh Tutankhamen’s tomb (Botnick et 
al., 2 12). In Hebrew the black seed is called “Ketzah” (Bible, in the book of Isaiah 28:25-27) 
and sprinkling the seeds over bread, cake and flavouring dishes is a postbiblical custom (Botnick 
et al., 2012). In Islamic culture it is known as “The blessed seed” and there is an ideological 
belief that this seed can cure different diseases. This belief is based on the words of Mohamad 
"There is healing in black seed for all diseases except death" 
*
  (Buḫārī et al., 1997, Duke, 2  7). 
 
 
The biological activity of Nigella sativa seeds is mainly attributed to components of its essential 
oil including p-cymene, carvacrol, thymo-hydroquinone, dithymoquinone (nigellone), thymol, 
nigellicine, nigellidine, α-hedrin and thymoquinone (TQ) (Botnick et al., 2012). Thymoquinone 
is considered the major active ingredient of black seeds and most of the known biological actions 
of this seed have been attributed to TQ (Darakhshan et al., 2015). There are monoterpene 
composition changes upon seed maturation, in a pattern that reflects the proposed biosynthetic 
pathway to thymoquinone (Botnick et al., 2012). Different studies have shown varying 
concentrations of TQ in N. sativa essential oil. For instance, it has been found to constitute 27.8 
% – 57 % (Ali et al., 2003) or 0.2 % w/v of the essential oil (Houghton et al., 1995). In another 
study it was shown to constitute 7.9-13.8 % w/w of the seed (Botnick et al., 2012). This 
* In other version “The black seed is healing for ..etc” 
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difference might relate to the different sources of the seed and different extraction methods that 
have been used. 
 
 
(a) 
 
    
(b)                                             (c) 
Figure 1.3  (a) Thymoquinone chemical structure , (b) Nigella sativa seeds (black seeds) , (c) 
Nigella sativa flowers. 
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1.2.2 Chemical properties of thymoquinone 
Thymoquinone (2-isopropyl-5-methylbenzo-1, 4-quinone) is present in the fixed oil of N. sativa 
and is the most abundant constituent of its volatile oil. The most relevant properties of TQ are 
summarized in table 1.1. The UV–visible spectra of TQ has one sharp peak (max) at 254–257 
nm. Thymoquinone exists in tautomeric forms mostly as the keto form (∼90%) which is 
responsible for the pharmacological properties of this compound. It is a hydrophobic molecule 
and its solubility depends on time. Thymoquinone is light sensitive and unstable in aqueous 
solutions, particularly at an alkaline pH (reviewed by(Darakhshan et al., 2015, Salmani et al., 
2014). As TQ is soluble to about 5   μg/ml after 24 h, the aqueous solubility is not a major 
hindrance for drug formulations. This solubility might be sufficient to exert a pharmacologic 
effect if administered via the parenteral route (Salmani et al., 2014).  
 
Table 1.1 Summary of the most relevant properties of thymoquinone. Adapted from (Darakhshan et al., 
2015).  
IUPAC name 2-Isopropyl-5-methylbenzo-1,4-quinone 
Molecular formula C10H12O2 
Composition C (73.15%), H (7.37%), O (19.49%) 
Molar mass 164.2011 g/mol 
Appearance Crystalline and dark yellow 
CAS number 490-91-5, 73940-92-8 
PubChem CID 10281 
Melting point 44-47 ºC 
Boiling point 230-232 ºC 
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1.2.3 Thymoquinone toxicity 
There have been a number of reports investigating in vitro and in vivo measurements of 
thymoquinone toxicity.  Reported data regarding the maximum tolerated dose (MTD) for TQ in 
cell lines and animals is presented in table 1.2. As an example, 32.8 µg/ml of TQ was not toxic to 
a normal human lung fibroblasts cell line (80% viability) at the highest concentration used in that 
study (Gurung et al., 2010). Another study showed erythrocyte death following treatment with ≥ 
1.6 µg/ml (Qadri et al., 2009). Normal human cervical squamous cells were sensitive to about 18 
µg/ml after 72h (IC50) of treatment with thymoquinone. In the same study, thymoquinone was 
less toxic to normal cells than cisplatin (IC50 = 2.8µg/ml) which is a known treatment for human 
cervical squamous carcinoma. Thymoquinone showed higher efficiency in killing these cancer 
cells as well (Ng et al., 2011). Animal models differ in their toxicity patterns depending on the 
animal type and mode of administration. In mice, the lethal dose (LD50) of TQ after 
intraperitoneal injection was 104.7 mg/kg and after oral ingestion 870.9 mg/kg. The LD50 in rats 
after intraperitoneal injection was determined to be 57.5 mg/kg (Al-Ali et al., 2008). Another 
study on TQ toxicity in rats suggested lower maximum tolerated dose (MTD) values for 
intraperitoneal injections. Values obtained were 22.5 mg/kg in male rats and 15 mg/kg in 
females, whereas for oral ingestion it was 250 mg/kg in both male and female Wistar rats 
(Abukhader, 2012). More recently, in mice, TQ cream was used safely for vaginal candidiasis at 
concentrations of 10% (Abdel Azeiz et al., 2013).  
A suitable dose for the whole seed extract in humans can be extrapolated from animal studies 
based on the human equivalent dose of no observed adverse effect level (NOAEL). The human 
dose was estimated to be approximately 0.6 mg/kg/day oral TQ or  . 5 ml/kg/day oral of N. 
sativa extract reported in a study of postmenopausal women and this study reported no side 
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effects (Shuid et al., 2012). A chronic toxicity study has been performed using  N. sativa as an 
adjunct to therapy for Helicobacter pylori. In humans it was found that 3 g per day for 4 weeks 
was considered safe (Salem et al., 2010). Alkharfy et. al., 2014 used an equation of allometric 
relationship in animals that can be used to predict a starting dose in man:  
                                                 Doseman=Doseanimal*(Wtman/Wtanimal)
0.75
 
                                                                                                                               (Wt = weight) 
 
Based on the effective dose obtained from mouse model in their study and according to the body 
weight ratio of man to mouse, the expected effective dose in humans was between 0.05 and 0.25 
mg/kg. In conclusion these studies suggest a wide margin of therapeutic safety for thymoquinone 
doses. 
 
 
1.2.4  The therapeutic potential of thymoquinone 
Advances in technology have allowed the identification of the active components in Nigella 
sativa extracts. Despite lack of scientific verification of their effectiveness and safety, they were 
used as treatment of different diseases (Al-Rowais, 2002). 
 
Since the first extraction of thymoquinone by El-Dakhakhany in 1963 many studies have tested 
this compound for its therapeutic efficacy (El–Dakhakhny, 1963, Woo et al., 2012a). The anti-
oxidant and anti-inflammatory effects of thymoquinone have been reported in various disease 
models, including diabetes, asthma and encephalomyelitis (reviewed by Woo et al., (2012). It has 
been reported to act as a free radical and superoxide radical scavenger, as well as maintaining the 
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activity of various anti-oxidant enzymes such as glutathione peroxidase, catalase and 
glutathione-S-transferase (Badary et al., 2003, Nagi et al., 2009). On the other hand, as a quinone 
TQ can undergo enzymatic or non-enzymatic redox cycling with their corresponding 
semiquinone radicals to generate superoxide anion radicals (Fig. 1.4) (Bolton et al., 2000). This 
induction of reactive oxygen species (ROS) generation has been reported in various studies (El-
Najjar et al., 2010, Dergarabetian et al., 2013). There is reported consensus that the antioxidant 
or pro-oxidant properties of TQ are dependent on the milieu of the interaction (El-Najjar et al., 
2010, Mansour et al., 2002, Staniek et al., 2010).   
 
Thymoquinone has been found to inhibit different proinflammatory cytokines and chemokines 
including, monocyte chemoattractant protein-1, TNF-α, IL-1β, COX-2 and iNOS. It inhibits the 
activation of transcription factor NF-кB, ERK and Akt signaling pathways and its effect was 
more dramatic than the specific histone deacetylases (HDAC) inhibitor-Trichostatin A (Chehl et 
al., 2009, Woo et al., 2012a, Darakhshan et al., 2015).  In addition the studyn of Alkharfy et al., 
(2011) has demonstrated the protective effect of TQ against sepsis induced by E. coli and LPS in 
a mouse model. 
 
Alleviation of oxidative stress and inflammation is an important strategy that could be affected 
by TQ. This might help to prevent various chronic diseases such as bone and joint complications, 
respiratory diseases such as asthma and dyspnoea, gastric dysfunction and stomach ulcer, 
nephrotoxicity, Aβ-induced neurotoxicity and other diseases (reviewed by Darakhshan et al., 
2015). 
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Table 1.2 List of selected studies demonstrating data on thymoquinone toxicity. 
 
In vitro studies 
Tested Model Toxic dose of TQ Reference 
Normal human lung 
fibroblasts cell line 
32.8 µg/ml resulted in 80% viability (Gurung et al., 2010) 
Erythrocyte cells ≥ 1.6 µg/ml (suicidal) (Qadri et al., 2009) 
Normal human cervical 
squamous cells 
18 µg/ml (IC50 after 72h)  
Normal human osteoblasts ~ 6.5 µg/ml (IC50 after 24h) (Roepke et al., 2007) 
Human pancreatic ductal 
epithelial cells 
8.2 µg/ml resulted in 80% viability after 72h. (Banerjee et al., 2009) 
Monkey kidney epithelial 
cells  
˃ 16 µg/ml (Vance et al., 2008) 
In vivo studies 
 Mode of dministration  Toxic dose Reference 
Mice Intraperitoneal injection 104.7 mg/kg (LD50) (Al-Ali et al., 2008) 
Mice Intraperitoneal injection 5 mg/kg were safe (Khan et al., 2015) 
Mice Oral ingestion 870.9 mg/kg (LD50) (Al-Ali et al., 2008) 
Mice Oral ingestion 2.4 g/kg (LD50) (Badary et al., 1998) 
Mice Cream ˃ 10% (Ahmed Z. Abdel 
Azeiz, 2013) 
Rat Intraperitoneal injection 57.5 mg/kg (LD50) (Al-Ali et al., 2008) 
Rat Intraperitoneal injection 
 
Oral ingestion 
22.5 mg/kg (male) 
15 mg/kg (Female) 
 
250 mg/kg (male & female) 
(Abukhader, 2012) 
Rat Oral ingestion 10 mg/kg/day was safe (Kara et al., 2012) 
Human Oral  .6 mg/kg/day (safe) (Shuid et al., 2012) 
Human Skin 1% in 96% ethanol (53% 
irrational) 
(Coenraads et al., 
1975) 
Human Oral 400 mg/day (not toxic) (Al-Amri et al., 
2009) 
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Accumulation of superoxide may contribute to the pro-oxidant effect of TQ particularly in the 
absence of detoxifying enzymes, which is common in numerous cancers. The anti-tumor effect 
of thymoquinone has been investigated in tumor mice models for colon, fore stomach, prostate, 
fibrosarcoma, Ehrlich ascites carcinoma, pancreatic, lung cancer and its toxicity towards breast 
cancer cell lines has been frequently reported (reviewed by Banerjee et al., 2009, Motaghed et 
al., 2013, Ng et al., 2011, Woo et al., 2012).  
 
The combination of thymoquinone with conventional chemotherapeutic drugs could reduce the 
toxicity of the latter and produces better therapeutic effects. Thymoquinone also increases the 
radiosensitizing effect on human breast carcinoma cells. More importantly, TQ has showed some 
selectivity to cancer cells compared to normal cells (reviewed in Rahmani et al., 2014). 
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Figure 1.4 Oxido-reduction cycling of TQ. Thymoquinone can be converted to thymohydroquinone  by a 
two-step one-electron reduction, or by a one-step two-electron reduction enzymatic reaction. In one 
electron reduction of TQ, microsomal NADPH cytochrome P450 reductase, microsomal NADH 
cytochrome-b5 reductase, and mitochondrial NADH ubiquinone oxido-reductase, catalyse the conversion 
of TQ to semiquinone. Semiquinone which is a pro-oxidant can be converted into thymohydroquinone. 
Otherwise, a one-step reaction may cause direct formation of thymohydroquinone. A non-enzymatic 
reaction also may take place and reduce TQ through interaction with GSH to generate glutathionyl-
dihydro-TQ. The reduced products of TQ, glutathionyl-dihydro-TQ and thymohydroquinone are known 
for their anti-oxidant activity. Superoxide anion generated through oxidation of reduced TQ can be 
detoxified by SOD and CAT; Adapted from (Darakhshan et al., 2015). 
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Banerjee et al., (2009) have reviewed the anticancer effect(s) of thymoquinone and reported that 
these effects are mediated through different modes of action, including antiproliferation, 
apoptosis induction, cell cycle arrest, ROS generation and anti-metastasis/anti-angiogenesis. This 
quinone was found to exhibit anticancer activity through the modulation of multiple molecular 
targets, including p53, p73, p16, PTEN, STAT3 and PPAR-g. It interferes with essential steps of 
neovascularization from proangiogenic signalling to endothelial cell migration and tube 
formation. Thymoquinone down-regulates the nuclear factor-κB (NF-κB), Bcl-2 family, and NF-
κB-dependent anti-apoptotic genes (X-linked inhibitors of apoptosis, survivin, and 
cyclooxygenase-2) which result in chemosensitization. The review by Rahmani et al., (2014) has 
reported that TQ has a vital role in preventing cancer via modulation of phase I (cytochrome 
p450) and phase II detoxifying enzymes (glutathione transferase and N-acetyl transferase). 
 
Despite all of these promising data from in vitro and animal models studies, there has been no 
reported phase I pilot studies to evaluate TQ’s promising anticancer effects in humans. One 
study that has been reported by Al-Amri and Bamosa (2009) examined the effectiveness of oral 
TQ as an anticancer drug in advanced malignant breast cancer patients. The authors reported 
neither toxicity nor therapeutic response when patients were treated with 400 mg/day for 2 
weeks. (AbuKhader, 2013) suggested that the low effectiveness could be due to the oral 
administration. This might lead to TQ biotransformation due to induction of phase II enzymes in 
the liver such as DT-diaphorase which catalyses two electron reduction of TQ into a 
hydroquinone. Another reason could be that binding of TQ to serum proteins reduces its activity 
in vivo. Thymoquinone-loaded poly (lactide-co-glycolide) nanoparticles and TQ-loaded 
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liposomes particles might overcome these challenges and these alterations can be applied 
clinically to optimize the desired result to treat cancer patients (AbuKhader, 2013). 
 
Thymoquinone has shown antimicrobial properties against bacteria including Staphylococcus 
spp., Streptococcus spp., Salmonella spp., Pseudomonas aeroginosa, Escherichia coli, Shigella 
flexneri, Klebsiella pneumonia, Mycobacterium phlei (an acid-fast bacterium), Vibrio 
parahaemolyticus, Bacillus cereus, Listeria monocytogenes and shows weak antibacterial 
activity against Enterococcus faecalis, Enterococcus faecium and  Streptococcus salivarius 
(Chaieb et al., 2011, Halawani, 2009, Jrah Harzallah et al., 2011, Kouidhi et al., 2011, Shohayeb 
et al., 2012). In addition, thymoquinone’s anti-parasitic activity against Plasmodium spp., 
Trypanosoma spp. and Leishmania spp. has been reported (reviewed in (Bero et al., 2014). In 
another study a reduction in the cytogenetic damage caused by schistosomiasis infection has 
been attributed to thymoquinone (Aboul-Ela, 2002). The anti-viral ability of N. sativa extracts 
have been tested more frequently than purified thymoquinone. The whole seed antiviral property 
was demonstrated against murine cytomegalovirus and hepatitis C virus in human and this 
property was attributed mainly to its immune modulation ability (reviewed in (Forouzanfar et al., 
2014).  In vitro, purified thymoquinone could efficiently inhibit the survival of Epstein-Barr 
virus (EBV) infected B cells and altered EBV gene expression (Zihlif et al., 2013).  
 
 Thymoquinone’s antifungal property has been reported for dermatophyte molds (Aljabre et al., 
2005), Aspergillus niger (Al-Qurashi et al., 2007) and Candida albicans (Abdel Azeiz et al., 
2013). Aqueous and oil extracts of Nigella sativa have been found to inhibit the growth of C. 
albicans (Bhuvan et al., 2010, Bita et al., 2012), C. parapsilosis, C. tropicalis, Aspergillus spp., 
Cryptococcus spp. and Issatchenkia orientalis (Bhuvan et al., 2010). Thymoquinone was found 
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to be effective also against dairy spoilage yeast which has been suggested as useful for the dairy 
industry as a chemical preservative of natural origin (Halamova et al., 2010). Other yeast 
including C. glabrata and C. krusei have been not tested for their susceptibility to TQ. 
 
In contrast to the amount of data which has been reported for thymoquinone antitumor mode of 
action, there are few reports on the antimicrobial mode of action of TQ. An investigation into 
thymoquinone’s mode of action as an antifungal compound will be a major focus of the current 
study. 
 
 
1.3 Rational and scope of this study 
 
Candida glabrata causes life threatening disseminated candidiasis mainly in immunodeficient 
individuals. Given thymoquinone’s broad pharmaceutical profile, it is likely that thymoquinone 
can inhibit Candida glabrata growth and acts on one or more fundamental metabolic functions. 
As thymoquinone may act as immunostimulator, have anticancer activities and be a 
chemoprotective, it would be useful if it also simultaneously prevents Candida infection in those 
more susceptible to fungal infections. In addition, therapeutic options available to treat fungal 
infections are limited compared with antibacterials. Some antifungal treatments can trigger 
adverse side-effects because of the close biological similarity between fungal and mammalian 
cells. Furthermore, the emerging resistance of C. glabrata to antifungals further limits the 
available options (Román et al., 2007). Chapter 2 investigates the antifungal properties of 
thymoquinone towards different Candida species with more focus on C. glabrata planktonic 
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cells and biofilms. Chapter 2 also aims to optimise an in vitro model to stabilise C. glabrata 
biofilms and test their sensitivity to thymoquinone. 
 
Studying thymoquinone molecular targets in the context of drug-pathogen interactions may assist 
with anti-fungal therapy and drug development. Yet relatively little is known about TQ effects 
on the cellular level of fungi. Chapter 3 aims to report the effects that occur at the cellular level 
of C. glabrata with regards to oxidative status.  
 
Previous studies on Saccharomyces cerevisiae have demonstrated regulation of oxidative stress 
response through Slt2p activation (a component of cell wall integrity (CWI) MAPK) (Krasley et 
al., 2006a, Vilella et al., 2005). In C. glabrata activation of Slt2p is proposed in Chapter 4 as a 
response to oxidative stress and a hypothesis is investigated. An important question to address in 
this thesis is if TQ causes activation of CWI MAPK, does chemical inhibition of this signalling 
pathway increase the efficacy of TQ? 
 
Finally Chapter 5 further investigates this hypothesis by utilizing mutant strains of C. glabrata to 
highlight interactions between the C. glabrata cell wall and thymoquinone. 
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CHAPTER 2:  
Antifungal effect of thymoquinone against Candida spp. planktonic cells and 
C. glabrata biofilms 
 
 
2.1 Introduction 
Candida spp. are the third leading cause of infection resulting in catheter-related mortality after 
Staphylococcus aureus and coagulase-negative staphylococci (Bouza et al., 2014). 
Thymoquinone (TQ) has been shown to exert antifungal properties (Abdel Azeiz et al., 2013, Al-
Qurashi et al., 2007, Bhuvan et al., 2010, Bita et al., 2012); however C. glabrata and other 
Candida species such as C. krusei have not been tested for their sensitivity to TQ. Antifungals 
such as azoles and echinocandins have been used safely against many Candida infections, 
unfortunately C. glabrata more rapidly develops resistance to these antifungal agents than other 
Candida species (Alexander et al., 2013, Chen et al., 2015, Pfaller et al., 2012, Posteraro et al., 
2006).  Therefore, development of new effective, affordable and safe antifungal agents is 
required. Thymoquinone might be an option to develop such an antifungal drug. 
Candidiasis which is caused most frequently by C. albicans, and to a lesser extent by C. 
glabrata, C. tropicalis, or C. parapsilosis is often associated with the formation of  a biofilm 
extracellular matrix. Candida glabrata cells are able to adhere, surround themselves by an 
external matrix and establish biofilms on surfaces of medical devices such as central venous and 
urinary catheters (Nett et al., 2007a, Toulet et al., 2012, Mohammadi et al., 2012). The major 
clinical relevance of Candida biofilms is their elevated antifungal resistance compared to their 
planktonic counterparts (Seneviratne et al., 2008b).  In addition, adhesion and dispersion of cells 
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from biofilms are an important part of the biofilm developmental cycle which is associated with 
disseminated invasive diseases such as candidemia (Uppuluri et al., 2010a, Braga et al., 2008). 
In vitro antimicrobial susceptibility broth dilution standard assays such as CLSI (Clinical and 
Laboratory Standards Institute) and EUCAST (The European Committee on Antimicrobial 
Susceptibility Testing) are methods developed for testing the susceptibility of planktonic cells 
rather than the biofilm form.  In published studies, different groups showed significantly 
different results for biofilms antifungal susceptibility. Despite using the same strain, the variation 
was present because of different biofilm formation models and different viability measuring 
assays (Maiolo et al., 2014, Ramage et al., 2001). Therefore there is effort by the researchers to 
standardise models to test the susceptibility of biofilms to antimicrobial agents. 
Several in vitro models have demonstrated the impact of different nutrients and surface materials 
(in flow or static conditions) on adhesion and biofilm properties of several Candida species.  
These models include a 96-well polystyrene plate, as well as discs of catheters made from 
different substrates in 6- or 24-well plates and the Calgary Biofilm Device (CBD) (Tournu et al., 
2012, Ceri et al., 2001b).  Many of them have been assembled from readily available laboratory 
materials and showed good reproducibility (Uppuluri et al., 2010b).  The CBD is one of the most 
widely used methods for testing the susceptibility of microbial biofilm to antibiotics and toxic 
compounds (Coenye et al., 2011).  It consists of two parts: a plastic lid with 96 polystyrene pegs, 
which sits in the wells of a standard 96-well plate (MBEC Assay System, Innovotech, Canada 
(Harrison et al., 2006)).  The CBD, shown in Figure 2.1, facilitates the production of 96 biofilms 
grown on pegs.  These biofilms are used in standard experiments for biofilm susceptibility and 
minimum biofilm eradication concentration (MBEC) assays after exposure to toxic chemicals 
(Ceri et al., 2001a).  
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Figure 2.1 Calgary Biofilm Device (CBD) 
Innovotech website <http://www.innovotech.ca/products_mbec.php>, viewed on 17
th
 August 
2015 
 
Following formation of the biofilm, quantification is the critical step to obtain data on the effect 
of different treatments on the biofilms. These are based on the quantitation of matrix and both 
living and dead cells. Qualitative data can be obtained by using crystal violet staining which 
binds to negatively charged surface molecules and polysaccharides in the extracellular matrix. 
Qualitative data also can be obtained using fluorescent dyes such as syto9, which binds to DNA 
and carbohydrate-specific dyes (e.g., calcofluor and concanavalin A, Con-A) (Braga et al., 2008, 
Chandra et al., 2001). Imaging by scanning electron microscopy and measuring the dry weight of 
the biomass have also been used to estimate biofilm growth and the architecture (Silva et al., 
2009). 
Quantitation of viable yeast cells in biofilms can be determined by utilization of several dyes 
such as fluorescein diacetate and tetrazolium salts. This salt is hydrolyzed by the intra- and 
extracellular esterases of living cells to free fluorescein which exhibits a strong absorbance at 
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490 nm as well as an intense fluorescence. The tetrazolium salt XTT [2,3-bis (2-methoxy-4-
nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide is reduced inside 
cells to a water-soluble formazan (da Silva et al., 2008). Another tetrazolium salt is 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) which is colorimetrically 
determined in the cell supernatant (Schillaci et al., 2008). In addition, counting of colonies has 
been used to count viable cells in biofilms after detachment using sonication and (or) vortex 
(Coenye et al, 2011; Honraet et al., 2005; Hawser, 1994; (Honraet et al., 2005, Hawser et al., 
1994).  
The last stage of testing biofilms susceptibility is the presentation of data. The terms used to 
present biofilm susceptibility data differ from those used for planktonic cells. If  minimum 
inhibitory concentration (MIC) is defined as the concentration that is required to prevent 
establisment of biofilms, this is equal to that of planktonic cells. Therefore, biofilm inhibitory 
concentration was defined as the minimum concentration of antimicrobials that inhibits shedding 
of planktonic cells rather than inhibiting microbial growth within biofilms (Ceri et al., 1999, Qu 
et al., 2010). The shedding can be measured by using CBD assay via counting the number of the 
cells which sediment at the bottom of the microwells (Ceri et al., 1999, Qu et al., 2010). In terms 
of clinical response, killing of microbial cells is the most meaningful. When targeting biofilms 
the minimal biofilm eradication concentration (MBEC) is defined as a reduction in biofilm 
growth by 99.9% which is empirically achievable in vitro but not in vivo as biofilms contains 
recalcitrant cells. These cells might resume multiplication when the level of antimicrobials drops 
in immunodeficient patients (reviewed by Qu, 2010). 
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When yeast cells are exposed to harsh conditions and cellular defence mechanisms fail, cells die 
by undergoing apoptosis or necrosis. Apoptosis features including autophagy, phosphatidylserine 
externalization, DNA condensation and  caspase-like processing were observed in yeast  (Madeo 
et al., 2002). Thus apoptotic death is accepted to occur in yeast (Büttner et al., 2006, Eisenberg et 
al., 2007). Apoptosis has been defined as programmed cell death, which is an organized energy 
dependent process, where the intracellular content (such as DNA) undergoes ordered 
degradation, exposure or secretion of diverse factors promotes phagocytic cell elimination and 
the plasma membrane integrity is maintained. An apoptotic ‘dead cell’ will finally suffer from a 
decline in metabolism which necessarily causes the breakdown of plasma membrane integrity 
and thus necrotic morphology. This phenomenon is defined as ‘secondary necrosis’. 
Alternatively, yeast cells can undergo necrosis, a cell death pathway which has been 
conveniently dismissed as uncoordinated and accidental death (Eisenberg et al., 2007). Necrosis 
(primary necrosis) is defined as the characterization of cells that die as a result of injury or 
typically swell and burst, consequently releasing their contents (Eisenberg et al., 2010, Kroemer 
et al., 1998). Activation of caspases (cysteine aspartate-specific proteases) has been connected 
with apoptotic death in mammalian cells. In yeast, since the open reading frame YOR197 was 
desribed as caspase-like protein, there were attempts to characterise the activity of this ORF. A 
detailed analysis of the proteolytic activities of YOR197p was demonstrated by Madeo et al., 
(2002) and proposed its function as a metacaspase like protein in S. cerevisiae when it was 
treated with H2O2 (Madeo et al., 2002). YOR197 has been named as a metacaspase 1 (MCA1) 
(http://www.yeastgenome.org) or as it is called by Madeo et al. (2002) yeast caspase 1 (YCA1) 
(reviewed in (Váchová et al., 2007, Madeo et al., 2002). Like mammalian caspases, caspase–like 
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proteins in yeast (YCA1) were shown to undergo cleavage to activate their proteolytic activity 
toward several synthetic caspase substrates (Madeo et al., 2002).  
 
The investigations of this chapter cover: 
(i) Evaluation of the in vitro activity of thymoquinone against planktonic cells of different 
Candida sp. in comparision to their susceptibility to fluconazole. 
(ii) Determination of thymoquinone’s Minimum Fungicidal Concentration (MFC) by broth 
assay and monitoring the killing kinetic in C. glabrata.  
(iii) Establishment of a biofilm model of C. glabrata to test its susceptibility to 
thymoquinone. 
(iv) Testing the efficacy of thymoquinone in the form of nanoparticles. 
(v) Obtaining data on the death mode in C. glabrata which might be caused by TQ. 
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2.2  Materials and methods 
2.2.1  Yeast strains and media 
The yeast strains employed in these studies are listed in Table 2.1. Candida krusei 6832 was used 
as a reference strain according to CLSI standards (CLSI document M27-A3, 2008). Candida 
albicans ATCC14053 and Candida glabrata clinical isolates (A2a2, A5d7, A6c7) were kindly 
provided by Dr. Danilla Grando (RMIT University).  The C. glabrata strains were obtained from 
women infected with vaginal candidiasis (Watson et al., 2013). These strains were characterised 
using CHROMagar plates (Thermo Fisher, Adelaide, Australia) and their identity confirmed 
using API ID 32 C™ (bioMerieux, Lyon, France). 
Strains were maintained and grown on YEPD agar medium. The test medium used for the 
minimum inhibitory concentration assay was RPMI1640 containing L-glutamine, but lacking 
sodium bicarbonate (Invitrogen), buffered to pH 7.0 with 0.165 M MOPS (Sigma) (for media 
preparation see appendix A). 
 
2.2.2   Determination of TQ and fluconazole minimum inhibitory concentration 
The in vitro antifungal activities of fluconazole (FL) and thymoquinone (TQ) were performed in 
accordance with Clinical and Laboratory Standards Institute guidelines (CLSI M27-A3, 2008), 
using a broth microdilution method. Minimum inhibitory concentration (MIC) values were 
determined in 96 well flat-bottomed plates by measuring the optical density (OD600) of Candida 
cultures in RPMI1640. The inocula were prepared from overnight Candida cultures grown on 
YEPD agar plates. Candida cell suspensions were prepared in sterilized MilliQ water at ~ 106 
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CFU/ml and diluted 1:50 followed by 1:20 dilution in RPMI1640 to give a final inoculum of 
5x10
2 
- 2.5x10
3 
CFU/ml. Because of the crusty nature of C. krusei 6832, before adjusting the 
turbidity, colonies were further broken up in a drop of sterile water using a sterilized inoculation 
loop on the surface of the agar plate and then suspended in sterile water. Thymoquinone and 
fluconazole (FL) stocks were prepared in DMSO according to the manufacturer’s 
recommendations. The stocks were diluted in RPMI1640 medium to achieve a final 
concentration of 1 % DMSO. The solvent control wells contained inoculum suspension in 1, 2 
and 3 % DMSO in medium to prove that solvent had no inhibitory effect on the investigated 
Candida at the applied concentration.  Thymoquinone stocks of 20 mg/ml were diluted 1:10 and 
a further 1:2.5 in RPMI1640 before adding in equal volume to RPMI1640 in the wells. MIC tests 
were set up in a total volume of 0.2 ml/well with 2-fold dilutions of FL or TQ. 
 
The final concentration of TQ and fluconazole in the wells was 6.5-200 µg/ml, and 0.125-64 
µg/ml respectively. The 96 well plates were incubated for 24 to 48 h at 35 °C in the dark, and the 
absorbance (OD600) was measured with a POLARstar Omega Microplate Reader (BMG Labtech, 
Australia). Uninoculated medium was used as the background for the spectrophotometric 
calibration for each drug concentration; the growth control wells contained inoculum suspended 
in the drug-free medium were set as 100% growth. The MIC was defined as the lowest 
concentration of drugs that totally inhibited growth. All experiments were repeated at least three 
times with three replicates each time. 
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Table 2.1 Strains used in this study 
Candida Strain Source or reference 
C. glabrata ATCC 90030  ATCC90030 
C. glabrata CBS138 (or ATCC2001) ATCC2001 
C. glabrata (clinical isolate ) A5d7  (Watson et al., 2013) 
C. glabrata (clinical isolate) A6c7  (Watson et al., 2013) 
C. glabrata (clinical isolate) A2a2  (Watson et al., 2013) 
C. albicans ATCC14053  Danilla Grando (RMIT University) 
C. albicans WM1172  Helen Williams (RMIT University) 
C. krusei ATCC6832 Helen Williams (RMIT University) 
C. dubliniensis  Helen Williams (RMIT University) 
 
 
2.2.3  Testing of thymoquinone fungicidal activity   
After MIC determination, the fungicidal kinetics of TQ were determined for C. glabrata ATCC 
90030 planktonic cells from three wells in flat bottom 96 well plates by a conventional culture-
based method. The protocol followed Pfaller and colleagues (2004b) review. Plates were 
prepared as previously described for MIC determination except the inoculum preparation. To 
prepare inocula, cells from overnight C. glabrata cultures grown on YEPD agar plates were 
suspended in sterilized MilliQ water to reach an OD600 of 1 (approximately equal to 10
7
 
CFU/ml), then diluted 1:50 and 1:2 respectively. Suspensions were then added to an equal 
volume of media or media with different concentrations of TQ. At each time point 10 µl were 
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collected and diluted 1:10 in RPMI1640.  A volume of 100 µl was spread on YEPD agar plates. 
Plates were incubated for 48 h at 37°C and fungicidal activity was defined as 3-log10-unit 
reduction in CFU/ml from the starting inoculum (Klepser et al., 1998, Cantón et al., 2004). 
 
2.2.4 Biofilm establishment 
2.2.4.1  Microwell plates 
C. glabrata isolates and C. albicans ATCC14053 were examined visually for their adherence 
ability to polystyrene surface using 96 or 6 well plates (Nunc, for cell culture). Cell suspensions 
of OD600= 1 were prepared from overnight plates. The wells were filled with these suspensions 
until their surface were covered (about 1/ 4 of the well volume) and incubated at 30 - 35 ºC. The 
ability of these cells to adhere was checked after 1, 2 and 4 h. Shaking was stopped once a 
monolayer of cells was observed, then the plates were incubated overnight at 35 ºC.  
Siliconized glass cover slips were also used to visually examine the adhesion ability of these 
isolates. Slides were sterilised by submerging them in ethanol and passing them on flame. One 
sterilised slide was placed in each well and then were merged with cell suspension (OD600 = 1). 
Testing media were including YEPD, YMM or RPMI1640 (appendix A).  
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2.2.4.2  Polypropylene biofilm reactor  
  
2.2.4.2.1  Reactor assembly 
The reactor was assembled manually using commercially available laboratory materials.  The 96 
well plate that is used in the CBD was replaced with a pipette tip box and the pegs of the CBD 
were replaced with microcentrifuge tubes. In detail, the reactor consisted of a two-part reaction 
vessel (Fig. 2.2A) which was a recycled empty 200 µl pipette tip box (Barrier) which can 
accommodate 96 capped microcentrifuge tubes (400 µl, 7 mm x 47 mm).  These parts are made 
from polypropylene (PP) and can be autoclaved.  The box is divided internally into nine 
compartments (6 large compartments (105 cm
3
) and 3 small ones (23.8 cm
3
) Fig. 2.2B), allowing 
for nine simultaneous separate treatments.  The surface pipette tip locator plate was modified by 
enlarging the holes by drilling with an 8 mm drill bit.  This enabled enough space around the 
microcentrifuge tubes so that they could be inserted and removed without contacting the surface 
of the tubes.  The tubes were stabilised in their positions by the addition of tape on the top 5 mm 
of the tube (Fig. 2.10).  The box with added tubes was autoclaved before use.  In addition, empty 
tip boxes were also autoclaved for use in second growth rounds if it was needed (see  2.2.4.2.2). 
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Figure 2.2  Polypropylene Biofilm reactor mimicking CBD consists of a 200 µl pipette tips box and 0.4 
ml PP microcentrifuge tubes. (A)  The complete reactor with PP tubes.  A, B and numbers indicate the 
compartments and rows which were used for Fig. 2.9. (B) The tip rack without tip locator showing the 
separate compartments, indicates large compartments (*) and small compartments (**).  A & B indicate 
the compartments that were used for Fig. 2.9.  
  (A) 
(B) 
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2.2.4.2.2   Biofilm establishment  
An inoculum of approximately 10
7
 CFU/ml (OD600 = 1) was prepared by obtaining a cell 
suspension in YEPD liquid medium. The cells were picked from colonies grew overnight on 
solidified YEPD media.  The large compartments of the box were filled with 8 ml of the cell 
suspension by aseptically lifting the tip locator plate complete with tubes or by pipetting directly 
through an empty tip locator plate opening (all small compartments and the big compartments at 
the middle raw were not used in this step).  The height of medium in each compartment was 
about 1.5 cm which is approximately one third of the compartment depth. The complete biofilm 
reactor with culture was then incubated at 35 °C with shaking at 220 rpm on a rotary shaker for 2 
h (adhesion phase) and then left for ~30 min to sediment planktonic cells.  The shaking during 
incubation caused fluid flow around the tubes, generating shear forces across all tubes and 
allowing cells to either stay in suspension or attach to tubes.  One tube was lifted from the 
reactor and the surface of the tube was observed using a Leica DM2500 microscope and 
photographed with a Leica DFC310 FX camera to visualise the established monolayer.   
A second growth cycle was performed in fresh YEPD to form mature biofilms.  Briefly, the 
clean sterile compartments of the PP device were filled with YEPD liquid media, 12 to 15 ml for 
small compartments, 18 ml in the case of larger compartments.  The medium volume depends on 
the desired amount of biofilm that is wanted to be produced.  The most important issue is the 
similarity in the height of the media in the compartments.  Thus equal areas of the PP tubes are 
covered, leading to equal surface area of biofilm.  Tubes with established biofilms (2 h) were 
transferred (by holding them by their caps using sterile forceps) to the new reactor with fresh 
YEPD.  The box was covered by its lid and incubated at 35 °C for 24 h.  All these steps were 
performed aseptically. 
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2.2.4.3  Enumeration of CFU in biofilms and testing PP reactor reproducibility 
Cells were removed from the surface of the tubes by a 30 sec vortex in 3 ml sterile MilliQ water 
or PBS in a 15 ml centrifuge tube (Buck et al., 1999).  Viable cell numbers (CFUs) were 
determined by subculture after measuring turbidity of the resulting suspension using a 
spectrophotometer (Eppendorf).  CFU/ml was calculated for the bulk solution which was 3 ml of 
MilliQ water.  Efficiency of detachment of cells after vortexing was checked by choosing three 
PP tubes and repeating a further wash and vortexing followed by colony counting. To determine 
the reproducibility of assays, each test was repeated three times in independent experiments. 
 
2.2.4.4 Viewing attached cells by Environmental Scanning Electron Microscopy (ESEM)   
The PP tubes incubated in the tip box (24 h) were washed in MilliQ water to remove media.  
Washing was performed by dipping the PP tube in and out of 8 ml of sterile MilliQ water in a 10 
ml centrifuge tube.  The tubes were then immersed in 4 % formaldehyde and stored at 4 °C.  For 
ESEM, tubes were dried at room temperature and then visualized using a SEM (RMIT facility, 
FEI Quanta 200 ESEM (2002)) in low vacuum mode at 10 kV.  
 
2.2.5 Testing TQ toxicity against C. glabrata biofilm  
Preliminary testing showed that the C. glabrata A2a2 strain showed a better ability to form 
biofilms than other strains. This strain was used to test the biofilm inhibitory effects of TQ. 
Biofilms were grown in the polypropylene reactor which included 0.4 ml polypropylene 
microcentrifuge (PP) tubes in pipette tip box (section 2.2.4; Almshawit et al, 2014a). Briefly, the 
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big compartments in the reactor were each filled with 8 ml of A2a2 cell suspension in YEPD 
(OD600 = 1) incubated at 35°C with shaking (220 rpm) for 2 h (adhesion phase). Boxes were left 
to rest for approximately 30 min to sediment planktonic cells, then PP tubes were transferred to 
sterile small compartments in the same reactor or a new reactor was used for treatment with TQ. 
The small compartments were filled with 15.5 ml RPMI1640 medium (same medium that was 
used in 2.2.2) containing different concentrations of TQ. The medium was warmed to 45 °C in a 
water bath to dissolve the high concentrations of TQ. The established biofilms, which had 
adhered to PP tubes, were transferred to TQ filled compartments and incubated for a further 24 h 
at 35 °C without shaking. These biofilms were considered as established immature biofilms. 
Mature biofilms were tubes with established biofilms (2 h old biofilm) transferred to new YEPD 
media (18 ml) in a new big compartment in the reactor and incubated without shaking at 35 °C 
for 24 h. The mature biofilms were then treated with TQ as described for the established 
biofilms. These steps are summarised in figure 2.3. The number of viable cells was determined 
by transferring each PP tube to a 15 ml centrifuge tube containing 3 ml of phosphate buffered 
saline (PBS buffer) followed by detachment of the cells by vortexing for 30 sec. Cell suspensions 
were spotted, dried partly and spread on YEPD plates after dilution.  
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Figure 2.3 Diagram summarising steps of C. glabrata biofilm establishment in PP reactor and 
treating them with TQ. Stars indicate the location of PP tubes. 
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2.2.6 Susceptibility of C. glabrata to Protein-polymer TQ nanoparticles 
Thymoquinone nanoparticles were kindly provided by Vishal Mistry (RMIT University) and 
were stored at 37 ºC in the dark. The stocks provided had a concentration of ~ 333 µM (~ 55 
µg/ml) and diluted using 2x RPMI1640 medium. Examination of C. glabrata sensitivity to TQ 
was performed according to CLSI standard method (2008) as described in 2.2.2. 
 
2.2.7   In vivo staining of caspase activity and membrane integrity 
Staining of caspase activity in vivo was analysed by using FITC-VAD-fmk (fluorescein-5-
isothiocyanate-VAD-fluoromethylketone; CaspACE, Promega) which has been used before to 
label YCA1 in S. cerevisiae (Madeo et al., 2002). Cell membrane integrity was tested by staining 
cells with propidium iodide (Sigma Aldrich). Caspase activation and cell intact was labelled 
following previous described protocol (Madeo, et al., 2002, Wysocki & Kron, 2004) except a 
modification in the concentration of PI staining which is lower in this study. Briefly, about 10
6
 
cell/ml of C. glabrata ATCC2001 from an exponential phase culture (4 h old) in YEPD were 
treated with 25 and 50 µg/ml of TQ for 0.5, 1 and 4 h, harvested, washed once in 1 ml PBS and 
resuspended in 200µl staining solution containing 10µM FITC-VAD-fmk (CaspACE, Promega). 
After incubation for 20 min at 30°C, cells were washed in 1 ml PBS.  Then cells were suspended 
in 500 µl PBS contains 2 µg/ml (PI) and incubated 15 min at 30 °C. After that cells were 
harvested, washed and resuspended in 500 µl PBS. Fluorophore emission was analysed by a BD 
FACs Diva flow cytometer using FITC (494/519-nm excitation /emission) and PE-Cy5-A 
(482/695 nm excitation/ emission) filters. 
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2.2.8  Cell cycle analysis 
The cell cycle of cells that were treated with TQ was analysed by flow cytometry. The main aim 
of analysing the cell cycle is observing cells that contain degraded DNA. DAPI (4′,6-diamidino-
2-phenylindole dihydrochloride; Sigma) was used for DNA staining. Candida glabrata cells 
from exponential phase culture (4 h old) were washed and suspended in RPMI1640 to the 
density of 10
6 
cell /ml. Suspensions were treated with TQ for  4 or 24 h. Cultures with 0, 25, 50 
and 100 µg/ml TQ in RPMI1640 were harvested by centrifugation at 5890 g for 1 min, washed 
with PBS then fixed and permeabilized with 70 % cold ethanol on ice for 5 min. Pellets were 
resuspended in PBS at room temperature for another 5 min and then cells were harvested and 
stained with 3 µM DAPI and incubated for 15 min in room temperature in the dark (Li et al., 
2006; Liang & Zhou, 2007). Cells were analysed by flow cytometry using a pacific blue filter 
(351/450-65 nm excitation/emission). 
 
2.2.9  Data analysis 
GraphPad Prism 6 was used to analyse the data statistically.  A one way analysis of variance 
(ANOVA) test combined with Tukey's multiple comparisons test and e-test were used. A  p 
value of < 0.05 was considered significant. Flow cytometer data were analysed by Flowing 
software which was created by Perttu Terho (Cell Imaging core, Turku Centre for 
Biotechnology, Finland). 
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2.3  Results  
2.3.1 Thymoquinone inhibits Candida glabrata growth 
Exposure of different Candida sp. to TQ resulted in inhibition of growth in a concentration- 
dependent manner. The NCCLS subcommittee suggest that determination of  MIC at 100% or 
complete growth inhibition could more reliably detect azole resistance (Espinel-Ingroff et al., 
2001). Therefore, the values depicted in Table 2.2 were obtained by using the 100% inhibition 
criterion of MIC compared to the growth in the control to avoid bias. The clinical isolate C. 
glabrata A2a2 showed high resistance to fluconazole and needed a higher TQ concentration to 
inhibit its growth. The MICs of fluconazole for Candida sp. in this study range from 0.125 to > 
64 µg/ml. The MICs of TQ ranged between 25 to 50 µg/ml for most strains except C. glabrata 
A2a2 which was fluconazole resistant (MICTQ=100 µg/ml, MICFL> 64 µg/ml). The effect of 
fluconazole on other C. glabrata clinical isolates (A5d7 and A6c7) was intermediate (8-16 and 
32 µg/ml) and 50 µg/ml of TQ inhibited their growth. However, C. glabrata ATCC2001 and 
ATCC90030 strains had a lower MIC to TQ (25 µg/ml). Candida krusei 6832 and C. glabrata 
A2a2 exhibit slow growth rates, therefore they were incubated for longer than 24 h before the 
readings were performed. In conclusion, the effect of both drugs on C. glabrata strains was strain 
dependent; however TQ inhibited growth in a narrow concentration range of 25 to 100 µg/ml.  
 
2.3.2  Thymoquinone time-kill curve study 
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The killing activity of TQ for C. glabrata ATCC 90030 (mean and SEM) is presented in Fig. 2.4.  
A reduction of 3 log10 units (99.9%) in CFU/ml from the starting inoculum was used to define 
the fungicidal activity of TQ (Qu et al., 2010). The fungicidal activity of 100 µg/ml TQ occurred 
within 2 h and caused a greater than 3 log10 units reduction. A reduction of 3 log10 was achieved 
by 50 µg/ml of TQ within 6 h. The MIC concentration (25 µg/ml) correlated with the extent of 
growth inhibition but did not achieve a significant reduction in the viability. Treatment at the 
MIC caused a gradual decrease in the colony number at the beginning of the experiment; 
however, after 24 h, there was evidence that survivors in the population grew. Since the cell 
number of the inoculum in the MIC assay differed from the fungicidal assay, an experiment was 
conducted using C. glabrata ATCC90030 to roughly estimate the relationship between TQ 
toxicity and cell number in RPMI1640. Figure 2.5 shows a decrease in TQ inhibition of growth 
with increasing cell number. The MIC (25 µg/ml) of TQ inhibited the growth of 10
3
 cells/ml and 
was sub-inhibitory for cell concentrations >10
4
 cells/ml. 
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Candida Strain MIC (µg/ml) 
Thymoquinone Fluconazole 
C. glabrata ATCC 90030  25 16 
C. glabrata CBS138 (or ATCC2001) 25 4 
C. glabrata (clinical isolate ) A5d7  05 8-16 
C. glabrata (clinical isolate) A6c7  05 32 
C. glabrata (clinical isolate) A2a2*  100 >64 
C. albicans ATCC14053  50 0.25 
C. albicans WM1172  50 1 
C. krusei ATCC6832**  25 32-64 
C. dubliniensis  25 0.125-0.25 
 
Table  2.2  Minimum inhibitory concentration of thymoquinone and fluconazole. The values 
represent MIC100 of three replicates after 24 h and each experiment was performed at least three 
times independently. * after 2 d, ** after 3 d. 
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Figure 2.4  In vitro kinetics of fungicidal activity of thymoquinone against C. glabrata.   
C. glabrata ATCC 90030 cells were treated with TQ in a 96 well plate at concentrations ranging 
from 25-200 µg/ml. Viable cells were determined by plating aliquots at each time point to 
measure CFU/ml. All incubations were at 35 ºC. This experiment was performed three times 
independently. The mean of three independent replicates was shown with the standard error of 
the mean (SEM).  
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Figure 2.5 Population densities versus concentrations of TQ. Suspensions of C. glabrata 
ATCC90030 in RPMI1640 were prepared from an overnight plate and incubated for 24 h at 
35°C with shaking. The initial optical density of 10
6
 cell/ml culture at time zero was equal to 0.1. 
Error bars indicate the mean and SEM of three replicates. 
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2.3.3 Biofilm formation and reproducibility  
Adherence of C. glabrata strains and C. albicans on polystyrene in 96 well plates (Nunc, for cell 
culture) and 6 well plates was examined using different media including YEPD, YMM and 
RPMI1640 media. The cells were not able to attach except for A2a2 strain cells. This strain 
could form a thin visible biofilm layer after shaking for 2 h (Fig. 2.6 A) and formed white thick 
layer after static overnight incubation (Fig. 2.6 B). In contrast, C. glabrata ATCC2001, 
ATCC90030, A6c7, A5d7 and C. albicans ATCC14053 did not form any observable adherence 
after 2 h or overnight incubation (Fig. 2.6 B). However, a gentle washing procedure which 
included pipetting off the medium and pipetting in PBS caused a notable destruction in biofilm 
architecture. Figure 2.7 reveals the effect of the first steps of washing on biofilm topography 
with or without TQ treatment.  Candida glabrata ATCC2001 was able to form a fine biofilm 
layer while A2a2 formed a thicker white biofilm layer on the surface of siliconized glass cover 
slips which were located in a 6 well plate. Again these biofilms slipped and were easily 
destroyed once they were washed gently with PBS (data not shown). Candida glabrata A2a2 
cells were able to adhere to the internal wall surface of 50 ml polypropylene centrifuge tubes 
(Sigma-Aldrich) when they were incubated at 30 ºC or 35 ºC with shaking. Therefore the surface 
of polypropylene microcentrifuge tubes (PP tubes (Fig. 2.10)) was the preferred option for 
establishing C. glabrata biofilms.  
 
 
 
Chapter2 
- 52 - 
  
 
(A) 
    
 
(B) 
 
 
Figure 2.6  Adhesion of C. glabrata isolates and C. albicans ATCC14053 to polystyrene. (A) 
Two micro-wells show the visual observation of monolayer formation by C. glabrata A2a2 after 
shaking for 2 h using YEPD medium, (B) Candida spp. suspensions in YEPD (OD600 = 1) were 
incubated at 35°C with shaking (220 rpm) for 2 h followed with overnight static incubation. 
Polystyrene 6 well cell culture plates were used. C. glabrata isolates (wells with white labels) 
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did not show adhesion to the bottom of the well except for A2a2 strain which formed a white 
biofilm layer. 
 
 
 
 
(A) 
 
 
 
 
 
(B) 
 
 
 
 
 
(C) 
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Figure 2.7  Effect of washing process on C. glabrata A2a2 biofilms architecture. The biofilms were 
established in 6 well plate  (A) Biofilms before washing  (B) Biofilms after pipetting off medium (C) 
biofilms after pipetting in PBS solution. The three wells in the upper row were not treated with TQ. Wells 
in the lower row from right to left were treated with 50, 100 and 200 µg/ml of TQ.  
Adhesion of C. glabrata cells on the surface of PP tubes after 2 h was observed by light 
microscopy (Fig. 2.8).  The clinical isolate A2a2 had more apparent adhesion than the two 
ATCC strains after 2 h incubation.  Figure 2.9 shows a comparison between cell numbers in 
biofilms that were formed after 24 h on different PP tubes in two different compartments, and 
between different rows of one compartment.  The results show reproducibility of cell counts in 
different compartments with means of 2.5 x 10
7
 and 2.2 x 10
7 
CFU/ml for compartment A and B 
respectively and for counts between rows of a single compartment (P > 0.05, Fig. 2.9 A & B). 
Counting cells from biofilms by vortex disruption has been used in a previous study (Buck et al., 
1999). The efficiency of removing the attached cells by vortexing was checked by repeating a 
further wash and vortexing. The mean cell number after the first wash and vortexing was 2 x 10
7 
CFU/ml whereas after further washing and vortexing was 0.9 x 10
4
 CFU/ml. This means less 
than 0.1% of the original CFU/ml was obtained through this extra wash.  
 
The ability of A2a2 strain to produce biofilm was compared with the control strains (ATCC2001 
(also known as CBS138) and ATCC90030) by counting colonies.  Table 2.3 compares the mean, 
standard error of the mean, P-value, maximum and minimum counts found between biofilms of 
these strains in the same conditions.  The cell concentrations after detachment from biofilms 
were 2.3 x 10
7
, 5.8 x 10
5
 and 1.1 x 10
5
 CFU/ml for C. glabrata strains A2a2, ATCC2001 and 
ATCC90030, respectively.  The variation between maximum and minimum counts for each 
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strain are comparable to those which were achieved by the CBD device (Ceri et al., 1999).  This 
indicates that the reproducibility of this reactor is comparable to the CBD device.  Figure 2.10 
demonstrates a visual difference in biofilm producing ability of the clinical and a control strain.  
A2a2 was able to build a thick white biofilm layer whereas the control strain tubes looked clear. 
This demonstrates that the PP reactor shows a difference between strong biofilm producing 
strains and weak or non-biofilm forming strains.  The experiment was repeated with RPMI 1640 
medium supplemented with 2% dextrose (Kucharikova et al., 2011), and coating the tubes with 
lysine to increase the positive charge on the PP tubes surface (Harrison et al., 2006) or by using 
foetal calf serum.  However, the attachment of C. glabrata ATCC2001 and 90030 could not be 
improved and the attachment of the clinical isolate was optimal when YEPD medium was used. 
 
 
 
  
 
 
 
(b) (a) 
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Figure 2.8  Establishment of biofilm by the isolates on the surface of PP microcentrifuge tubes 
after shaking for 2 h in media. (a) C. glabrata ATCC2001 scale bar = 35 µm (b) C. glabrata 
A2a2 scale bar = 70 µm. 
                       
                
(A) 
  (B) 
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Figure 2.9 Comparisons between biofilm formation of A2a2 strain at different sites in the PP 
reactor (A) difference in cell number between two big compartments (B) comparison between 
cell number between different rows in each compartment. ns - Insignificant difference (P > 
0.05), error bars represent the standard error of the mean (SEM).  
Table 2.3 The variation of colonization capability on four PP tubes surface by different C. 
glabrata strains after 24 h. Maximum, minimum counts and the calculation of Means and 
Standard deviations (SD) were based on log10 of CFU/ml per tube. 
 
C. glabrata 
strain 
Mean  SD  Maximum 
count  
Minimum count  P value 
A2a2  7.34 0.05 7.42 7.28 A2a2 vs ATCC2001 (P < 
0.01) 
ATCC2001 5.61 0.50 6.07 5.07 A2a2 vs ATCC 90030 (P 
< 0.0001) 
ATCC 90030 4.84 0.45 5.36 4.28 ATCC2001 vs ATCC 
90030 (P > 0.05) 
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Figure 2.10   Biofilms of C. glabrata ATCC2001 (left) and the clinical isolate C. glabrata A2a2 
(right).  PP microcentrifuge tubes after incubation for 24 h in the biofilm reactor.  The arrow 
indicates the tape which was used to stabilise the tube in the rack. 
2.3.4  Candida glabrata biofilm observed by scanning electron microscopy  
Scanning electron microscopy analysis was used to examine biofilm structure and to determine 
C. glabrata biofilm morphological characteristics. C. glabrata A2a2 (Fig. 2.11) showed a 
discontinuous monolayer of large blastospores in clusters adhering to the PP tube surface 
associated with an amount of extracellular polymeric substances matrix (EPS).  The collapsed 
appearance of the yeast could be due to the formaldehyde fixation.  
 
2.3.5  Thymoquinone fungicidal activity against C. glabrata biofilms 
Figure 2.12 shows the fungicidal activities of TQ against C. glabrata A2a2 biofilms. The effect 
was examined on established, pre-adhered biofilms (2 h biofilm) and mature biofilms (24 h old). 
The minimum TQ concentration which could successfully inhibit the growth of pre-adhered 
biofilms by 3 log10 CFU/ml in the biofilm was 1.25 mg/ml. This is fifty times higher than the 
MIC for planktonic cells. However, this concentration failed to reduce the viability effectively 
with mature biofilms (≤ 2 log10 CFU/ml). Higher concentrations could not be tested due to the 
low solubility of TQ in the media. 
 
2.3.6 Susceptibility of C. glabrata to TQ nanoparticles 
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Candida glabrata ATCC2001 was neither more sensitive nor more resistant to TQ protein 
polymer based nanoparticles compared with TQ.  The minimum inhibitory concentration of TQ 
protein polymer nanoparticle was approximately 24.6 µg/ml similarly the MIC of TQ was 25 
µg/ml. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.11  Scanning electron micrograph of C. glabrata clinical isolate (A2a2) biofilm formed on the 
biofilm reactor.  PP microcentrifuge tubes were removed from the device after 24h washed and fixed with 
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formaldehyde.  Note the discontinuous layer of large blastospores in clusters on the PP surface.  The inset 
at right corner on the top indicates the small amounts of extrapolymeric substances (white arrows). 
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Figure 2.12 Activities of different concentrations of thymoquinone (TQ) against C. glabrata A2a2 
biofilms. Lined bars show TQ activity against 2 h established biofilms under treatment with various 
concentrations of TQ.  White bars show activity of TQ against mature biofilm (24 h old biofilm) under 
treatment with different concentrations of TQ for 24 h. Results represent the means of two independent 
experiments with four replicates each time. Data analysed by using one way ANOVA combined with 
Sidak’s multi comparisons test, error bars indicate SEM values ( *** = p < 0.001, **** = p < 0.0001 
comparing with untreated control). 
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2.3.7  Thymoquinone induces FITC-VAD-FMK activation in dead cells  
Fluorescein-5-isothiocyanate-VAD-fluoromethylketone (FITC-VAD-FMK) has been widely 
used to detect caspase activation in aged yeast cells and cells treated with H2O2 (Herker et al., 
2004, Madeo et al., 2002, Qi et al., 2003). Exponentially growing C. glabrata cells were treated 
with 25 and 50 µg/ml of TQ for 0.5, 1, 4 and 24 h. Then activation of yeast caspsase-1 (YCA1) 
was detected using FITC-VAD-FMK combined with PI for cell membrane integrity analysis. 
This assay can help to distinguish the sequence of events leading to cell death. Labelling with 
FITC-VAD-FMK and PI can distinguish four distinct cell states: (a) live non-apoptotic cells 
(FITC-negative/PI-negative), (b) live cells with activated caspases/early apoptotic cells (FITC-
positive/PI-negative), (c) dead post-apoptotic cells (FITC-positive/PI-positive), and (d) dead 
necrotic cells (FITC-negative/PI-positive) (Madeo et al., 2002). The results in Fig. 2.13 
demonstrate that most of the cells which were FITC positive had lost their membrane integrity at 
the same time. Microscopic observations showed few of FITC positive / PI negative cells. 
However flow cytometric analysis did not show significant number of these cells. An 
interpretation of these data might be treated cells picked up caspase fluorophore as a result of 
death and not before death, indicative of necrotic death. These samples were analysed after 24 h 
as well and the same pattern was observed. 
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Figure 2.13 Monitoring of metacaspase1 activation and cell membrane integrity. (A) exponentially growing 
cells were treated with 50 µg/ml TQ for 5 h and observed by fluorescence microscopy after labelling with 
FITC-VAD-FMK and PI, white arrows indicate FITC positive and PI negative cells (B) Exponentially 
growing cells were treated with 25 or 50 µg/ml of TQ then analysed by flow cytometry after labelling with the 
same fluorophores; 10,000 cells were analysed for each sample. (N) cells did not emit any fluorescence; error 
bars represent the standard error of the mean (SEM) of two independent experiments. 
2.3.8 Thymoquinone treated cells did not exhibit DNA degradation 
It has been well documented that apoptotic cells show reduced DNA staining with a variety of 
fluorochromes, including PI and DAPI. A large portion of DNA in apoptotic cells is of low 
molecular weight due to activation of endogenous endonucleases which break the DNA linking 
the nucleosomes. These small fragments of DNA can leach out from ethanol-fixed 
(permeabilized) cells during rehydration and staining process. Consequently, flow cytometric 
analyses detect cells with lower staining intensity than those at G0/1 phase, a phase when live 
cells have their minimum content of non-fragmented DNA. These cells can be observed as a 
‘sub-G /1’ peak in a DNA histogram. In contrast, necrotic cells generally do not show an 
immediate reduction in DNA staining, and sub-G0/1 cannot be discriminated from a DNA 
histogram content analysis of live cells (Darzynkiewicz et al., 1992, 2010; Dive et al., 1992; 
Riccardi & Nicoletti, 2006; Calvert et al., 2008). Flow cytometry analysis of C. glabrata 
ATCC2001 cells which were treated with sub-inhibitory and inhibitory concentrations of TQ (25 
and 50 µg/ml) in figure 2.14 showed no events in the sub-G0/1 region after 4 h or 24 h treatment, 
which indicates an absence of apoptotic cells in the periods of analysis.  Equal numbers of cells 
from growth control and treated cells plus same the concentration of DAPI stain were used. An 
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artificial shift of the fluorescence intensity peaks may result from these factors (Haase & Reed, 
2002).   
 
 
Figure 2.14 Monitoring the cell cycle of TQ treated cells by using DAPI. (A) 4 h treatment, (B) 
24 h treatment. (1) Untreated cells without staining, (2) Stained untreated cells, (3) Stained cells 
treated with 25 µg/ml TQ and (4) Stained cells treated with 50 µg/ml. H-1 no fluorescent 
emission zone where sub G0/1 phase can be recorded, H-3 fluorescent emission zone. 
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2.4 Discussion  
2.4.1 Thymoquinone anti-Candida effect  
The results of the present study demonstrated the anti-Candida activity of the Nigella sativa 
compound thymoquinone.  The results show evidence of TQ antifungal activity against different 
Candida sp. including C. glabrata.  C. glabrata is an agent of human mycoses which is an 
important opportunistic fungal pathogen that causes minor infections in many individuals but 
very serious infections in those who are immuno-compromised. Considering that C. glabrata is 
able to develop resistance against most commercial antifungal agents and many antifungal drugs 
have unwelcome side effects (Laniado-Laborín et al., 2009), TQ might be a new option for 
treating Candida infections.  
Candida glabrata is known to have varying susceptibility to fluconazole (Pfaller et al., 2003, 
Bruder-Nascimento et al., 2010). The C. glabrata strains in table 2.2 showed high variability in 
their sensitivity to fluconazole (0.25 to > 64 µg/ml), but their susceptibility to TQ had a narrow 
range with MICs between 25 and 50 µg/ml in most cases.  This was true for the other Candida 
spp. as well, indicating that the MIC for many yeasts is around 25-50 µg/ml.  
The fungicidal effect which was determined over 24 h by using C. glabrata ATCC90030 showed 
an inhibitory effect of TQ rather than a strong fungicidal effect at the MIC concentration of 
25µg/ml. In contrast, 50 µg/ml of TQ could decrease the viable number of cells by ≥ 99.9% 
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within six hours. According to CLSI M26-A (1999) the antibacterial agents which cause 99.9% 
reduction in viability were considered to be bactericidal. Still there is no standardised guideline 
to test the fungicidal activity of antifungal agents, however, many studies attempted to 
standardise method to determine the fungicidal activity of antifungal agents have been 
summarised and reviewed by Pfaller and collegues (2004). In this review a reduction of survivor 
cells by ≥ 99.9% or 3 log10 in population of about 10
5
 cells/ml was considered to be an indicator 
of the fungicidal activity of antifungal agent. In this assay there was another challenge for TQ 
toxicity which is the cell number (about 10
5 
CFU/ml) which was higher than that in the MIC 
assay (5x10
2
 to 10
3 
CFU/ml). This might be the reason of less efficient killing by 25µg/ml TQ 
which is the MIC value. To highlight the relationship between MIC of TQ and cell density, 
another measurement of growth inhibition in C. glabrata cultures with different cell number was 
performed. Figure 2.5 showed that the MIC concentration caused a delay in culture growth but 
not total inhibition of growth in cultures that have a high cell number (>10
4 
CFU/ml).  These 
results are in agreement with Perumal’s study (2  7) which demonstrated that a correlation 
exists between cell density and phenotypic resistance to fluconazole independent of whether the 
source of the cells is in a planktonic or biofilm form. 
 
The concentrations which were needed to kill C. glabrata in this study are higher than those that 
were needed to kill some types of cancer cell lines. For example, breast cancer and other cancer 
cell lines including human glioblastoma cells need between 4.1-16.4 µg/ml to reduce their 
viability (Gurung et al., 2010, Motaghed et al., 2013, Attoub et al., 2013). Explanations for this 
difference may relate to the permeability of the yeast cell, efflux pumps in yeast and the method 
of cell killing. Data reviewed in section 1.2.3 regarding thymoquinone toxicity indicate a wide 
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range of safety for TQ therapeutic doses. Thus its anti-Candida MIC range (25-100 µg/ml) is 
still acceptable as it is within the estimated maximum tolerated oral dose of TQ (approximately 
 .6 mg/kg/day (Shuid et al., 2012)). Using TQ cream (10% TQ) to treat vaginal candidiasis 
(Abdel Azeiz et al., 2013) is the main study that supports the idea of using TQ safely to treat 
such infections. 
 
 The results of this study revealed that complete eradication of C. glabrata biofilm by TQ is still 
challenging but preventing of biofilm stabilisation and biofilm growth inhibition might be 
achievable. Free TQ might be not successful in treating biofilm related infection or systematic 
Candida infections due to its binding to serum proteins which reduce its activity in vivo (El-
Najjar et al., 2010). Alternative applications to use thymoquinone such as liposomal TQ which 
showed high efficiency in treating systematic infection caused by C. albicans (Khan et al., 2015) 
or TQ loaded nanoparticles might improve TQ efficiency. In this study TQ protein polymer 
nanoparticles were used to increase the sensitivity of C. glabrata biofilms to TQ by increasing 
the absorption of this compound. In fact these nanoparticles did not increase sensitivity of 
Candida glabrata ATCC2001 to TQ in vitro. This strain showed lower MIC than A2a2 isolate 
which forms thicker biofilm. Therefore the ability of these nanoparticles to increase biofilm 
sensitivity was not predictable.  Despite that,  TQ protein polymer nanoparticles might improve 
TQ’s anti-candidiasis effect in vivo as it occurred with liposomal TQ (Khan et al., 2015). 
Possibly these nanoparticles may add more stability to TQ action by blocking interaction 
between TQ and serum proteins. Therefore further investigation for this possibility is required. 
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2.4.2 Polypropylene biofilm reactor affordability and reproducibility 
Washing process caused destruction of C. glabrata biofilm formed in microwell plates. In 
addition, fixation with chemicals such as formaldehyde is not helpful because of the need to 
count viable cells.  The Calgary biofilm device (CBD) offers less destruction (Ceri et al., 1999) 
and consequently more reliability in terms of defining minimum inhibitory concentration of 
biofilms. However, its costly features and the combined sonication were considered as 
disadvantages in using this model. Sonication was supposed to be relatively inefficient in 
dissociating biofilm cells and can cause contamination by spreading droplets between wells (Qu, 
2010).  
The major advantages offered by the biofilm reactor developed for this study are its affordability 
and being a partly re-usable device, leading to less environmental waste.  While the CBD device 
costs 8.5-19 USD (Nunc-Immuno TSP; Innovatech), the reactor described here costs about 3 
USD.  Polypropylene microcentrifuge tubes (PP tubes) are available for 3 USD per 100 
(California Pacific Labs) and PP tips boxes are a negligible cost since these have been recycled.  
Media are an additional cost for the reactors.  The CBD uses 20 ml of media but the device 
described here needs 168 ml to be filled completely at a cost of approximately 1.3 USD for 
YEPD medium and 0.5 USD for RPMI1640 (according to Sigma Aldrich website (2015)).  
In addition, this reactor allows the handling of each biofilm separately without disruption to 
other biofilms and enables dissociation of microbial cells aseptically. More important is the 
reproducibility of the quantitative counts of the biofilms produced in this reactor.  The method 
was found to produce uniform and reproducible results with no significant differences between 
biofilms formed on PP tubes incubated in various compartments of the device.  In addition, the 
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difference between maximum and minimum counts for each strain were comparable to those 
which have been reported for the CBD device (Ceri et al., 1999) which makes this reactor a 
promising method for measuring the susceptibility of biofilms to antifungal or toxic materials.   
It is well recognized that the chemical nature of the implanted material plays a critical role in 
initial Candida colonization and thus helps define the overall characteristics of the resultant 
Candida biofilms (Tournu et al., 2012).  The adherence of different C. glabrata strains to 
polyvinyl chloride (PVC), Teflon, polyurethane, polystyrene, polymethylmethacrylate, 
hydroxyapatite, silicone elastomer and soft denture liner surfaces has been studied (Estivill et al., 
2011, Hawser et al., 1994, Kuhn et al., 2002).  Since polypropylene is used widely in medical 
devices (e.g. catheters, hernia meshes and sutures) (Nava-Ortiz et al., 2010), the development of 
reproducible and cost effective in vitro PP models to study Candida biofilms is important.  
 
Microbial cells which are surrounded by EPS, adhere to each other, to a surface and form 
aggregates that can be defined as biofilm. In my study C. glabrata cells adhered to each other 
and to the surface. The EPS was not absent, but it was present in small amounts. The thickness of 
EPS usually depends on strain type and the environmental conditions. The amount of EPS which 
appear in figure 2.11 are similar to those which were obtained in other studies on C. glabrata. 
Such studies are (Mota et al., 2015, Silva et al., 2011). 
 
Examination of the adhesion of C. glabrata cells to PP in this study demonstrates that C. 
glabrata strains vary in biofilm production on polypropylene under the same conditions of 
nutrient, temperature and flow.  Biofilms that can be formed on discs that are made from 
catheters or other clinical devices (Hawser et al., 1994) can be easily disrupted because of the 
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transfer process using forceps.  The tubes used in this study have a top section separate from the 
biofilm forming site that can be used to handle the tubes without disturbing the biofilm.  The 
washing after biofilm formation may not be necessary since unattached cells will be lost under 
the effect of gravity.  However, the washing procedure in this PP reactor is very gentle compared 
with the washing procedure used in published methods using plates (Tournu et al., 2012).  
Furthermore, the separate sections (compartments) in the box allow eight different treatments 
simultaneously for at least eight replicates of one treatment.  
 
Candida biofilms have dramatically reduced susceptibility to antifungal drugs resulting in 
increased mortality rates for candidiasis patients (Tumbarello et al., 2007). Because of this the 
efficacy of TQ on C. glabrata biofilms was tested. C. glabrata A2a2 immature biofilms needed 
50 times the planktonic MIC to inhibit their growth by 3 log10, which is a typical clinical 
property of biofilms. Biofilms are famous with their development of antimicrobial resistance that 
can be up to 1,000-fold greater than planktonic cells (Mah et al., 2003). Therefore, removal of 
devices from patients with candidemia is recommended, as patients with biofilm-infected devices 
are rarely cured with only antifungal therapy (Nett et al., 2007b). Perumal and his group (2007) 
attribute candida biofilm resistance to antimicrobial agents to the high density of cells in biofilms 
rather than protection by the extracellular polymeric substances (EPS). In contrast, Nett et al. 
(2007) explained this resistance as a result of the increased β-1,3 glucan content in biofilms 
compared with planktonic cells. By referring to figure 2.5 this study supports the idea of high cell 
number influence on biofilm susceptibility to TQ; and further investigations on the effect of the 
observed EPS matrix on TQ susceptibility are needed (Fig. 2.11). Overall these observations 
suggest that concentrations higher than MICs are necessary to disinfect biofilm contaminated 
medical devices and equipment, and confirm the importance of early recognition and treatment 
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of Candida infection and contamination. Success is possible by using the concentrations guided 
by the conventional susceptibility tests against non-attached cells, however, Abdel Azeiz’s study 
(2013) in which vaginal Candida albicans infection was treated with 10% TQ indicates the 
possible safe elimination of biofilms by this compound.  
 Despite of TQ protein polymer based nanoparticles did not inhibit C. glabrata growth at 
concentrations lower than TQ, these nanoparticles will be good approach if they prevent fast 
degradation of TQ in vivo or minimise its binding with serum proteins which makes the free 
available amount of TQ higher.  
 
2.4.3 Thymoquinone causes necrotic death in C. glabrata 
Activity of caspase-like protein in yeast could be reported by binding of specific fluorochrome-
labelled caspases FITC-VAD-FMK. This binding was prevented by pretreatment with 
pancaspase inhibitor Z-VAD-FMK (Madeo et al., 2002, Silva et al., 2005) or generating of 
mca1(yca1) mutant (Madeo et al., 2002, Silva et al., 2005, Wysocki et al., 2004). According to 
the Candida Genome Database www.candidagenome.org C. glabrata has YCA1 homolog 
(CAGL0I10945g) but this ORF has been not characterised experimentally yet. Because of the 
fact of C. glabrata is genetically closely related to S. cerevisiae and previous studies 
observations on S. cerevisiae (Madeo et al., 2002; Herker et al., 2004) regarding utilization of 
FITC-VAD-FMK were encouraging, this assay was used to detect caspase-like activity in this 
study. Emission of green fluorescence was recorded which might be an indicator of caspase-like 
activity (Fig. 2.12). However analysing FITC-VAD-FMK emission over different time intervals 
did not indicate any significant activation of caspase-like proteins before cells had lost their 
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viability. Thymoquinone treated cells were either PI and FITC positive or just PI positive 
indicative of post apoptotic or necrotic death. Because live cells were not FITC positive, non-
specific binding of FITC dye to live cells was not estimated. In contrast, it has been shown that 
dead S. cerevisiae cells non-specifically bind fluorescein and FITC or FITC-conjugated caspase 
inhibitor FITC-VAD-FMK and live cells do not (Wysocki et al., 2004). The counter-argument to 
these claims was the cells were exposed to extreme death conditions in that study, which either 
induced non-apoptotic cell death or caspase-independent apoptosis (Farrugia et al., 2012). In this 
study, because no FITC-VAD-FMK positive intact cells were observed, the post apoptotic phase 
might be an artificial labelling. In contrast with Wysocki et al. (2004) C. glabrata cells were 
treated with both sub inhibitory and toxic concentrations of TQ but apoptotic cells (FITC 
positive/ PI negative) were not observed. Therefore, the initial conclusion of this result is TQ 
might cause necrotic death. However further detailed proteolytic analysis of CAGL0I10945g C. 
glabrata ORF activity should be conducted to confirm the presence of caspase-like proteins in C. 
glabrata. Since the results obtained indicate that FITC-VAD-FMK usage can be rather 
controversial, further analysis of the cell cycle was performed to decide whether TQ induces 
necrotic death or not. DNA condensation and degradation is a known marker of apoptotic death 
in yeast and it has been reported by us in C. glabrata (Almshawit et al., 2014). Analysis of 
permeablised DAPI labelled cells showed no events at sub G0/1 zone which indicates DNA 
degradation did not occur when treating C. glabrata with sub-toxic or toxic concentrations of 
TQ. In conclusion, these results indicate that TQ exerts activity against C. glabrata by direct 
killing of cells results probably in necrotic death.  
Generally, antimicrobial compounds that cause apoptotic-like death of microbes are preferred 
since they do not induce inflammation. Antifungal agents such as caspofungin causes necrotic 
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death of C. albicans treated with inhibitory concentrations and apoptosis when sub-inhibitory 
concentrations are used, however this agent is considered to be highly safe. Others such as 
amphotericin induce apoptotic death in C. albicans in vitro but show side effects in vivo (Phillips 
et al., 2003). Although Abdel Aziz’s study demonstrated no side effects such as inflammation 
were caused by treating infected C. albicans mice with TQ (Abdel Azeiz et al., 2013), further 
studies on treating C. glabrata infected animal models are required to demonstrate such possible 
side effects. 
 
2.5 Conclusion 
This chapter concludes that thymoquinone is able to inhibit the growth of different Candida 
species and has a fungicidal effect. A high density of cells (> 10
4 
cell/ml) reduces the fungicidal 
effect of TQ. In addition, thymoquinone can inhibit growth of 2 h old C. glabrata biofilms by 3 
log10 but not mature biofilms. The polypropylene biofilm reactor which was developed in this 
study is a useful, simple, low cost device for parallel study of C. glabrata biofilms and might be 
useful for other microbial species which produce biofilms.  Due to the reproducibility of biofilms 
formed on each tube in the reactor, this assay can enable rapid and reproductive screening of 
Candida biofilms for antifungal resistance testing. It can also help to establish biofilm models for 
molecular microbiology investigations. The interest in performing biofilm experiments is 
widespread. The Almshawit et al. (2014a) article was amongst the ten most downloaded articles 
as it was classified by ScienceDirect in the first six months of 2014 (publisher’s report).  Death 
mode caused by TQ might be necrotic and further investigations confirming this result are 
required. 
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CHAPTER 3 
 
Thymoquinone’s effect on the oxidative status of C. glabrata 
 
3.1 Introduction 
Several mechanisms have been suggested for the chemopreventative and anticancer activity of 
TQ; however a clear mechanism of the action of TQ as an antifungal has not been elucidated. TQ 
is a known ROS scavenger at low concentrations (Kruk et al., 2000) and most of the studies in 
mammalian cells illustrate the mechanism centers on this antioxidant property   (Ragheb et al., 
2009, Abdel-Wahab, 2013). In contrast TQ may act as a pro-oxidant at higher concentrations in 
mammalian cells (Zubair et al., 2013). However, other groups show that the anti-oxidant/pro-
oxidant ability of TQ depends on the milieu where it is present (Mansour et al., 2002, Staniek et 
al., 2010, El-Najjar et al., 2010). As a quinone, TQ can be reduced by a variety of reductases to 
yield semiquinone (one reduction) or thymohydroquinone (two reductions). Thymohydroquinone 
is reported to have antioxidant effects, while semiquinone acts as a pro-oxidant and generates 
reactive oxygen species. For more details see figure 1.4 (Mansour et al., 2002, Staniek et al., 
2010, El-Najjar et al., 2010).  
Reactive oxygen species (ROS) such as hydrogen peroxide (H2O2), superoxide anion (˙O2
-
), and 
hydroxyl radical (˙OH) arise continually during aerobic metabolism (with an estimated 2% of 
oxygen utilized by yeast cell being converted into the superoxide anion) (Shanmuganathan et al., 
2004). These ROS typically arise because of electron leakage from the electron transport chain 
onto dioxygen (O2) during aerobic respiration. Therefore, living organisms including yeast have 
developed defence mechanisms to protect against ROS. C. glabrata has a well-defined oxidative 
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stress response, which include both enzymatic and non-enzymatic mechanisms. Enzymatic ROS-
scavenging molecules (e.g. superoxide dismutases, catalases and thioredoxin reductase), and non-
enzymatic mechanisms such as the S-thiolation of oxidation-susceptible proteins, which prevents 
oxidation by forming reversible mixed disulfide bonds with glutathione (L-
glutamylcysteinylglycine; reduced form GSH; oxidized form GSSG) (Briones-Martin-Del-
Campo et al., 2014, Gutierrez-Escobedo et al., 2013). In addition production of an ascorbic acid 
homolog (D-erythroascorbic acid), a five-carbon analog of ascorbic acid, has been described in 
Saccharomyces cerevisiae and C. albicans (Huh et al., 2001, Huh et al., 1998). The ALO1 gene 
is a gene that encodes D-Arabino-1,4-lactone oxidase catalysing the final step of D-
erythroascorbic acid (EASC) biosynthesis. The ALO1 gene and the biosynthetic pathway of 
EASC from D-arabinose by d-arabinono-1,4-lactone oxidase (ALO) D-arabinose dehydrogenase 
have been well described. According to the Candida Genome Data Base 
(http://www.candidagenome.org/) CAGL0H04125g open frame in C. glabrata genome is an 
ortholog of ALO1 gene, nevertheless, this gene has not been experimentally characterized to 
date.  
Accumulation of ROS under external factors such as exposure to drugs, metals or phagocytic 
cells, which are the first line of defence against fungal infections, may lead to potential oxidative 
damage to proteins, nucleic acids and other macromolecules, which can severely compromise 
cell health and viability (Ferreira et al., 2013, Cuéllar-Cruz et al., 2008, Fujs et al., 2005).  
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The main aims of this chapter were to: 
(i) Investigate whether induction of oxidative stress by TQ is a cause of fungal cell death.  
(ii) Clone CAGL0H04125g open reading frame, which was predicted to be an ortholog to   
ALO1 gene.  
(iii)  Examine whether cloning of CAGL0H04125g may contribute to over production of 
EASC and whether this will provide protection to C. glabrata cells against TQ toxicity. 
 
 
 
3.2 Materials and methods 
3.2.1 Chemicals 
Thymoquinone, fluconazole, hydrogen peroxide, dimethyl sulfoxide (DMSO), L-reduced 
glutathione, 2′,7′ dichlorodihydrofluorescein diacetate (H2DCF-DA), rhodamine 123, 
monochlorobimane ascorbic acid and D-isoascorbic acid were purchased from Sigma Aldrich 
(Australia).  
3.2.2 Yeast strains and media 
The yeast strains employed in this study are listed in Table 3.1. Yeast strains were maintained 
and grown on YEPD agar medium. Yeast minimal medium without amino acids (YMM w/o AA) 
was used for screening of transformants. RPMI1640 containing L-glutamine, but lacking sodium 
bicarbonate was used for sensitivity assay and measuring oxidation stress. 
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Escherichia coli strains were maintained and grown at 37 ºC on Luria-Bertani medium (LB 
medium) containing 1   μg/ml ampicillin for selection of recombinant plasmids. 
 
 
Table 3.1 Strains used in this study. 
Strain Description Source or reference 
Escherichia coli DHαTM Wild type Helen Williams (RMIT university) 
Escherichia coli DH10B E. coli DHα carrying pCU-
HHT2 empty plasmid.  
(Zordan et al., 2013) 
(Addgene plasmid # 45319) 
Escherichia coli 16a DHα transformed with HHT2-
ALO1 plasmid. 
This study 
Candida glabrata ATCC2001 Wild type ATCC 
Candida glabrata ATCC90030 Wild type ATCC 
Candida glabrata MH100 ATCC2001 ura3∆ (Muller et al., 2008)  
Candida glabrata HHT2 MH100 transformed with pCU-
HHT2 plasmid (empty vector) 
This study 
Candida glabrata 16a MH100  transformed with 
HHT2-ALO1 plasmid 
This study 
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3.2.3 Effect of antioxidants 
In experiments involving antioxidants, cells of C. glabrata ATCC90030 were used. Reduced 
glutathione and ascorbic acid stocks were freshly prepared as 40 mM stocks in RPMI 1640. The 
same procedure which was used in preparing 96 wells microplates for determining MICs in 
section 2.2.2 was performed except adding of ascorbic acid or L-reduced glutathione to the 
medium to achieve final concentration of 10 mM.  Addition of antioxidants was performed 
before treatment with TQ. 
 
3.2.4 Detecting reactive oxygen species (ROS) 
The level of ROS was examined using  2′,7′-dichlorodihydrofluorescein diacetate (H2DCF-DA). 
This molecule can diffuse freely into cells. The acetate moiety is cleaved by cellular esterases, 
leaving impermeable, non-fluorescent, 2′,7′-dichlorodihydrofluorescein (H2DCF). The H2DCF 
is oxidized by ROS to dichlorofluorescein (DCF), which emits fluorescence at 530 nm in 
response to 488 nm excitation (Martin et al., 2004, Eruslanov et al., 2010). 
C. glabrata ATCC2001 cells from a freshly grown YEPD plate, were resuspended in the same 
medium that was used in determining MICs. Thymoquinone was added to the cell suspensions at 
density of approximately 10
6
 cell/ml and incubated for 2 h at 35 °C with agitation (200 rpm). 
2′,7′-dichlorodihydrofluorescein diacetate stocks were prepared freshly in DMSO. H2DCF-DA 
(Sigma-Aldrich) was added directly to have a final concentration of 10 µg/ml of cell culture 
(Madeo et al., 1999) and incubated further 2 h in the dark. One ml from each sample was 
centrifuged at 9000 rpm for 1 min. The pellets were resuspended in RPMI 1640 and left to re-
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grow at 35°C for 1 h. Cells were washed and resuspended in filter sterilized PBS before flow 
cytometry analysis using a FITC filter in a FACS Canto II (BD Biosciences). Controls including 
untreated cells with and without H2DCF-DA, cells treated with DMSO or TQ with and without 
H2DCF-DA. 
 
3.2.5 ROS and cell membrane integrity 
Cells in exponential phase (2 h in liquid YEPD medium) were used to examine whether ROS 
generation follows cells death or TQ causes ROS generation which then leads to cell death. 
About 10
6
 cell/ml were treated with 50 µg/ml TQ for 4 h in total. Untreated cells which were 
used as negative control, were stained with H2DCF-DA as described above (section 3.2.4). After 
washing with filter sterilized PBS buffer, cell pellets were suspended in 500 µl of 2 µg/ml 
propidium iodide solution and incubated 30 min at 30 °C in the dark. Cell suspensions were 
washed with PBS and observed with an Epifluorescent microscope (Leica DM 2500) fitted with 
a Leica DFC310 FX camera. A GFP filter was used to observe DFC positive cells and Texas red 
filter was used to observe PI positive cells and Blue filter was used for imaging both stains. 
To obtain data from a higher number of cells, cell suspensions were further analysed by flow 
cytometry using a FITC filter in a FACS Canto
TM
 II (BD Biosciences) and perCP-Cy5-5A filter. 
Controls including untreated cells with and without H2DCF-DA, cells treated with DMSO or TQ 
with and without H2DCF-DA were included. 
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3.2.6 Estimation of intracellular reduced glutathione content   
The cellular level of reduced glutathione (GSH) was estimated with monochlorobimane (Staleva 
et al., 2002, Kwolek-Mirek et al., 2009, Nair et al., 1991). C. glabrata ATCC 90030 cells (OD600 
= 0.96) from an overnight plate were suspended in RPMI 1640 (medium as in MIC assay), then 
were treated with 0, 25 and 50 µg/ml of TQ for 2 h at 35°C with agitation at 170 rpm. One ml 
was washed with PBS, and incubated for 30 min with 4  μM monochlorobimane (Sigma-
Aldrich) at room temperature. Cells were washed again and resuspended in PBS. The 
fluorescence of the bimane–glutathione conjugates was observed using Nikon® A1 confocal 
laser-scanning microscope equipped with a Plan Apo VC X60 water-immersion objective, an 
argon laser (488 nm) and a solid state laser (561 nm) using 488 nm excitation laser (excitation: 
36 /4  nm). Flow cytometry data were recorded using a BD FACS Canto™ II equipped with a 
pacific blue fluorescent filter (351- 450/65 nm excitation and emission). 
 
3.2.7 Measuring of mitochondrial membrane potential 
Staining of mitochondria was performed as described by (Vandeputte et al., 2009). Briefly, cells 
of C. glabrata ATCC90030 from overnight YEPD plates were suspended in RPMI 1640 (0x106 
cell/ml) and incubated 4 h with TQ at 35 °C with shaking (200 rpm). Cells were harvested then 
washed with PBS and incubated for 30 min at 35 °C with 250 µl of 10 µg/ml rhodamine 123 
solution in the dark. Cell suspensions were then again washed with PBS and resuspended in 250 
µl PBS. Resulting aliquots were analysed by flow cytometry using an FITC filter (494-519 nm 
excitation /emission). The cells were observed microscopically using an FITC filter to examine 
staining efficiency. An epifluorescence microscope (Leica DM 2500) combined with a Leica 
DFC310 FX camera for image visualization was used. Controls included untreated cells with and 
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without rhodamine 123, cells treated with DMSO and TQ with and without rhodamine 123.  
 
For all fluorochrome experiments, 50 ml centrifuge tubes were used with working volumes not 
more than 4 ml. The tubes were not protected from light after adding of TQ but they were 
protected from light after the fluorophore was added. 
 
 
3.2.8 Amplification of ALO1 gene by polymerase chain reaction  
The template genomic DNA for polymerase chain reaction (PCR) was isolated from C. glabrata 
CBS138 according to the manufacturing guideline of Isolate II Genomic DNA kit (Bioline). The 
concentration of isolated DNA was quantified by measuring absorbance (A260/ 280) using a 
NanoDrop spectrometer (NanoDrop Lite™). Prior to running of conventional PCR procedure, a 
gradual PCR was carried out with gradual annealing temperature between 45 °C to 70 °C to find 
out the suitable annealing temperature. The 25 µl PCR reaction mixture contained 0.5 µl of 10 
mM of each primer, 5 µl of 10X Taq polymerase buffer (supplied by Bioline), 0.145 µl My Taq 
polymerase (Bioline) and about 75 ng template genomic DNA. The mixture was subjected to 30 
cycles of  denaturation at 95 °C for 0.5 min, 1 min annealing at 50 °C, 2 min extension at 72 °C 
and incubated at 4ºC until further investigation. The sequence of interest was amplified using a 
bench top thermocycler (G-STORM, Geneworks, Australia). The oligonucleotide primers for 
amplifying the ALO1 gene were designed based on the nucleotide sequence of the open reading 
frame (ORF) CAGL0H04125g which was obtained from the CGD. Clone Manager 9 software 
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(www.scied.com) was used to check the primers design. The ORF of C. glabrata CBS138 ALO1 
was amplified using the primer pair ALO1F and ALO1R (table 3.2). 
 
 
Table 3.2 Primers used in this study: the restriction sites are underlined and arrows indicate the 
restriction sites. 
Primer name Primer Sequence Source of design 
ALO1F 5’-GCCCGGGATGGATTTGAAAACATTTGGTG-3’ This study 
ALO1R 5’-GCCGCTCGAGTTATTCGTTTTCATCAATGATACC-3’ This study 
ALOiF 5’- ACCACAGACTAAGTCAAG -3’ This study 
HHT2F 5’-TGTTATTGATTATTTATTTATTTG-3’ (Zordan et al., 
2013) 
 
 
 3.2.9 Agarose gel electrophoresis 
Products of PCR were analysed by agarose gel electrophoresis. One percent of agarose (w/v) was 
prepared in 1 x TAE buffer (appendix A) and heated in a microwave with stirring intervals until 
it was completely dissolved.  Dissolved agarose was left to cool then poured into a gel tray with 
a comb. Cool gels were located in a gel tank (Bio Rad) filled with TAE buffer. One microliter of 
loading dye (Cat 31022, Biotium) was added to each 10 µl sample before loading to gel wells. A 
DNA marker (New England Biolabs® Inc.) was run in parallel with the samples for MW 
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comparison.  Gel electrophoresis was run at 100 Volts for 65 min, then gels were placed in a 1 
mg/ml ethidium bromide bath for approximately 10 min. Agarose gels were then destained by 
washing under running tap water for 20 min before viewing. Gels were visualised under UV light 
in a Bio-Rad Gel Doc™ UV transilluminator system. Images of gel electrophoresis were 
processed using Quantity One 1-D analysis software (Bio-Rad, Australia; version 4.6.8). 
 
3.2.10 Vector digestion and ALO1 ligation  
 The amplified DNA fragment of 1,595 bp was cloned into pCU-HHT2 vector (Plasmid 45319; 
Addgene) at the multiple cloning site between HHT2 promoter, which is a constitutive promoter, 
and HIS3 terminator (Fig. 3.1). Plasmids were isolated form E. coli DH10B using Quick plasmid 
miniprep kit (Invitrogen). Then 1 µl of XmaI and  XhoI restriction enzymes and 5 µl of 10x 
NEBuffer 3.1 (NEW ENGLAND BioLabs® Inc.) were added to approximately 1.5 µg of 
plasmid DNA. The reaction volume was completed to 50 µl using nuclease-free water and the 
digestion reaction mixture was incubated at 37ºC for 3 h followed by heat inactivation of the 
enzymes at 65ºC for 20 min. After that digested DNAs were cleaned prior to ligation by utilizing 
of ISOLATE II PCR and Gel Kit (Bioline) and kept at -20ºC until use. For ligation T4 DNA 
ligase (M0202; New England Biolabs
®
 Inc.) was used to generate HHT2-ALO1. The desired 
amount of insert DNA was calculated using Ligation calculator which was developed by 
Düsseldorf University website (http://www.insilico.uni-duesseldorf.de/Lig_Input.html). Twenty 
microliters of ligation mixture contained vector DNA, insert DNA, T4 DNA ligase and T4 DNA 
ligase buffer (New England Biolabs® Inc.) was incubated overnight at 16 ºC. Ligation products 
were transformed chemically into E. coli DH5α competent cells which were prepared according 
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to a protocol adapted from Mrs Kim Stevenson (RMIT University). Briefly, 5 µl of the ligated 
DNA were added to 100 µl of E. coli DH5α competent cells and the mix kept on ice for 1  to 15 
min and then heat shocked at 42 ºC for 50 sec. Samples were located back on ice for 2 min, then 
1 ml of LB broth medium containing 0.4 % glucose was added. Cells were left to recover for 30 
min at 37 ºC then plated on LB agar plates supplemented with ampicillin (appendix A). 
Transformants were inoculated into LB broth supplemented with ampicillin and incubated 
overnight at 37 ºC. The recombinants were purified and sequenced using primers ALOiF and 
HHT2F (table 2 & Fig. 3.1).  Sequencing of the cloned DNA was performed at Micromon DNA 
sequencing facility (Monash University). 
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Figure 3.1 Schematic diagram of ALO1 plasmid developed in this study. The pCU-HHT2 plasmid 
backbone caters for expression of ALO1 gene (CAGL0H04125g) in C. glabrata. The graphic map was 
generated using Addgene software from the full sequence supplied by Zordan et al., (2013). The 
restriction sites of XhoI and XmaI in the multiple cloning site (MCS) between the promoter and terminator 
are underlined.  
 
 
HHT2 promoter 
HIS3 terminator 
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3.2.11 Overexpression of ALO1 in C. glabrata 
A 6.1 kb pCU-HHT2 vector containing ALO1 (HHT2-ALO1) was isolated from E. coli DH5α 
using Quick plasmid miniprep kit (Invitrogen). The DNA sequence of interest in the purified 
plasmids was sequenced by the Micromon sequencing centre (Monash University, Clayton, 
Australia) using the primers that were used for amplification of the PCR product and multiple 
samples of plasmids with the gene of interest were also sequenced using ALOiF and HHT2F 
primers (Table 3.2). The HHT2-ALO1 plasmid was used to transform C. glabrata HM100 cells 
using EZ yeast transformation kit (MP Biomedicals). URA3+ cells were selected using complete 
yeast minimal medium lacking uracil (YMM). 
 
3.2.12 Measurement of intracellular EASC 
The extraction of EASC from C. glabrata was carried out according to the method proposed by 
Huh et al. (1998) with some modifications. C. glabrata cells from overnight culture (about 1 g in 
wet mass) grown in a YNB liquid medium were recovered by centrifugation at 5000×g for 10 
min at 4 ºC, washed twice with cold MilliQ water and resuspended in 10 % trichloroacetic acid 
(1 ml per 1 g of wet weight cells). This suspension was stored for 30 min at 4 ºC with vortexing 
every 5 min. The insoluble residue was removed by centrifugation at 10,000 g for 2 min 
followed by filtration of the supernatant through a 0.22 µm filter.  
 
20 µl from the soluble extract of each strain were subjected to analytical liquid 
chromatography/tandem mass spectrometry (LC-ESI-MS/MS).  The LC-MS/MS system was an 
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Agilent 1200 liquid chromatograph and a 6410 triple quadrupole mass spectrometer with an 
electrospray ionisation source. Separation was performed on a Zorbax SB-C18 column (4.6 mm 
x 150 mm, 5 µm particle size) by gradient elution using the following gradient: 0-5 min 2 % B 
isocratic; 5-35 min linear gradient to 95% B; 35-36 min isocratic 96% B, 36-40 min to 2 % B 
and the column was equilibrated with 2% B for 10 minutes. Eluent A was 0.1 % formic acid and 
B was methanol. Mass spectrometry was performed on a triple quad spectrometer in ESI positive 
ion mode. High purity nitrogen served as both the nebulising and drying gas, with a drying gas 
flow 8 L/min and a nebuliser pressure 15 psi. The capillary voltage was set at 4000 V and the 
source at 3000 C. The system was calibrated using D-isoascorbic acid (the supplier synonym of 
D-erythroascorbic-acid).  
 
3.2.13 Assay for resistance to oxidative stress 
The effect of ALO1 overexpression on the sensitivity of C. glabrata to TQ and H2O2 was 
examined. Candida glabrata transformed with ALO1 gene (C. glabrata 16a) and its control 
strain C. glabrata HHT2 were used in this assay. Experiments in liquid medium were carried out 
according to the method proposed by Izawa et al., (1995) with some modifications. Cells were 
grown in minimal defined medium (YMM) to mid-logarithmic phase to obtain the initial OD600= 
0.5. Then 2 ml of cell suspensions were treated with 38.8 or 77.7 mM of H2O2 or 50 µg/ml TQ. 
The treatment process was performed in YMM media or in PBS after washing the cells with the 
same buffer. After incubation for 1 h at 30 ºC with agitation (200 rpm), 100 µl aliquots were 
taken from the cell suspensions, diluted appropriately in PBS and plated onto solid minimal  
 
LC-MS/MS data collection and analysis was done kindly by Mr. Sushil Anand (RMIT University) 
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defined medium. Colonies were counted after incubation for 72 h at 30 ºC.  
In addition, sensitivity of C. glabrata 16a to TQ and H2O2 was compared to the control strain C. 
glabrata HHT2 and its parental strain on YMM agar plates. Ten-fold serial dilutions were 
processed using colonies grown on YMM plates. Five microliters of cell suspension were spotted 
on YMM plates containing 38.8 or 77.7 mM of hydrogen peroxide H2O2 or 50 µg/ml of 
thymoquinone. Plates were incubated overnight at 30 ºC.  
 
3.2.14 Data analyses  
The corresponding geometric mean (G mean) values of the replicates was calculated using 
GraphPad Prism Software. Error bars represent Standard Error of the Mean (SEM) and one way 
ANOVA test combined with Tukey's multiple comparisons test and e-test were used to analyse 
the data and find p values. 
 The BLAST analysis tool was used to match the sequence of CAGL0H04125g ORF with cloned 
sequence and alignment of ALO1 protein sequence.  
Fluorescence distributions were obtained from 10,000 events per sample. The fluorescence of 
cell populations was analysed using Flowing software (Cell Imaging Core of the Turku Centre 
for Biotechnology, Finland, version 2.5.1).  
LC-MS/MS data were analysed using the MassHunter software package (Agilent Corporation, 
MA, USA).   
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3.3 Results 
3.3.1 Antioxidants protect against the toxicity of TQ 
To demonstrate the role of oxidative stress in the toxicity of TQ, antioxidant protection of C. 
glabrata against this quinone was examined. Ten milimolar of ascorbic acid and L-reduced 
glutathione protected C. glabrata ATCC 90030 from TQ toxicity (Fig. 3.2). This indicated the 
pro-oxidant effect of TQ. 
 
3.3.2  Thymoquinone stimulates the generation of reactive oxygen species (ROS) 
To measure the increase of ROS in cells exposed to TQ, ROS level in the cells treated with TQ 
was estimated using H2DCFDA which indicates oxidation by hydrogen peroxide, peroxynitrite, 
hydroxyl radical and at lesser extent superoxide anions (Eruslanov et al., 2010). After treating C. 
glabrata ATCC2001 for four hours with 25 or 50 µg/ml TQ, the green fluorescence intensity 
which corresponds to levels of ROS was found to depend on TQ concentration (Fig. 3.3). About 
50% of the cells were stained with H2DFC-DA after 4 h once they were treated with 50 µg/ml 
TQ. Sub-inhibitory concentration of TQ (25 µg/ml) did not significantly affect cells. Additional 
controls indicated that neither autofluorescence nor nonspecific binding of fluorochromes 
contributed significantly to the staining patterns observed. 
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Figure 3.2  Elimination of TQ toxicity using 10 mM of reduced glutathione (GSH) and ascorbic 
acid (AA). 
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DFC fluorescence intensity 
 
Figure 3.3  Thymoquinone induces ROS production in C. glabrata ATCC2001. Cells were 
treated for 4 h with TQ and stained with H2DCF-DA. Cells were treated with 0 (black), 25 (blue) 
or 50 µg/ml TQ (green). The percentages of fluorescence intensity are averages of three 
independent replicates ± SD. Percentages colour correspond to each lines colour. 
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3.3.3  Induction of ROS generation causes cell death 
To investigate whether ROS generation was the cause of cell death or it was a result of cell 
death, C. glabrata ATCC2001 cells were stained by H2DFC-DA to observe ROS generation as 
described in section 3.3.2 followed by propidium iodide (PI) staining to detect loss in membrane 
integrity. Cells were treated with 25 or 50 µg/ml TQ for 5 h and observed by epifluorescence 
microscopy or by flow cytometry. Labeling with H2DFC-DA and/or PI can distinguish four 
distinct cell states: (a) live unstressed cells (DFC-negative/PI-negative), (b) live cells that suffer 
from oxidative stress (DFC-positive/PI-negative), (c) dead cells (DFC-positive/PI-positive or 
DFC-negative/PI-positive). This assay can help to establish the sequence of events leading to cell 
death.  If all cells are both DFC and PI positive it means ROS was a result of cell death whereas 
if only part of the population is DFC positive that means ROS generation leads to cell death. 
Figure 3.4 shows  cells which have been treated with 50 µg/ml TQ for 5 h. A portion of these 
cells was only DFC positive which indicated induction of oxidation in these live cells, others 
were both DFC/PI positive or PI positive which indicated the death of cells after suffering from 
ROS damage. In addition, there were some live cells which did not stain with either dye. Cells 
which were treated with 25 µg/ml TQ did not show any significant number of positive events for 
either stain. 
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         (A)                                    (B)                                  (C) 
 
 
 
Figure 3.4 Pro-oxidant effect of thymoquinone leads to cell death. Microscopy images of C. glabrata 
cells treated with 50 µg/ml TQ for 5 h then stained with H2DFC-DA and PI (A) bright field (B) cells 
suffer from oxidative stress (DFC fluorescent positive), (C) cells that lost their cell membrane integrity 
(PI positive) merged with DFC positive cells. Scale bars represent 10 µm, (D) Flow cytometry analysis 
for DFC and PI stained untreated cells. (E) Flow cytometry analysis for DFC and PI stained cells which 
were treated with 50 µg/ml TQ for 4 h.  Data are representative of three independent experiments.  
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DFC 
                                 (D)                                                                  (E) 
 
 
 
PI 
  
 
 
PI 
48% 
18% 12% 
Chapter3 
- 94 - 
  
3.3.4 Thymoquinone depletes cellular glutathione 
Depletion of the reduced form of glutathione was shown to be another possible marker of 
oxidation in yeast (Castro et al., 2010). After treatment of cells with TQ, the level of intracellular 
reduced glutathione was determined using monochlorobimane (mBCl), a dye that shows a high 
degree of specificity for reduced glutathione (Nair et al., 1991). In this experiment cells from an 
exponential phase culture had an insignificant number of bimane–glutathione conjugate positive 
cells, while cells that were taken from overnight plates showed higher rate of positive events. 
Therefore the latter cells were used. Cells treated with 50 µg/ml TQ showed a reduction in 
fluorescence intensity within 2 h compared with untreated cells. Figure 3.5 shows an example of 
GSH depletion which was caused by TQ.  About 50% of the cells had reduced ability to emit the 
fluorescence of bimane–glutathione conjugate after treating them with 50 µg/ml TQ for 2 h 
compared with untreated cells. This demonstrates a depletion in the reduced glutathione (GSH) 
intracellular content.  Controls of TQ, DMSO and untreated cells indicated that neither 
autofluorescence nor nonspecific binding of fluorochromes contributed significantly to the 
staining patterns observed.  
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Figure 3.5 Thymoquinone caused a depletion in reduced glutathione in C. glabrata ATCC90030. Flow 
cytometry analysis of  monochlorobimane (mBCl) staining. Cells inoculated in RPMI 1640 and stained 
with mBCl (black line). Cells were treated for 2 h with 50 µg/ml TQ and stained with mBCl (red line). 
Percentages represent the mean of fluorescence intensity of three independent replicates. Percentages 
colour correspond to each lines colour. The histogram adapted from one experiment. The inset shows C. 
glabrata cells stained with mBCl. 
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3.3.5  Thymoquinone causes depolarization of mitochondria 
The lipophilic cationic fluorochrome rhodamine123 stains mitochondria selectively in a 
membrane potential and mass dependent manner. This fluorochrome incorporation depends on 
the electrochemical potential difference between the intermembrane space and the mitochondrial 
lumen (Riesbeck et al., 1990). A defect in the electron flow through the mitochondrial 
respiratory chain leads to lower incorporation of this dye (Riesbeck et al., 1990, Skowronek et 
al., 1990, Vandeputte et al., 2009, Ludovico et al., 2001).  Figure 3.6 shows great incorporation 
of rhodamine123 by untreated cells whereas TQ treated cells showed a dose dependent decreased 
rate of rhodamine123 staining. Compared to the untreated control, treatments with 50 and 100 
µg/ml TQ led to approximately 30 % and 49 % decreases in rhodamine123 fluorescent intensity. 
These results indicate that in these conditions the membrane potential and the mass of 
mitochondria in C. glabrata cells that were treated with TQ was much lower than that of the 
control. Similar results were obtained in two independent experiments, and incubation of the 
cells without rhodamine123 confirmed the absence of autofluorescence. 
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Figure 3.6 Thymoquinone causes a decrease in mitochondrial membrane potential. Flow 
cytometry analysis of rhodamine123 staining of C. glabrata ATCC90030. Black line indicates 
untreated cells with (right) and without (left) rhodamine123 staining, green line is cells treated 
with 0.5% DMSO (the highest concentration used), blue line cells treated with 50 µg/ml TQ and 
red line cells treated with 100 µg/ml TQ. Data are representative of two independent biological 
replicates. The inset shows fluorescent microscopy image of mitochondria in C. glabrata cells 
without treatment after staining with 10 µg/ml Rhodamine 123. 
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Figure 3.7 Digestion of HHT2-ALO1 vector with XhoI and XmaI enzymes resulted in a band of 
approximately 1.6 kb (lane 2), lane 1 is digested empty HHT2 vector, lane 3 DNA markers. 
 
 
 
3.3.6 Characterization of the ALO1 gene in C. glabrata 
The ORF CAGL0H04125g from the chromosomal DNA of C. glabrata ATCC2001 was 
amplified by PCR using the oligonucleotide primer pair ALO1F and ALO1R. When cloned and 
digested the 1,595 bp fragment was observed in plasmid HHT2-ALO1 but absent in the starting 
vector pCU-HHT2 (Fig. 3.7). The nucleotide sequence of the cloned ALO1 open reading frame 
was compared with that of the same gene sequence obtained from C. glabrata ATCC 2001 in the 
Candida Genome Database (CGD, http://www.candidagenome.org). The identity was 99.6% 
because six mismatches were found within the coding region of the gene (Fig. 3.8).   
 
1          2           3 
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Cg16a: 1    ATGGATTTGAAAACATTTGGTGGTCGGCGGAACTTTGTGTTTCGCAATTGGGCTGGTATC 60 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
CgCBS: 1    ATGGATTTGAAAACATTTGGTGGTCGGCGGAACTTTGTGTTTCGCAATTGGGCTGGTATC 60 
 
 
Cg16a: 61   TATTCCTCAAGACCAGAATGGTACTTTCAGCCTTCCTCAGTCGACGAAGTTGTCGAAATT 120 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
CgCBS: 61   TATTCCTCAAGACCAGAATGGTACTTTCAGCCTTCCTCAGTCGACGAAGTTGTCGAAATT 120 
 
 
Cg16a: 121  GTCAAAGCTGCTAAACTAAAGAACAAGACTATTGTTACAGTTGGTTCAGGCCACTCCCCT 180 
            |||||||||||||||||||||||||||||||||||||||||||| |||||||||||||||  
CgCBS: 121  GTCAAAGCTGCTAAACTAAAGAACAAGACTATTGTTACAGTTGGCTCAGGCCACTCCCCT 180 
 
 
Cg16a: 181  AGTAACATGTGTGTTACCGACGAATGGATGATGAACTTGGACAAGATGAACAAGTTACTA 240 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
CgCBS: 181  AGTAACATGTGTGTTACCGACGAATGGATGATGAACTTGGACAAGATGAACAAGTTACTA 240 
 
 
Cg16a: 241  GATTTTGTGGAAAACGAGGATAAGACATACGCAGACGTTACTATTCAAGGTGGTACTAGG 300 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
CgCBS: 241  GATTTTGTGGAAAACGAGGATAAGACATACGCAGACGTTACTATTCAAGGTGGTACTAGG 300 
 
 
Cg16a: 301  TTGTATGAGATCCACAGAATATTAAGGGAAAAGGGATACGCCATGCAAAGTTTGGGGTCC 360 
            |||||| ||||||||| |||||||||||||||||||||||||||||||||||||||||||  
CgCBS: 301  TTGTATAAGATCCACAAAATATTAAGGGAAAAGGGATACGCCATGCAAAGTTTGGGGTCC 360 
 
 
Cg16a: 361  ATTTCTGAACAAAGTATTGGTGGTATTATCTCTACTGGTACTCATGGTTCGTCTCCATTC 420 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
CgCBS: 361  ATTTCTGAACAAAGTATTGGTGGTATTATCTCTACTGGTACTCATGGTTCGTCTCCATTC 420 
 
 
Query: 421  CATGGTCTGGTATCTTCTACTATTGTCAACTTGACTGTTGTCAATGGTAAAGGTGAAGTA 480 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct: 421  CATGGTCTGGTATCTTCTACTATTGTCAACTTGACTGTTGTCAATGGTAAAGGTGAAGTA 480 
 
 
Query: 481  TTATTTTTAGACGAAAAGTCTGACCCTGAAGTTTTCAGGGCTGCTACTTTGTCGCTTGGT 540 
            ||||||||||||||||||||| ||||||||||||||||||||||||||||||||||||||  
Sbjct: 481  TTATTTTTAGACGAAAAGTCTAACCCTGAAGTTTTCAGGGCTGCTACTTTGTCGCTTGGT 540 
 
 
Query: 541  AAGATTGGTATTATTGTGGGTGCAACTGTTCGTGTTGTTCCAGCTTTCAACATTAAATCA 600 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct: 541  AAGATTGGTATTATTGTGGGTGCAACTGTTCGTGTTGTTCCAGCTTTCAACATTAAATCA 600 
 
 
Query: 601  ACCCAAGAAGTTATCAAATTTGAAACTCTTTTGGAAAAATGGGACTCTCTCTGGACTTCT 660 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct: 601  ACCCAAGAAGTTATCAAATTTGAAACTCTTTTGGAAAAATGGGACTCTCTCTGGACTTCT 660 
 
 
Query: 661  TCAGAATTTATCAGAATTTGGTGGTACCCATATACACGTAAGTGTATCCTTTGGAGAGGT 720 
            ||||| ||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct: 661  TCAGAGTTTATCAGAATTTGGTGGTACCCATATACACGTAAGTGTATCCTTTGGAGAGGT 720 
 
 
Cg16a: 721  GTAAAGACTAATGAACCACAGACTAAGTCAAGATATTCGTGGTGGGGTTCTACTCTAGGT 780 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
CgCBS: 721  GTAAAGACTAATGAACCACAGACTAAGTCAAGATATTCGTGGTGGGGTTCTACTCTAGGT 780 
 
 
Cg16a: 781  AGATTTTTCTACCAGACTTTGTTGTTCATATCTACCAAGATTTACCCACCTTTGACTCCA 840 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
CgCBS: 781  AGATTTTTCTACCAGACTTTGTTGTTCATATCTACCAAGATTTACCCACCTTTGACTCCA 840 
 
 
Cg16a: 841  TATGTTGAAAGATTTGTCTTCAGAAGACAATATGGTGAAGTTGAAACCCTAGGTAAAGGT 900 
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            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
CgCBS: 841  TATGTTGAAAGATTTGTCTTCAGAAGACAATATGGTGAAGTTGAAACCCTAGGTAAAGGT 900 
 
 
Cg16a: 901  GATGTGGCAATTGAGGATTCTGTTACTGGGTTCAACATGGACTGTTTGTTTTCTCAGTCC 960 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||| |  
CgCBS: 901  GATGTGGCAATTGAGGATTCTGTTACTGGGTTCAACATGGACTGTTTGTTTTCTCAGTTC 960 
 
 
Cg16a: 961  GTTGATGAATGGGGTTGTCCAATGGACAATGGTTTAGAAGTCTTGCGTTCTCTTGACCAC 1020 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
CgCBS: 961  GTTGATGAATGGGGTTGTCCAATGGACAATGGTTTAGAAGTCTTGCGTTCTCTTGACCAC 1020 
 
 
Cg16a: 1021 TCAATTGCTCAAGCCGCTGCTAACAAGGATTTCTATGTACATGTCCCAGTTGAGGTTCGT 1080 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
CgCBS: 1021 TCAATTGCTCAAGCCGCTGCTAACAAGGATTTCTATGTACATGTCCCAGTTGAGGTTCGT 1080 
 
 
Cg16a: 1081 TGTGCAAACACAACTTTGCCAAAGGAACAACCTGAAACTTCTTTCCGTTCTAACACTAGT 1140 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
CgCBS: 1081 TGTGCAAACACAACTTTGCCAAAGGAACAACCTGAAACTTCTTTCCGTTCTAACACTAGT 1140 
 
 
Cg16a: 1141 AGAGGTCCAGTTTACGGTAACCTATTACGTCCTTACTTGGATAACACCCCATCTCAATGC 1200 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
CgCBS: 1141 AGAGGTCCAGTTTACGGTAACCTATTACGTCCTTACTTGGATAACACCCCATCTCAATGC 1200 
 
 
Cg16a: 1201 TCTTATGCTCCTATCCACAGTGTTACTAATAGTCAGTTGACGCTATACATTAACGCGACA 1260 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
CgCBS: 1201 TCTTATGCTCCTATCCACAGTGTTACTAATAGTCAGTTGACGCTATACATTAACGCGACA 1260 
 
 
Cg16a: 1261 ATTTACAGACCATTCCACACCAATGCCCCAATTCACAAGTGGTTCACCTTGTTTGAAGAT 1320 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
CgCBS: 1261 ATTTACAGACCATTCCACACCAATGCCCCAATTCACAAGTGGTTCACCTTGTTTGAAGAT 1320 
 
 
Cg16a: 1321 ACAATGTCTGCTGCTGGCGGTAAACCACATTGGGCTAAGAACTTCTTGGGCTCTACCTCT 1380 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
CgCBS: 1321 ACAATGTCTGCTGCTGGCGGTAAACCACATTGGGCTAAGAACTTCTTGGGCTCTACCTCT 1380 
 
 
Cg16a: 1381 TTTGCTCAAGGTCAAGTTAAGGCTGAAGGTCAATACCAAGACTATGAGATGAGAGGTATG 1440 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
CgCBS: 1381 TTTGCTCAAGGTCAAGTTAAGGCTGAAGGTCAATACCAAGACTATGAGATGAGAGGTATG 1440 
 
 
Cg16a: 1441 GCTACAAGAGTCAAGGAATGGTATGGTTCAGACTTGGAAACCTTTAAGAAGGTTAGAAGA 1500 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
CgCBS: 1441 GCTACAAGAGTCAAGGAATGGTATGGTTCAGACTTGGAAACCTTTAAGAAGGTTAGAAGA 1500 
 
 
Cg16a: 1501 GAACAAGACCCAGACAACATTTTCTTGGCAAACAAACAGTGGGCCTTGATCAACGGTATC 1560 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
CgCBS: 1501 GAACAAGACCCAGACAACATTTTCTTGGCAAACAAACAGTGGGCCTTGATCAACGGTATC 1560 
 
 
Cg16a: 1561 ATTGATGAAAACGAATAA 1578 
            ||||||||||||||||||  
CgCBS: 1561 ATTGATGAAAACGAATAA 1578 
 
 
Fig 3.8   Alignment of CAGL0H04125g ORF published in the CGD with the sequenced insert (16a) in this study.  
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Using the ExPASy gene sequence translate tool http://web.expasy.org/translate/ , cloned ALO1 gene 
sequence was translated to its protein sequence (Fig. 3.9). Based on BLAST search prediction the 
submitted ALO1 protein sequence had a putative binding site for covalently bound flavin adenine 
dinucleotide (FAD) of oxygen-dependent oxidoreductases corresponding to amino acid residues 25-161 
and ALO1 domain between intervals 188-510 (Fig. 3.10). Comparing the ALO1 protein in this study 
(Cg ALO1) with the sequence available on CGD, the six nucleotide changes result in four amino acid 
changes.  The first three changes appear conservative, while the fourth is a less conservative change, 
resulting into substitution of a serine with a phenylalanine at residue 320 (Fig. 3.10). Comparing the 
ALO1 protein sequence in C. glabrata with characterised ALO1p in S. cerevisiae and C. albicans (Fig. 
3.11) the first yellow highlighted lysine in CAGL0H04125g was replaced with glutamic acid in the 
sequenced Cg ALO1 (C. glabrata 16a in this study) which is similar to C. albicans ALO1p and 
asparagine (blue highlight in Fig 3.11) was replaced with aspartic acid which is similar to S. cerevisiae 
ALO1sequence. 
In order to overexpress ALO1 in C. glabrata, the plasmid HHT2-ALO1 was constructed by inserting the 
entire ALO1 gene and its flanking sequences into the plasmid pCU-HHT2, as described in Materials and 
Methods. C. glabrata (ΔURA3) cells were transformed with the parental plasmid pCU-HHT2 or HHT2-
ALO1, and transformants containing either plasmid C. glabrata HHT2 or C. glabrata 16a subsequently, 
were selected by plating on minimal media lacking uracil.  
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M C V T D E W M M N L D K M N K L T D F V E N E D K T Y A D V T I Q G G T R L Y E I H R M L R E K G Y A M Q S L 
G S I S E Q S I G G I I S T G T H G S S P F H G T V S S T I V N L T V V N G K G E V L F L D E K S D P E V F R A A T L S 
T G K I G I I V G A T V R V V P A F N I K S T Q E V I K F E T T L E K W D S T W T S S E F I R I W W Y P Y T R K C I T W 
R G V K T N E P Q T K S R Y S W W G S T T G R F F Y Q T L L F M S T K I Y P P L T P Y V E R F V F R R Q Y G E V E T 
T G K G D V A I E D S V T G F N M D C L F S Q S V D E W G C P M D N G L E V L R S T D H S I A Q A A A N K D F Y V 
H V P V E V R C A N T T L P K E Q P E T S F R S N T S R G P V Y G N T L R P Y L D N T P S Q C S Y A P I H S V T N S Q 
L T T Y I N A T I Y R P F H T N A P I H K W F T L F E 
Figure 3.9  ALO1 protein sequence which resulted from translation of the sequenced Cg ALO1 gene 
in this study. The highlighted amino acids are different from those in the predicted sequence of C. 
glabrata ALO1 protein as it was published by the CGD. 
 
 
 
 
 
Figure 3.10  Diagram represents FAD binding domain (interval 25-161) and ALO1 (interval 188-510) 
domain, which is specific to D-arabinono-1,4-lactone oxidase, in the submitted C. glabrata ALO1 
sequence. Conserved domains have been detected in the submitted protein sequence using NCBI Blast 
tool http://blast.ncbi.nlm.nih.gov/Blast.cgi. 
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Scer|YML086C             ----------------------------MSTIPFRKNYVFKNWAGIYSAKPERYFQPSSI 
Cgla|CAGL0H04125g        --------------------------MDLKTFGGRRNFVFRNWAGIYSSRPEWYFQPSSV 
Calb|orf19.7551          ----------------------MTDIPESLKPFVTKKVIHSTWAGTFLCKPQAIFQPRNV 
 
 
Scer|YML086C             DEVVELVKSARLAEKSLVTVGSGHSPSNMCVTDEWLVNLDRLDKVQKFVEY--------- 
Cgla|CAGL0H04125g        DEVVEIVKAAKLKNKTIVTVGSGHSPSNMCVTDEWMMNLDKMNKLLDFVEN--------- 
Calb|orf19.7551          EEIQELIKQARLHGKTIMTVGSGHSPSDLTMTTEWLCNLDKFNHVLLEEPYYAPKSPTDD 
* 
 
Scer|YML086C             -PELHYADVTVDAGMRLYQLNEFLGAK-GYSIQNLGSISEQSVAGIISTGSHGSSPYHGL 
Cgla|CAGL0H04125g        -EDKTYADVTIQGGTRLYKIHKILREK-GYAMQSLGSISEQSIGGIISTGTHGSSPFHGL 
Calb|orf19.7551          TPEIKFVDLTVEAGTRIFELNEYLKRN-NLAIQNLGSISDQSIAGLISTGTHGSTQYHGL 
 
 
Scer|YML086C             ISSQYVNLTIVNGKGELKFLDAENDPEVFKAALLSVGKIGIIVSATIRVVPGFNIKSTQE 
Cgla|CAGL0H04125g        VSSTIVNLTVVNGKGEVLFLDEKSNPEVFRAATLSLGKIGIIVGATVRVVPAFNIKSTQE 
Calb|orf19.7551          VSQQVVSVKFLNSAGELITCSSVDKPEYFRAILLSLGKIGIITHVTLRTCPKYTIKSKQE 
 
 
Scer|YML086C             VITFENLLKQWDTL--WTSSEFIRVWWYPYTRKCVLWRGNKTT--------DA-QNGPAK 
Cgla|CAGL0H04125g        VIKFETLLEKWDSL--WTSSEFIRIWWYPYTRKCILWRGVKTN--------EP-QTKSRY 
Calb|orf19.7551          IINFETLLNNWDNL--WLESEFIRIWWFPYTNKCVLWRANKST--------DP-LSDPRP 
 
 
Scer|YML086C             SWWGTKLGRFFYETLLWISTKIYAPLTPFVEKFVFNRQYGKLEKS--STGDVNVTDSISG 
Cgla|CAGL0H04125g        SWWGSTLGRFFYQTLLFISTKIYPPLTPYVERFVFRRQYGEVETL--GKGDVAIEDSVTG 
Calb|orf19.7551          SWYGTKLGRFFYESLLWVSVHLFPRLTPFVEKFVFGQQYGEVETL--GKGDIAVQNSVEG 
 
 
Scer|YML086C             FNMDCLFSQFVDEWGCPMDNGLEVLRSLDHSIA-------------QAAINKEFYVHVPM 
Cgla|CAGL0H04125g        FNMDCLFSQFVDEWGCPMDNGLEVLRSLDHSIA-------------QAAANKDFYVHVPV 
Calb|orf19.7551          LNMDCLFSQFVNEWSSPLNSGPEILTELKKIIT-------------DASQTGDFFVHAPI 
 
 
Scer|YML086C             EVRCSNTTLPSEPLD---------------TSKRTNTSPGPVYGNVCRPFLDNTPSHCRF 
Cgla|CAGL0H04125g        EVRCANTTLPKEQPE---------------TSFRSNTSRGPVYGNLLRPYLDNTPSQCSY 
Calb|orf19.7551          EVRCSNVTYSDEPFT-DDKNQKSLYPSQEWLSNRSKTSAGPIPGNNLRPYLDNSPK-LPY 
 
 
Scer|YML086C             APLEN---VTNSQLTLYINATIYRPFGCNTP---IHKWFTLFENTMMVAGGKPHWAKNFL 
Cgla|CAGL0H04125g        APIHS---VTNSQLTLYINATIYRPFHTNAP---IHKWFTLFEDTMSAAGGKPHWAKNFL 
Calb|orf19.7551          SKDGK---ITNDQLTLFINATMYRPFGTNVE---THKWFQLFEDVMSKAGGKPHWAKNFI 
 
 
Scer|YML086C             GSTTLAA--------GPVKKDTDYDD---FEMRGMALKVEEWYGEDLKKFRKIRKEQDPD 
Cgla|CAGL0H04125g        GSTSFAQ--------GQVKAEGQYQD---YEMRGMATRVKEWYGSDLETFKKVRREQDPD 
Calb|orf19.7551          GLTQDEKYDKQ----QDLKTQLEFGGKPFYTMLGFKPVMQDWFGKDLVAFNKVRKETDPD 
 
 
Scer|YML086C             NVFLANKQWAIIN----------------------------------------------- 
Cgla|CAGL0H04125g        NIFLANKQWALIN----------------------------------------------- 
Calb|orf19.7551          GVFLSGKVWAERN----------------------------------------------- 
 
 
Scer|YML086C             ---------------------------------GIIDPSELSD----- 
Cgla|CAGL0H04125g        ---------------------------------GIIDENE-------- 
Calb|orf19.7551          ---------------------------------GILLD---------- 
 
K = E; K = R; N = D; F = S in C. glabrata 16a 
 
 
Figure 3.11 Multiple ALO1 protein sequence alignment in C. glabrata ATCC2001 (CAGL0H04125g) with S. 
cerevisiae (YML086C) and C. albicans (orf19.7551). Colored amino acids indicate a difference between published 
sequence on CDG data base and ALO1 sequence analysed in this study. The regions where the sequences have been 
extended to allow optimal sequence alignment are indicated with dashes. Identical residues are shaded. The asterisk 
indicates the histidine residue believed to be responsible for covalent attachment of FAD. 
 * 
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3.3.7 Candida glabrata transformants produce higher amounts of EASC 
The presence of intracellular EASC in the resulted transformants C. glabrata 16a (carrying 
HHT2-ALO1) and C. glabrata HHT2 (carrying pCU-HHT2) was confirmed and the level 
quantified by comparison to a known standard using LC-ESI-MS/MS run in Multiple Reaction 
Monitoring (MRM) mode. 20 µl from the soluble extract of each strain were subjected to 
analytical liquid chromatography/tandem mass spectrometry to compare the concentration of 
EASC at each extract. The MS chromatogram of the strain 16a and HHT2 by LC/MS/MS is 
presented in figure 3.12A. The peak identity was determined by comparing the retention time of 
the analyte to the standard (EASC) as well as by MS at m/z 177.1 (Fig. 3.12B). Multiple 
Reaction Monitoring (MRM) recorded MS/MS ions at m/z 85.1 and 95.1 resulting from 
fragmentation of m/z 177.1 (data not shown). Strain 16a showed a notable increase of EASC 
production compared to the EASC produced by the control strain HHT2. The content of EASC 
in 16a strain was estimated to be about 2.5 fold higher than that of HHT2 strain. Moreover, 
MRM analysis of the EASC produced by both strains confirmed the characteristic fragment ion 
at m/z 95.1 which would have originated from a direct elimination of heterocyclic ring from the 
parent ion.  
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Figure 3.12 The Extracted Ion Chromatogram (EIC) for protonated EASC and ESI-MS Spectra (a) EASC 
in C. glabrata 16a strain (pink) and C. glabrata HHT2 strain (red). (b) ESI-MS Spectra. 
 
 
 
3.3.8 Effect of EASC over production on resistance to oxidative stress 
The difference in sensitivity of C. glabrata HHT2 and C. glabrata 16a to hydrogen peroxide and 
thymoquinone as pro-oxidants was tested in liquid and solid YMM media. Over three biological 
replicates in YMM liquid media no significant difference was observed between sensitivity of 
both strains to the oxidants. Likewise on YMM agar plates transformants did not show 
(A) 
(B) 
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differences in their sensitivity to either H2O2 or TQ compared with the strain that carries empty 
vector (Fig. 3.13). The wild type strain (C. glabrata ATCC2001) showed less sensitivity to H2O2 
than transformants when they were spotted on agar plates carrying the pro oxidants. The results 
of C. glabrata sensitivity to H2O2 are in agreement with other results were obtained in previous 
studies (Cuellar-Cruz et al., 2008, Roetzer et al., 2011b).  
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Figure 3.13 Sensitivity of C. glabrata 16a to H2O2 and TQ 
compared with the wild type C. glabrata ATCC2001(WT) 
and the control strain (C. glabrata HHT2). (A) Ten fold 
serial dilutions of cell suspensions were spotted on YMM 
plates supplemented with H2O2 or TQ. (B) Cells were treated 
with H2O2 or TQ for 1 h in YMM liquid medium then viable 
cells were counted, error bars indicate means of three 
replicates and SEM. 
(A) 
(B) 
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3.4  Discussion 
 
3.4.1 Thymoquinone induces death via oxidation in C. glabrata 
An oxidant/antioxidant ability of TQ depends on the milieu where it is present (Mansour et al., 
2002). Based on the possible involvement of pro-oxidant activity in the fungicidal effect of TQ 
two well-known antioxidants, GSH and ascorbic acid, were investigated.  Both antioxidants 
could abrogate drastically the toxicity of TQ (Fig.3.2). Combination of TQ and these 
antioxidants was examined to identify the initial products that are responsible for TQ toxicity 
which seemed to be reactive oxygen species (ROS). The increased production of ROS by cells 
treated with TQ confirmed the oxidative effect of TQ (Fig. 3.3).  However, a further experiment 
was needed to find out whether TQ induces ROS production which leads to cell death or ROS is 
a bystander that accumulates as a result of cellular demise. The results of cell staining with DFC 
and PI showed that part of treated population of cells generate ROS but still keep their cell 
membrane integrity, confirming the generation of oxidative stress leading to cell death. This 
accumulation of cellular ROS results in oxidative damage to important cell biomolecules such as 
proteins, DNA and lipids. Failure to avoid such damage is associated with cell death (Farrugia et 
al., 2012). Because accumulation of ROS involves a change in the redox state of cells, functions 
that are involved in setting redox and maintaining redox homeostasis are relevant to an 
understanding of the possible intracellular actions of TQ. For instance, interference with the 
electron flow through the mitochondrial respiratory chain is one of the major sources of ROS in 
yeast (Eisenberg et al., 2007, Vandeputte et al., 2009).  Drugs that cause a damage in the electron 
flow of the respiratory chain lead to reduction of mitochondrial dye uptake. Thus the effect of 
TQ on depolarization of mitochondrial membrane potential in C. glabrata was monitored by      
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rhodamine123 uptake. Figure 3.6 demonstrates that the membrane potential of TQ-treated C. 
glabrata mitochondria was much lower than that of the control mitochondria. Significant, yet 
incomplete, depolarization could be observed in the presence of 50 µg/ml TQ within 4 h. This 
indicates loss in the membrane potential. 
 
3.4.2 Reduced glutathione protects from TQ oxidation 
Glutathione has a low redox potential (E0 = 0.24 V) and high concentration (2–3 mM) in yeast 
cells. This intracellular reducing power provides an ability to eliminate potentially harmful free 
radicals and reactive oxygen species (Fortuniak et al., 1996, Jamieson, 1998, Yadav et al., 2011). 
Glutathione plays a major role in determining the cellular redox environment in most yeast 
cellular compartments including mitochondria, nucleus, cytosol and the endoplasmic reticulum 
which is the most oxidative compartment in the cell. Therefore the redox state of the GSH/GSSG 
redox couple provides a good indication of the redox environment of cells and most cell 
compartments (Ayer et al., 2013). Thymoquinone (50 µg/ml) at 2 h caused depletion in the GSH 
reduced form which indicates the consumption of GSH in an attempt to stabilize the redox 
homeostasis in the cell. The decrease in GSH concentration (relating to fluorescence intensity) 
was not significant once cells were exposed to 25 µg/ml: this is due to the high density of cells 
that was used in this assay (OD600= 1). It has been documented that exponential phase cells have 
a lower storage of glutathione than yeast cells in stationary phase (Izawa et al., 1995). In 
agreement with this less fluorescent intensity of mBCl was observed once untreated exponential 
phase cultures were used (data not shown). Therefore, in this experiment it was decided to use 
cells from an overnight plate rather than cells in exponential phase. Cells from a plate have a 
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mixture of cells at different growth phases similar in that respect to populations that are found in 
the environment. Yadav et al. (2011) showed that C. glabrata is not able to use exogenous 
glutathione due to the lack of a glutathione transporter. However, Gutierrez-Escobedo et al. 
(2013) showed that C. glabrata gsh1∆ pro2-4 and gsh2∆ mutant strains are able to incorporate 
GSH from the medium. This study also shows the protective effect of exogenous reduced 
glutathione to rescue C. glabrata from TQ toxicity which indicates the ability of these cells to 
incorporate GSH from the medium.  
 
3.4.3 C. glabrata can produce intracellular D-erythroascorbic acid  
Supplementation of C. glabrata cells with extracellular ascorbic acid was protective against TQ 
toxicity and identifying whether endogenous ascorbic acid homolog would be protective was 
asked in this study. In C. glabrata, the ALO1 gene is 1,595 bp in size and encodes 557 amino 
acids with a calculated molecular mass of 63,428 Da. It was predicted to encode D-arabinono-
1,4-lactone oxidase (ALO1p) that catalyzes the final reaction of EASC biosynthesis.  This study 
confirmed further its sequence and function.  LC-MS/MS analysis indicates intracellular 
biosynthesis of  EASC in C. glabrata. In addition the increase in EASC production via cloning 
of CAGL0H04125g ORF confirms the involvement of this gene in EASC biosynthesis. The 
transformants, carrying ALO1 on a multicopy plasmid, showed a 2.5 fold increase in EASC 
production compared with the control strain. In S. cerevisiae EASC has been reported to function 
as an important antioxidant like ascorbic acid in higher animals and plants (Huh et al., 1998). 
The present study did not show a major role of EASC in defence against oxidation. This might 
be due to the limited increase (2.5-fold) in EASC production compared with that in S. cerevisiae  
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transformants which led to approximately 7-fold increase in EASC (Huh et al., 1998) and 4-fold 
increase in  C. albicans transformants (Huh et al., 2001). However, further investigation of the 
importance of ALO1 in C. glabrata as antioxidant needs to be confirmed by generation of C. 
glabrata ALO1 mutant strain. 
 
 
3.5 Conclusion 
In conclusion, these data support the hypothesis that generation of intracellular oxidative stress is 
definitely a part of thymoquinone’s mechanism of action as a fungicidal agent.  Oxidative stress 
caused by TQ leads to loss of cell membrane integrity, reduction in reduced glutathione amount 
and reduced mitochondrial membrane potential. D-erythroascorbic acid was identified as an 
important antioxidant in other yeast, the over produced amount in this study was not enough to 
create a significant difference in overcoming the oxidative stress caused by H2O2 or TQ.    
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CHAPTER 4:  
 
A model of hypo-osmotic stress to screen cell wall MAPK inhibitors in C. 
glabrata 
 
4.1 Introduction 
In yeast, oxidative stress induces several mitogen activated protein kinases (MAPK) and 
signalling routes. These include PKC1 MAPK, TOR and RAS-PKA-cAMP. Cross-talk between 
these signalling pathways exists to activate transcription factors required for the expression of 
response genes (reviewed by (de la Torre-Ruiz et al., 2010). The PKC1 (Protein kinase C)-
MAPK which is known also as the cell wall integrity (CWI) MAPK is activated usually in 
response to stress of the cell surface. Cell wall integrity is essential for viability of fungi and is 
an effective drug target in pathogens such as Candida glabrata (Hohmann, 2002). Cell wall 
stress sensors pass the signal through CWI MAPK cascade (Fig. 1.2) to activate transcription 
factors, mainly Rlm1 and SBF complex (consisting of Swi4 and Swi6) which are required for the 
expression of cell wall biogenesis genes (Jendretzki et al., 2011).  In Saccharomyces cerevisiae 
phosphorylation of the last mitogen-activated protein kinase SLT2 in the CWI MAPK cascade 
has been reported under stress conditions such as growth at high temperatures, hypo-osmotic 
shock, oxidative stress, polarized growth, actin perturbation or the presence of compounds or 
mutations that interfere with cell wall biosynthesis (Davenport et al., 1995, Soriano-Carot et al., 
2012, Krasley et al., 2006b). Therefore, the activation of SLT2 in C. glabrata under hypo-
osmotic and oxidative stress is proposed in this study. Phosphorylation of SLT2 has been 
reported to mediate cyclin C destruction in response to H2O2 treatment which enables the genetic 
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response in S. cerevisiae (Krasley et al., 2006a). Likewise, thymoquinone as a pro-oxidant might 
induce SLT2 phosphorylation in C. glabrata.  
 
Candida glabrata ∆slt2 strain has been shown to be more sensitive to antifungal agents such as 
caspofungin due to its decreased chitin content (Cota et al., 2008). In terms of thymoquinone’s 
action, inhibition of CWI MAP kinase might interfere with the normal response to oxidation and 
as a result the sensitivity of C. glabrata to TQ will be increased.  
 
As hypotonic shock is an inducer of CWI MAPK, suspending cells in water might be a useful 
model to screen inhibitors of this cascade. A considerable amount of work has been carried out 
on hyper osmotic stress signalling in S. cerevisiae (Dickinson and Schweizer, 2004), but less 
work has been reported on hypo-osmotic stress signalling response. Cells suspended in water 
experience hypo-osmolarity that may result in a rapid inflow of water, cell swelling and 
increased turgor pressure. Weaknesses in lipid–lipid bonding may also lead to cell lysis due to 
chaotropic solutes (Cray et al., 2013). However, activation of protective mechanisms, such as 
release of osmolytes and remodelling of the cell wall, plays an important role in preventing cell 
rupture (Hohmann, 2002). Efflux of intracellular electrolytes and small organic solutes 
‘osmolytes’ is a universal response to cell swelling (Strange et al., 1995). Protozoa and lung 
cancer cells release amino acids in response to acute hypo-osmotic stress (Kirk, 1997). In other 
organisms such as the algae Dunaliella tertiolecta, intracellular osmolytes are depleted by 
metabolism and not released in response to hypo-osmotic stress (Goyal, 1989). In yeast, glycerol, 
arabitol and erythritol are released in response to hypo-osmotic stress (Kayingo et al., 2001, 
Fuchs et al., 2009). Until recently, there was no clear evidence on whether yeast cells undergoing 
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apoptotic or necrotic death in case cellular defence mechanisms failed under hypo-osmotic 
stress. This study attempted to define whether death under hypo-osmotic stress would be an 
apoptotic or necrotic death (Almshawit et al., 2014). 
 
Cells in water might be a useful model to study CWI MAPK pathway and the physiology of the 
cells. Moreover, preparing yeast suspensions in water is a critical step in many experiments, 
including the preparation of inocula by standard methods to determine antifungal susceptibility. 
In addition, laboratory studies frequently involve yeast, including C. glabrata suspended in water 
to monitor the effects of carbon sources, drugs and peptides such as glucose, dopamine and 
amyloid beta (Macreadie et al., 2010, Granot et al., 1993, Bharadwaj et al., 2008). 
 
The hypothesis of this chapter is “thymoquinone induces SLT2 phosphorylation, and inhibition 
of SLT2 phosphorylation or CWI MAPK cascade activation will result in increasing the 
sensitivity of C. glabrata to TQ”.   Briefly the present study aimed to: 
i. Determine whether hypo-osmolarity and thymoquinone induce SLT2 phosphorylation in 
C. glabrata. 
ii. Monitor survival of C. glabrata in water as a hypo-osmotic environment. 
iii. Use cells in water to screen cell wall MAPK inhibitor(s) which might interact 
synergistically with thymoquinone.  
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4.2 Materials and methods 
4.2.1 Strains and media 
The strains used in this study were C. glabrata ATCC2001 and ATCC90030.  Yeast minimal 
medium (YMM), RPMI1640 and YEPD media (appendix A) were used where they were need. 
 
4.2.2  Detection of Slt2 phosphorylation 
Detection of Slt2 phosphorylation by flow cytometry was carried out using Phospho-p44/42 
MAPK (Erk1/2) (Thr202/Tyr204) Antibody (Cell Signaling Technology). Cells of C. glabrata 
ATCC2001 from an overnight YEPD plate were used to inoculate YEPD liquid medium and 
incubated 4-5 h at 30 ºC with agitation (200 rpm).  Cells were washed with RPMI1640 and 
resuspended in the same medium unless they were washed and suspended in water.  
 
For TQ, H2O2 and water treatment 10
6
 cell/ml were used. Cells were treated with 25, 50 or 100 
µg/ml of TQ or 30 mM hydrogen peroxide. Samples were collected after 1 and 2 h including 
untreated cells. For testing of Slt2 induction by doxycycline, four millilitres of OD600 = 1 of C. 
glabrata ATCC2001 exponential phase culture were collected at 0, 30 and 60 min after adding 
doxycycline at a final concentration of 25, 50 or 100 µg/ml. Cells were fixed, permeabilised and 
antigen detected according to the manufacturer’s instruction of the primary antibody. Briefly, C. 
glabrata ATCC2001 from an overnight plate was inoculated into YEPD liquid medium and 
incubated 4 – 5 h with shaking at 30 ºC. The cells were harvested and washed with RPMI1640 
medium then the cells were resuspended in the same medium to reach OD6   of ≥ 1. The 
suspension was diluted 1:10 and 1 ml was collected at the start (t=0). Part of the cell suspension 
was left without treatment and the rest was treated with TQ, H2O2 or washed and resuspended in 
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water. At different time intervals 1 ml sample was collected from each treatment and 100 µl of 
37% formaldehyde was added. The samples were incubated at 37 ºC for 10 min, chilled on ice 
for 1 min and centrifuged (9000 rpm) for 1 min. The pellets were resuspended in 100 µl PBS. 
Permeabilisation was carried out by adding 900 µl of 100% cold methanol (-20 ºC) and 
incubated on ice for 30 min. For immunostaining, Cells were harvested and washed with PBS. 
Pellets were resuspended in blocking buffer by vortexing and incubated for 10 min at room 
temperature. Then the cells were harvested and resuspended in blocking buffer contained 1:200 
diluted Phospho-p44/42 MAPK primary antibody. Cells were incubated 1 h at room temperature. 
After washing with PBS the cells were suspended in 1:1000 diluted an anti-rabbit HRP 
secondary antibody (Sapphire, Australia) in blocking buffer and incubated for 30 min in dark at 
room temperature. After three times washing with PBS, fluorescence intensity was detected by 
AmCyan filter in FACS Canto II (BD Biosciences) flow cytometer. 
 
Detection of SLT2 phosphorylation by TQ was also performed by total protein extraction and 
analyzed by western blot as previously described in (Casagrande et al., 2009). Briefly, C. 
glabrata ATCC2001 cells were growing exponentially in a flask containing YEPD medium (30 
°C, 175 rpm) to OD600nm = 0.2. Four millilitres of OD600= 1 were withdrawn for t = 0. 
Thymoquinone was then added to a final concentration of 50 µg/ml and the incubation was 
continued. Four OD units of cells were withdrawn after 30 and 60 min from TQ addition. Culture 
samples were centrifuged at 4 °C and washed with water. Cells were resuspended in 0.2 ml of 2 
M NaOH, 5% β-mercaptoethanol and incubated 10 min on ice. After the addition of 40 µl of 
50% trichloroacetic acid, samples were incubated on ice for further 10 min. After centrifugation 
(15 min at 13600g), the pellet was dried at room temperature (5 min) and resuspended in loading 
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buffer (50 mM Tris-HCl, pH 6.8, 1 % β-mercaptoethanol, 2% SDS, 0.1% bromophenol blue, 
10% glycerol). After SDS-polyacrylamide gel electrophoresis fractionation and transfer onto 
nitrocellulose membrane by using iBlot
TM
 Dry Blotting System (Invitrogen).  Phosphorylated 
SLT2 was detected by hybridization with antibody p44/42 (thr202/tyr204; Cell Signaling 
Technology #9101) and total SLT2 was detected with antibody Slt2 (Santa Cruz Biotechnology 
#sc-6802). Alkaline phosphatase (AP) secondary antibody (anti- rabbit-IgG-AP conjugated 
antibody) was used to detect both proteins.  
 
4.2.3 Viability assays 
Candida glabrata cryogenic stocks were subcultured at least five times on YEPD plates, 
inoculated into 2 ml YEPD liquid medium and incubated for 24 h with agitation (170 r.p.m.). 
Cells were collected by centrifugation in a high-speed microcentrifuge (LaboGene ApS, 
Denmark) at 8500 rpm for 1 min, washed six times with sterile MilliQ water and suspended in 
MilliQ water to a specific cell density. Cultures were then incubated at 30 °C with agitation (170 
rpm) in 50 ml centrifuge tubes with a working volume of 2 ml. One hundred microlitre aliquots 
of cells were taken at indicated time points to measure cell viability, as colony-forming units on 
YEPD agar plates. 
 
4.2.4 Propidium iodide staining 
Propidium iodide (PI) was purchased from Sigma-Aldrich (Australia). A modified PI staining 
protocol from Invitrogen was used to measure cell viability. Briefly, 3 µM solution of PI was 
made by diluting 1 mg/ml (1.5 mM) stock solution 1:500 in phosphate-buffered saline (PBS), 
which was then filtered through 0.22 µm syringe filters (Millex). One ml samples of C. glabrata 
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cells in water were centrifuged at 8500 rpm. for 1 min, and the pellets were suspended in PBS 
containing 3 µM PI. The samples were incubated at 30 °C for 30 min before flow cytometry 
analysis using a FACS Canto II (BD Biosciences) flow cytometer. 
 
4.2.5 Bio-protection assays 
Materials released by cells were obtained by incubating cells at 10
6
 CFU/ ml for 1–2 days in 
water. Cells were removed by filtration through 0.22 µm syringe filters. Aliquots of filtrates were 
plated on YEPD to check sterility before further investigations. The filtrates were used either 
directly, or they were lyophilized and reconstituted as concentrated samples. Samples were 
analysed using spectrophotometer (Shimadzu UV-1800) before using the filtrate for bio-
protection assay. 
 
For protection studies using dead cells, 10
4
 CFU/ml were left in water for 4 days to die naturally 
(99.7% death as quantified by counting colonies). After that, C. glabrata cells from a YEPD 
culture grown for 24 h were washed and mixed with the dead cells at a concentration of 5.7x10
3
 
CFU/ml. The growth was monitored by counting the colonies. Two independent experiments 
were performed with three replicates each time. 
 
To test whether the effect of hypo-osmolarity on low density cells can be eliminated by sorbitol, 
about 2x10
3
 CFU/ml was suspended in 5 µM, 50 µM or 1 M of sorbitol (Sigma) and incubated 
for 24 h at 30 °C with shaking (170 rpm). The impact of low concentration of nutrients on the 
survival of low-density cells was tested by suspending the cells in diluted yeast minimal media 
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(YMM) which was sterilized by filtration through 0.22 µm syringe filters (Millex). Then cells 
were suspended in 1:100 or 1: 1000 diluted YMM. 
 
4.2.6 Testing for apoptosis 
Due to the difficulty in collection and observation of dead cells in low-density cell suspensions 
through the microscope, apoptosis was observed by dialysing high density cell cultures. About 
10
6 
CFU/ml was washed as described above, and 4 ml of the cell suspension was dialysed in 
dialysis membranes (12 kDa MWCO), surrounded by 3 L of MilliQ water. The number of 
colonies per millilitre was determined after 2 or 3 days at 30 °C. The annexin V-FITC Apoptosis 
Detection kit (APOAF-20TST; Sigma-Aldrich) was used for detecting apoptotic cells. Two 
samples of 1 ml from 3 days dialysed high-density cells (10
6
 CFU/ml) were centrifuged (8500 
rpm, 1 min) and resuspended in 1 ml binding buffer. Ten microlitre PI and 5 µl FITC-annexin V 
solutions were added to each 500 µl dialysed cell suspension and incubated 10 or 30 min at room 
temperature. After that, cells suspensions were centrifuged at 8500r.p.m. for 1 min, and the 
content of the tubes (pellet from 500 µl sample each) were combined in one tube by washing 
with 500 or 20 µl sterile MilliQ water for flow cytometry or fluorescence microscopy analysis, 
respectively. Cells grown in YEPD media to exponential phase were used as a negative control. 
Cells were analysed by a FACS Canto II (BD Biosciences) flow cytometer or observed using an 
epifluorescence microscope (Leica DM2500) provided with camera (Leica DFC310 FX ). 
For DNA microscopic observation, cells were harvested by centrifugation at 8000 rpm. for 1 
min, washed, resuspended in 3 µM DAPI (4′,6-diamidino-2-phenylindole dihydrochloride; 
Sigma) and incubated for 15 min at room temperature in the dark. Then, cells were washed and 
resuspended in PBS. For cell cycle analysis by flow cytometry, cell suspensions, of about 10
6
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cell/ml of overnight culture in YEPD, and dialysed cells were fixed and permeabilized with 70% 
cold ethanol on ice for 5 min, rehydrated in PBS at room temperature for another 5 min and then 
cells were harvested and stained with DAPI as described above (Liang et al., 2007, Li et al., 
2006). Cells were analysed by flow cytometry using a pacific blue
TM
 filter (Ex-Max 401 nm). 
 
4.2.7 Toxicity of compounds on cell’s survival in water 
One mg/ml stausporine stocks were prepared in ethanol and stored at -20°C. Sorafenib and 
XMD8-92 (Santa cruz, USA) stocks were prepared freshly in DMSO and doxycycline was 
dissolved directly in water. Cells in water were prepared as in 4.2.2. Thymoquinone stocks were 
prepared freshly in DMSO or stocks were kept at -20 °C for no longer than 2 weeks. 
Susceptibility testing to TQ, stausporine and doxycycline was performed using the standardized 
broth microdilution assays as defined by CLSI (see 2.2.1). 
 
4.2.8 Statistical analysis 
For statistical analysis, One-way ANOVA with Tukey’s multi comparisons test was performed 
using GraphPad Prism 6 software. The control groups were the cultures at time zero. Error bars 
represent the standard error of the mean (SEM). Differences were considered significant for P < 
0.05. WEASEL software (WEHI, Parkville, VIC, Australia) or Flowing software (Cell Imaging 
Core of the Turku Centre for Biotechnology, Finland, version 2.5.1) were used for flow 
cytometry data analysis. 
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4.3 Results 
4.3.1 Thymoquinone, hydrogen peroxide and hypo-osmolarity induces SLT2 
phosphorylation in C. glabrata 
Many pro-oxidants including H2O2 and diamide were found to be inducers of SLT2 
phosphorylation in S. cerevisiae (Vilella et al, 2005). In this study H2O2 and TQ induced SLT2 
phosphorylation in C. glabrata. Flow cytometry data analysis showed no difference between the 
fluorescence intensity after 1 h and 2 h treatment of TQ or H2O2. The shift in the fluorescence 
intensity was not too high in cells which were treated with 50 µg/ml of TQ (~ 9%) but enough to 
be statistically significant. Higher concentration of TQ (100 µg/ml) result in higher fluorescent 
intensity (~34%) (Fig. 4.1A). Treatment with water caused insignificant increase in intensity 
after 1 h (~4%) but the intensity was increased to be about 17 % after 2 h. Additional 
examination was carried out to observe SLT2 phosphorylation under TQ stress. Western blotting 
analysis of the total protein showed bands indicating the phosphorylation of SLT2 after treatment 
with 50 µg/ml of TQ for 30 min (Fig. 4.1B).  
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Figure 4.1 Induction of SLT2 phosphorylation by TQ, H2O2 and water treatment. (A) Representative 
FACS histograms of C. glabrata without treatment or with TQ, H2O2 or water. Cells were analysed after 
1 h and 2 h. Data were analysed using Flowing software: the percentage represent the fluorescence 
emission mean of two independent experiments. (B) Western blot analysis for C. glabrata cells treated 
with 50 µg/ml TQ; samples were taken at 0, 30 and 60 mins. This figure represents one of two 
independent experiments. 
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4.3.2 Cell viability and cell density 
The effect of cell density on the viability of C. glabrata in water was examined by plating cells 
to measure the number of colony-forming units (CFUs). As shown in Fig. 4.2, cultures with an 
initial high cell density (more than 8x10
4
 CFU/ml) maintained their viability over 3 days. In 
contrast, cells at low density (≤ 8x104 CFU ml) progressively lost their viability. In summary, 
cells at low density lost viability, while a quorum of more than 10
5
 CFU/ml allowed viability to 
be maintained. This experiment has been performed three times independently with four 
replicates each time. 
 
Cell death was also measured using flow cytometry to examine the proportion of cells that could 
be stained with PI, an indicator of cell death. After 24 h, cells in water at high density resulted in  
an average of 1.5 % of cells exhibited red fluorescence indicative of cell death (Fig. 4.3 A and 
B). Thus, the population had 98.5% viability. At low cell density (10
3
 CFU/ml), 44.4% of the 
population were PI-stained after 24 h (Fig. 4.3 C and D). Of the cells that became stained with 
PI, populations exhibited either moderate or higher levels of PI staining. Analysis of PI staining 
vs. forward light scatter which measure cell size (Fig. 4.3 D) indicates that the more highly 
stained cells were larger and therefore able to incorporate more PI.  
 
The question was then asked, could cells at high density be protected by materials from dead 
cells? It has previously been shown that yeast cells can proliferate by utilizing nutrients released 
from cells where 90–99% of the population has died (Fabrizio et al., 2004). In this study, the 
percentage of dead cells was very low. To determine whether such a population of dead cells 
could protect a low-density population, dead cells from an initial population of 10
4 
CFU/ml 
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(99.7% dead after 4 days in water) were added to low-density cell suspension (5.5x10
3 
CFU/ml). 
The suspension of dead cells was incapable of providing protection (data not shown). 
 
 
 
 
Figure 4.2 The relationship between cell density and cell survival in water.  Bars represent SEM.  
*P< 0.05; **P<0.003.  This experiment was repeated at least three times independently with four 
replicates each time, the results of one experiment are shown. 
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Figure 4.3  Analysis of cell viability by flow cytometry.  (A) Cells at high density (10
6 
CFU/ml) 
in water for 24 h without staining with PI.  (B) Same cells as A were stained with PI, and then 
analysed for PI staining versus forward light scatter. (C) Analysis of cells at low density (10
3
 
cells/ml) after 24 h for PI staining, (D) PI staining versus forward light scatter.  This experiment 
was performed three times independently. 
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4.3.3  Bio-protection 
Filtrates of about 10
6 
cell/ml were taken after 1-2 days and were analysed by the 
spectrophotometer. The spectrum showed a hump of peaks at wave length between 200 and 300 
nm (Fig. 4.4). To determine whether a soluble agent(s) could be involved in protection of cells 
from hypo-osmotic stress, a cell filtrate from high-density cells (3x10
6
 CFU/ml) which had been 
analysed by spectrophotometer was added to cells at low cell density (7x10
3
 CFU/ml). Cells at 
low density, suspended in the filtrate from high density cells (3x10
6
 CFU/ml) maintained 
viability (Fig. 4.5A). In the control (without the filtrate from the high density suspension), 
viability decreased to 50% after 24 h. This indicates that the high-density cells release material(s) 
that protect the population against hypo-osmotic sensitivity and starvation. When this protective 
filtrate was concentrated 10-fold by lyophilization and added to a suspension of cells at 7x10
3
 
CFU/ml, the filtrate enabled cells to multiply 40-fold in 2 days (Fig. 4.5B). This experiment was 
performed three times with independent filtrates. The dry weight of exuded materials is < 5 mg/L 
of filtrate. Our efforts to identify the protective agent(s) by lyophilization followed by mass 
spectroscopy and NMR have been unsuccessful due to these low levels and the diversity of 
materials in the filtrate. Many studies use 1 M sorbitol as an osmotic stabilizer (Soriano-Carot et 
al., 2012, de Nobel et al., 2000). Here, figure 4.6 shows that a low concentration of sorbitol (50 
µM) can provide protection to cells at low density, but not 5 µM sorbitol. In contrast, the 
addition of 1:100 diluted YMM media induced growth of the cells, whereas a dilution of 1:1000 
did not contain enough nutrients for growth and did not provide protection. 
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Figure 4.4  UV-CD spectra of high cell density filtrates. The CD spectra were measured at room 
temperature in a cuvette with a path length of 1 mm.  
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Figure 4.5 Bio-protection of low cells at low density by filtrates of high cell density (A) Cells were 
suspended at 7x10
3
 CFU/ml in the filtrate from 3x10
6
 CFU/ml, obtained after one day.  (B) The same 
filtrate was concentrated 10-fold and cells added to cells at a density of 7x10
3 
CFU/ml.  This experiment 
was performed three times with independent filtrates.  Bars represent SEM of four replicates of one batch 
of cells. 
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Figure 4.6  Protection of cells against hypo-osmolarity. (A) by sorbitol, (B) by Yeast Minimal 
Media (YMM) diluted 1:100 and 1:1000. Data represent the mean of two independent 
experiments with three replicates each time. The error bars indicate SEM values. 
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The compounds conferring survival were found to pass through 12-kDa MWCO dialysis 
membranes. After 2 days, about 80% loss of viability was observed in 7x10
5
 CFU/ml cultures 
after dialysis in 12-kDa MWCO dialysis sacs (Fig. 4.7). This indicates that the bioactive 
compounds have molecular weights ≤ 12 kDa, and these compounds have been diluted around 
the cells. As a result, they have lost their resistance to hypo-osmolarity. The loss of viability was 
similar to death rates seen when the population is at 7x10
3
 CFU/ml (Fig. 4.7). Because of the 
difficulty in examining cells when they are at low density, especially for microscopic 
observation, dialysed cells at high density were used to study the mechanism of cell death.  
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Figure 4.7  Effect of dialysis on survival of high cell density in hypo-osmolarity.  Cells at 7x10
5 
CFU/ml 
were dialysed in 14000 MWCO dialysis membranes.  Cells from 24 h YEPD liquid media were washed 
as described and resuspended in water to have 7x10
5
 CFU/ml and incubated at 30°C as indicated.  
Dialysis sacs were dialysed against 100 times the sample volume.  This experiment has been performed 
more than three times with two replicates each time. 
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4.3.4 Apoptotic cell death 
The analysis of flow cytometric data demonstrated that about one quarter of high density 
dialysed cells show FITC-annexin V staining after 3 days dialysis in water (Fig. 4.8). The cell 
staining by FITC-annexin V was further observed by epifluorescence microscopy which showed 
green fluorescence in the periphery of the cytoplasm, indicating phosphatidylserine 
externalization (Fig. 4.8c upper right). PI staining was used in combination with annexin V 
staining to distinguish between apoptotic and necrotic cells. Around 8% of the collected cells 
exhibited annexin V and PI staining, indicative of late apoptosis, while 21% of cells exhibited 
only PI staining. DNA staining shows that in growing cells, DAPI stains the single, large, 
homogeneous, round-shaped nucleus as well as the peripheral mitochondrial DNA (Fig. 4.9A 
and B). In contrast, dialysed cells in water show small condensed nuclei or distributed nuclear 
fragments (Fig. 4.9 C–H), which indicate chromatin condensation, DNA damage and nuclear 
fragmentation: these are features of apoptosis (Madeo et al., 1997, Andres et al., 2008). These 
cells were not fixed to avoid the loss of small DNA fragments, which can occur due to increase 
in the permeability of fixed cells. Figure 4.9 A–H also shows a difference in cell size. Cells in 
water are smaller compared to those from growth media. Flow cytometric analyses of the cell 
cycle using DAPI detect fixed cells, which are more permeable, with lower staining intensity 
than those at G0/1 phase, a phase when live cells have their minimum content of non-fragmented 
DNA. These cells can be observed as a ‘sub-G0/1’ peak in a DNA histogram. In contrast, necrotic 
cells generally do not show an immediate reduction in DNA staining, and sub-G0/1 cannot be 
discriminated from a histogram DNA content analysis of live cells (Riccardi et al., 2006, Dive et 
al., 1992, Darzynkiewicz et al., 1992, Calvert et al., 2008). In Fig. 4.9 I-J, about 20% of the 
population are in sub-G0/1 region and are comprised of apoptotic cells, apoptotic bodies and 
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debris. The accuracy of DNA content measurement was reflected by variation in fluorescence 
intensity between individual cells with identical DNA content in G0/1 cell population. The 
coefficient of variation (CV) of the mean value was about 3%, which is within the acceptable 
range (Darzynkiewicz et al., 2010). We have also used equal numbers of control and treated cells 
plus the same concentration of DAPI stain to overcome the drawbacks that may be a 
consequence of these factors (Haase et al., 2002). 
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(A)                                                 (B) 
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Figure 4.8  FITC-annexin V staining on high density cells dialysed for 3 days to examine externalization 
of phosphatidylserine. (a) Flow cytometry analysis of cells without staining. (b) Flow cytometry analysis 
of cells in A stained with PI and FITC-annexin V. (c) Flow cytometric analysis of unstained and FITC 
annexinV-stained cells. The inset shows a fluorescence microscopy image of FITC-annexin V-stained 
cells. This analysis was performed more than three times: the result of one experiment has been presented. 
 
0          10
2 
             10
3
                   10
4
                      10
5  
         
Annexin V fluorescence intensity 
Unstained cells Stained  cells 
 
C
o
u
n
ts
 
1
0
,0
0
0
 
Chapter4 
- 133 - 
  
 
 
 
Figure 4.9 DAPI staining of growing and 
dialysed cells. Fluorescence and light 
microscopy analysis of cells growing in 
YEPD (A) and cells dialysed in water (C, E 
and G), after DAPI staining, b, d, f and h are 
bright field for DAPI staining, respectively. 
Flow cytometric analysis of DNA content for 
cells growing in YEPD (I) and cells dialysed 
for 3 days (J). This experiment has been 
performed three times independently. 
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4.3.5 Effect of PKC1 inhibitor on C. glabrata viability in water 
Staurosporine is an antifungal compound that inhibits PKC1 phosphorylation, a control kinase 
affecting the CWI cascade in yeast (LaFayette et al., 2010). Therefore this compound was chosen 
to examine the effect of CWI inhibition on survival of high density cells of C. glabrata in water. 
Figure 4.10A demonstrates 50 % or more loss of viability within 24 h in cultures treated by 1 to 
4 µg/ml stausporine. However in RPMI1640 medium the minimum inhibitory concentration of 
staurosporine was 4 µg/ml and the fungicidal concentration was 8 µg/ml (Fig. 4.10 B-C). 
Toxicity of PKC1 protein inhibitor is four times higher than that in medium, indicative of the 
vital role of this protein in preserving cells from hypo-osmotic conditions. Toxicity of 
staurosporine in water could be eliminated by sorbitol which is an osmotic stabilizer (Fig. 4.10 
D).  This confirms that the death caused by staurosporine is due to the hypo-osmotic stress.  
Testing combinations between staurosporin and TQ in RPMI1640 medium indicated neither 
synergy nor antagonism between these two compounds (FIC = 0.5).           
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Figure 4.10  Low concentrations of staurosporine (Sts) kills C. glabrata ATCC2001 in water but not in 
RPMI1640 media. (A) Cells in water were treated with Sts, (B) Broth microdilution assay of Sts in 
RPMI1640, the arrow indicates the MIC value after 24 h of incubation at 35 ºC (C) Five microliter from 
wells in B were spotted on YEPD plates  (D) Abrogation of 1 µg/ml stausporine toxicity in water by 1M 
sorbitol. 
 Sts (µg/ml)      8      4      2       1     0.5       
 (A) 
    (B)                                                               (C) 
          Sts (µg/ml)        8            4             2           1           0.5    
(D) 
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4.3.6 Toxicity of XMD8-92, sorafenib and doxycycline in water 
XMD8-92, sorafenib (Nexevar) and doxycycline were chosen to examine their properties to kill 
C. glabrata cells in water. The selection of XMD8-92, sorafenib (nexevar) and doxycycline was 
based on the bioinformatic database analysis (Candida genome database) which indicates 48% 
identity and 65% similarity between SLT2 protein in yeast and ERK5 (also known as BMK1) 
and ERK2 in Homo sapiens. XMD8-92 was shown to be an ERK5 inhibitor (Yang et al., 2010). 
Sorafenib is an oral multikinase inhibitor that was originally developed because of its inhibitory 
effects on the serine/threonine kinase Raf and several RTKs that induce cell proliferation and/or 
angiogenesis. The ability of sorafenib to inhibit ERK1/2 in cancer cell lines was demonstrated by 
(Manov et al., 2011). Doxycycline also was shown to be an ERK1/2 inhibitor (Kim et al., 2005). 
Based on that, the effect of these compounds on C. glabrata cell viability in water was tested. 
Beside these compounds staurosporine was included as a positive control.  
XMD8-92 with concentrations of up to 50 µM did not reduce viability in water nor inhibited 
growth in RPMI medium (data not shown). Sorafenib (up to 10 µM) also was not effective 
against C. glabrata in water (data not shown) nor in medium. In contrast, doxycycline caused 
loss of viability in cells in water. Loss in viability of high density cells in water was caused by 40 
µg/ml of doxycycline whereas the minimum inhibitory concentration of doxycycline in 
RPMI1640 medium was 200 µg/ml (Fig. 4.11 A,B). The toxicity of doxycycline in water could 
be abrogated by adding 10 mM of the antioxidant ascorbic acid but not reduced glutathione. 
Sorbitol also could not save cells from doxycycline toxicity in water (Fig. 4.11C).  
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4.3.7 Doxycycline induces Slt2 phosphorylation 
Experiments were designed to find whether toxicity of doxycycline in water was due to 
inhibition of CWI cascade. Concentrations of 25, 50 and 100 µg/ml of doxycycline were tested 
for their ability to inhibit Slt2 phosphorylation.  The phosphorylation of Slt2 in C. glabrata 
ATCC2001 was measured using flow cytometry. Within 30 min incubation time with the lowest 
concentration of doxycycline (25 µg/ml), phosphorylation of Slt2 protein was detected, whereas 
untreated cells showed no detectable positive events indicating  no Slt2 phosphorylation in these 
cells (Fig .4.12). 
 
 
 
 
 
 
Chapter4 
- 138 - 
  
C.glabrata 90030 & Dox in water
Time (day)
C
F
U
/m
l 
(x
 1
0
6
)
0 1
0
1
2
3
4
0
40 g/ml
400 g/ml
 
 
0
D
o
x
D
o
x
+
G
S
H
D
o
x
+
A
s
c
o
D
o
x
 +
 s
o
rb
it
o
l
0
1 0 0
2 0 0
3 0 0
4 0 0
D o x  in  w a te r  2
C
F
U
/m
l 
(x
1
0
3
)
T im e =  0  d a y
T im e  =  1  d a y
n s
 
 
Figure 4.11 Susceptibility of C. glabrataATCC90030 to doxycycline. (A) Checking viability of 
C. glabrata ATCC2001 cells after MIC assay by spotting 5 µl from each micro well, (B) in 
water, (C) protection of cells against doxycycline toxicity in water using 1 M sorbitol, 10 mM of 
ascorbic acid (AA) or reduced glutathione (GSH). 
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Figure 4.12  Doxycycline induces SLT2 phosphorylation. C. glabrata cells growing 
exponentially were treated with 25 µg/ml doxycycline (red) and 50 µg/ml DOX (blue) after 30 
min in media. Black is untreated cells.  The percentages indicate the fluorescence intensity.  
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4.3.8 Toxicity of thymoquinone on cells in water 
Since both thymoquinone and doxycycline induced SLT2 phosphorylation and doxycycline 
caused death of cells in water, this led to examination of TQ toxicity on C. glabrata ATCC90030 
cells in water to see if it acts like doxycycline. The results showed that thymoquinone was not 
toxic in sub-inhibitory concentration to cells in water whereas doxycycline was. Thymoquinone 
caused killing of high density cells (2x10
7
 CFU/ml) in water at the same concentration (25 
µg/ml) which inhibited growth in RPMI1640 medium (Fig. 4.13 A, C). In addition, toxicity of 
sub-inhibitory concentrations did not increase the death rate in low density cultures in water 
compared with untreated cells in water (Fig. 4.13 B). Sorbitol did not protect high density cell 
cultures from TQ toxic concentration (25 µg/ml) in water, on the other hand ascorbic acid was 
protective. In contrast to treatment of cells with TQ alone, reduced glutathione provided some 
protection against TQ toxicity in water. But the difference in the number of viable cells was not 
statistically significant to consider reduced glutathione as a protector in these conditions (Fig. 
4.13 C).  
Notably, addition of reduced glutathione did not protect C. glabrata in water from TQ or 
doxycycline effect whereas ascorbic acid did. 
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Figure 4.13  Effect of thymoquinone on cells survival in water. (A)  Cells at high density. (B) Cells at low 
density. (C) High density cells were treated with 25 µg/ml of TQ, TQ and antioxidants or sorbitol. (ns) not 
significant, (**) p < 0.01, (****) p < 0.0001 according to Tukey’s multi comparisons test. 
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4.4 Discussion 
 
4.4.1 The hypothesis of inhibiting CWI MAPK to improve TQ efficacy.  
 The pro-oxidants TQ and H2O2 activated SLT2 phosphorylation in C. glabrata.  Hydrogen 
peroxide is reported to induce activation of the whole cascade of CWI MAPK in S. cerevisiae 
(Krasley et al., 2006a, Vilella et al., 2005). More investigations are needed to know whether TQ 
induces the upstream cascade of CWI MAPK signalling pathway as well.  Inhibition of SLT2 
phosphorylation or this signal pathway might delay the response of the transcription factors and 
cells would not be able to resist TQ toxicity. In this stage of the study inhibition of SLT2 or CWI 
MAPK by chemical compounds was assumed to act synergistically with TQ. The first challenge 
to examine this hypothesis was choosing the environment to screen inhibitors. It is known that 
hypo-osmotic stress and heat shock induce activation of SLT2 in baker’s yeast (Fuchs et al., 
2009, Truman et al., 2007).  Would hypo-osmolarity affect the survival of C. glabrata?   
 
4.4.2 Candida glabrata survival in hypo-osmolarity 
In previous studies of Saccharomyces cerevisiae, cells suspended at high density (2x10
7
 cells/ml) 
in water maintained high viability for 20 days (Granot et al., 1993). My study demonstrates that 
survival of C. glabrata cells in hypo-osmotic conditions depends on the number of cells. At low 
cell density C. glabrata is sensitive to the hypo-osmolarity and starts to lose viability within one 
day. At high density major loss in viability occur after 3 or 4 days (Fig. 4.2).  
As the concentrated filtrate of high density cells was enough to stimulate divisions in the low 
density cell population, it can be concluded that it contains all necessary nutrients for C. 
glabrata.  Herker et al., (2004) induced growth and survival in aged cells by addition of 
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secretions from high-density, aged yeast cells exhibiting massive cell death. In contrast, in this 
study, the bioactive materials leading to survival in hypo-osmotic conditions were obtained from 
populations with high viability (> 97% viable, Fig. 4.3). Since the inoculum was washed six 
times before adjusting the final cell suspension in water, the possibility of remaining nutrients 
from YEPD is excluded. The 40 fold increase in cell numbers is remarkable.  The experiment has 
been reproduced three times with independent filtrates.  It therefore appears that the material 
released from cells at 3x10
6
 cells/ml can support cell re-growth from 7x10
3 
cells/ml to 3x10
5
 
cells/ml after 48 hours.  In others words, material released from 10 cells can support the growth 
of one new cell. 
 
Sorbitol protected low density cells very well from hypo-osmolarity. Because protection in high 
density cells is provided by < 5 mg of solid matter per litre (after filtration and lyophilisation), 
the protection is unlikely to be ‘sorbitol-like’ osmotic protection. In addition, 1:100 diluted 
YMM media is a hypo-osmotic condition (Kayingo et al., 2001), but it was protective. This 
indicates miniscule amounts of nutrients in the milieu surrounding cells that appear sufficient to 
protect against death due to hypo-osmolarity.  
 
4.4.3 Apoptotic cells death in water 
There is a high probability that hypo-osmotic conditions cause necrotic death due to increasing 
fluidity in the cell membrane and rapid inflow of water which causes cell swelling and increased 
turgor pressure. The death mode was investigated in this study by observing some of the 
apoptosis markers, mainly, phosphatidylserine exposure, chromatin condensation and DNA 
degradation. First of all, shrinkage and not swelling of cells in water was noted (Fig. 4.9a-h), 
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which is a primary indicator of apoptosis. In general, necrotic cells show increased size and 
swelling (Elmore, 2007). Exposure of phosphatidylserine at the outer leaflet of the cytoplasmic 
membrane is an early morphological marker of apoptosis which is conserved from yeast to 
mammalian cells (Martin et al., 1995, Madeo et al., 1997). In yeast, phosphatidylserine can be 
detected by FITC-annexin V staining after digestion of the cell wall. However, in this study, 
annexin V was applied directly without any treatment to remove the cell wall. Unlike other 
studies of apoptosis in yeast, in this study, the production of protoplasts was not necessary to 
observe FITC-annexin V staining. In this study, annexin V staining of the phosphatidylserine 
was probably enabled by the hypo-osmotic conditions leading to increased permeability of the 
cell wall. Externalization of phosphatidylserine occurred in cells that were propidium iodide 
negative, indicative of early apoptosis.  
 
DNA fragmentation is also another marker of apoptosis.  It has been well documented that 
apoptotic cells show reduced DNA staining with a variety of fluorochromes, including PI and 
DAPI. A large portion of DNA in apoptotic cells is of low molecular weight due to activation of 
endogenous endonucleases which break the linkers between the nucleosomes. These small 
fragments of DNA can leach out from ethanol-fixed (permeabilized) cells during rehydration and 
the staining process. Consequently, flow cytometric analyses detect cells with lower staining 
intensity than those at G0/1 phase, a phase when live cells have their minimum content of non-
fragmented DNA. These apoptotic cells can be observed as a ‘sub-G0/1’ peak in a DNA 
histogram. In contrast, necrotic cells generally do not show a ‘sub-G0/1’ peak because there will 
be no immediate reduction in the fluorescence (Darzynkiewicz et al., 1992, Darzynkiewicz et al., 
2010, Dive et al., 1992).  Figure 4.9 shows a significant proportion of the population (20%) with 
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reduced fluorescence intensity indicating loss of DNA integrity. DNA degradation and chromatin 
condensation in the cells exposed to hypo-osmolarity was observed also using an epifluorescence 
microscope with unfixed cells.  This indicates apoptotic death. 
There is evidence of apoptotic death in yeast treated with death inducers such as H2O2, acetic 
acid or amphotericin B in Saccharomyces cerevisiae when applied at low concentration, but 
necrotic death was observed when used at higher doses (Ribeiro et al., 2006, Phillips et al., 2003, 
Eisenberg et al., 2010). DNA degradation, an indicator of apoptosis in S. cerevisiae was 
observed under hyper-osmotic stress (60% glucose) by Ribeiro et al. (2006). In this study, we 
demonstrate preliminary evidence of hypo-osmotic stress-induced apoptosis in C. glabrata, and 
further investigations to confirm this phenomenon may be required. 
 
 
4.4.4 Cells in water as a model for screen CWI MAPK inhibitors 
 
4.4.4.1 Cell wall integrity MAPK is necessary for maintaining viability in water 
It is well known that cell wall integrity MAPK activation is important for yeast cell survival 
under hypo-osmotic stress. Previous studies used diluted rich media as hypo-osmotic conditions 
to examine this theory (Kayingo et al., 2001, Davenport et al., 1995). In this study MilliQ water 
was chosen as an extremely hypo-osmotic medium. The loss in viability of the wild type strain 
treated with staurosporine, a known inhibitor of PKC1 phosphorylation in yeast indicates the 
importance of this upstream MAPKKKK protein in CWI to protect against hypo-osmolarity (Fig. 
4.10). Staurosporine at low concentration (1 µg/ml) was not toxic in RPMI1640 but reduced 
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viability in water. This indicates that inhibiting of PKC1 activation in CWI MAPK pathway is 
crucial in maintaining viability of C. glabrata cells under hypo-osmotic stress.  
 
 
4.4.4.2 Screening of CWI MAPK inhibitor 
The selection of XMD8-92, sorafenib (nexevar) and doxycycline was based on the bioinformatic 
database analysis (Candida genome database) which was discussed before in 4.3.6. Based on 
that, the effect of these compounds on C. glabrata cell viability in water was tested. Beside these 
compounds staurosporine was included as a positive control. Exposing C. glabrata to 50 µM of 
XMD8-92 did not cause loss of viability. This concentration was chosen as the maximum 
concentration tested because the most tolerated dose of XMD8-92 in mice was 10 µM (Yang et 
al., 2011). Survival of C. glabrata cells in water was also not affected by 10 µM of sorafenib 
which is the achievable concentration of sorafenib in the plasma (Manov et al., 2011). The lack 
of effect might be due to low concentrations which were used in this study, or different factors 
such as permeability of cells. It might also be due to differences between the structures of target 
proteins in yeast. In contrast, doxycycline affected survival rate of C. glabrata cells as much as 
staurosporine. The same concentrations (≤ 2   µg/ml) were not fungicidal against C. glabrata in 
the MIC assay. A concentration of one fifth of the MIC of DOX was enough to kill this fungus in 
water. Since doxycycline has been demonstrated as an ERK1/2 inhibitor (Kim et al., 2005), the 
question was asked, could this antibiotic act as a CWI MAP kinase inhibitor or might it alter the 
composition of cell wall or membrane? The toxicity of doxycycline in water was not abrogated 
by adding sorbitol. This indicates DOX has a target other than CWI-MAPK. In addition flow 
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cytometry analysis of SLT2 phosphorylation indicated activation of this protein once cells were 
treated with sub inhibitory concentrations of DOX in RPMI1640 medium. This means DOX is a 
Pkc1 MAPK activator and not an inhibitor. All together, the fungicidal effect of DOX in water is 
not due to inhibition of the CWI cascade. Doxycycline is an iron chelator leading to depletion of 
intracellular iron (Fiori and Van Dijck, 2012). Iron depletion has been proposed to decrease 
ergosterol content in C. albicans and S. cerevisiae, leading to higher fluidity in cell membranes, 
with consequent increased passive diffusion (Prasad et al., 2006, Shakoury-Elizeh et al., 2010). 
Water and DOX might diffuse passively and caused cell death. The elimination of DOX toxicity 
with ascorbic acid might indicate an interference with the oxidative homeostasis due to iron 
depletion. In addition, doxycycline was shown to be able to inhibit mitochondrial function in C. 
albicans, which eliminates the diauxic shift (Oliver et al., 2008). Lack of diauxic shift, or the 
lack of functional mitochondria alters sterol metabolism, resulting in lower ergosterol levels, 
consistent with the need for 12 molecules of oxygen to synthesize one molecule of ergosterol 
(Oliver et al., 2008). In addition, Saccharomyces cerevisiae was shown to require antioxidant 
function to resist the toxicity of doxycycline (Angrave et al., 2001) which has been demonstrated 
in this study as well via the addition of ascorbic acid. In conclusion this study supports the 
proposed mechanism of killing of doxycycline may be attributed to an alteration of oxidative 
homeostasis in C. glabrata which alters the cells permeability. However, the effect of efflux 
pumps which might be poorly activated in water because of nutrient limitation should not be 
ignored and should be further studied. Not every pro-oxidant increases permeability of cells. 
Thymoquinone which has been demonstrated to be a pro-oxidant and alter the membrane 
potential of mitochondria (see chapter 3), did not show the same phenomenon in water. 
Thymoquinone was not toxic to cells in water at sub-inhibitory concentrations and its toxicity 
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could not be eliminated by sorbitol which indicates it does not interfere with CWI-MAPK 
cascade activation or permeability of cells. In contrast, staurosporine caused loss in viability of 
cells in water at sub-inhibitory concentrations and its toxicity could be abrogated by sorbitol 
(Fig. 4.10), indicating its inhibitory effect on the CWI- MAPK cascade. 
 
4.5 Conclusion 
In conclusion, these preliminary data demonstrate that high cell density of C. glabrata provides 
protection towards hypo-osmolarity but not low cell density (< 10
5
 cell/ml). Death of C. glabrata 
caused by hypo-osmolarity is an apoptotic death. In addition, this study proposes a bio-protection 
through releasing of nutrients. Cells in water might be a useful model to screen and test CWI 
inhibitors. Compounds which inhibit the CWI MAPK cascade are toxic in water but they need 
higher concentrations to become toxic in media. The toxicity of the inhibitor can be abrogated by 
an osmotic stabilizer such as sorbitol.  However, other factors such as efflux pumps, which might 
be inactivated in water, should be considered. There was no observed synergy between TQ and 
the Pkc1 inhibitor. This indicates that inhibition of the upstream proteins of PKC1-MAPK might 
not assist in improving TQ efficacy.  
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CHAPTER 5 
Effect of thymoquinone on the cell wall 
 
5.1 Introduction 
The fungal cell wall is the essential cellular boundary and the first communication point with the 
environment. It provides protection from cell lysis and keeps cell integrity. In addition, several 
cellular transports, metabolism and sensing processes are controlled via the cell wall (Reinoso-
Martín et al., 2003). Proper cell wall architecture consists mainly of an external layer of 
mannoproteins and an internal layer of β-1,6-glucan and β-1,3-glucan which are linked via β-1,4-
glucan to chitin chains  (reviewed by Cabib et al., 2001). Chitin is a linear polymer of β-1,4-N-
acetylglucosamine (GlcNAc) units and spreads all over the cell wall at low levels (1.4–7.1% of 
the entire cell wall mass (Aguilar-Uscanga et al., 2003)), with more intensity at the septation 
region (Santos et al., 2000). The septum is a cross-wall between the mother and daughter cell 
formed during the budding process (Cabib et al., 1996). 
Despite its low amounts, chitin is essential for yeast cell survival and its synthesis is highly 
regulated. Three chitin synthases have been identified in S. cerevisiae: CHS1, CSH2 and CSH3 
The genes which encode the catalytic subunits of these enzymes have been cloned and are 
known as CHS1 to CHS7 (reviewed by (Lesage et al., 2006). CHS3 mediates chitin deposition at 
the cell membrane after its synthesis in the endoplasmic reticulum (ER). To export CHS3 from 
the ER, CHS7 is required. Chitin synthase 3 can then reach the next station which is the Golgi 
apparatus where CHS3 seems to be associated with CHS5. CHS5 and CHS6 are necessary for 
transferring CHS3 to vesicles (chitosomes) which finally carry CHS3 to the plasma membrane. 
CHS3 does not associate with CHS5 until it reaches the ring-like area at the emerging bud, 
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where the chitin ring is localized. As a substitute, CHS4 the putative activator of CHS3, 
maintains CHS3 in this location. CHS4 can also bind to BNI4, which in turn attaches to the 
septin microfilament ring at the bud neck. There is less information regarding CHS1 activity and 
CHS2, however CHS2 has been shown to be associated with building of the primary septum 
(reviewed by (Cabib et al., 2001). Under non-stress conditions, CHS3 is maintained mostly as 
chitosomes within the Golgi apparatus as early endosome compartments. In case of cell wall 
stress, CHS3 quickly redistributes to the plasma membrane (Levin, 2011). 
The transport of CHS3 from the intracellular pool to the plasma membrane occurs upon 
activation of the CWI-MAPK signalling pathway (Valdivia and Scheckman, 2003). The CWI-
MAPK pathway might be induced upon exposure to cell wall stretching (e.g. budding, heat 
shock) or cell wall damage which might be caused by antifungal action (e.g. caspofungin), hypo-
osmotic stress, calcium signalling-induced stress and oxidative stress (reviewed by (Howard et 
al., 2013) and (Fuchs et al., 2009). As described in section 1.1.4 environmental stress is detected 
mainly via the plasma membrane-localized sensors Wsc1 and Mid2. Then Rom1/2, the guanine 
nucleotide exchange factors are recruited and consequently trigger GTPase Rho1. Rho1 activates 
Pkc1 which triggers the MAPK cascade. The MAPK pathway comprises MAPKKKK Pkc1, 
MAPKKK Bck1, MAPKKs Mkk1/2 and finally the mitogen activated kinase, Slt2, which 
activates the transcription factors Rlm1 and Swi4/Swi6 (reviewed by(Levin, 2011) (Fig. 1.2).  
Several studies have explored the biosynthesis of chitin because of the central role of this 
polysaccharide in septum formation (Cabib et al., 2001). Studying this region has provided 
information on fundamental cellular processes and defined new targets for antifungal agents. As 
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a consequence, inhibitors of chitin (e.g. polyoxins and nikkomycin) and β(1-3) glucan synthesis 
(e.g. echinocandins) have become available (Cabib et al., 2001).  
The aims of this chapter are: 
1. As the cell wall integrity (CWI) pathway plays an important role in the oxidative stress 
response (Pujol-Carrion et al., 2013) and TQ causes oxidative stress in C. glabrata, this 
study investigates the role of CWI-MAPK components in the sensitivity of C. glabrata to 
TQ through mutants in CWI-MAPK.  
2. The cell wall in C. glabrata is the first interaction point between TQ and the yeast cell. 
This study aims to obtain information about this interaction which might define new 
approaches to improve the efficacy of TQ as an antifungal compound.  
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5.2 Materials and methods 
5.2.1 Yeast strains and media 
The yeast strains which were employed in this study are listed in table 5.1. TG11 and TG152 
strains were maintained and grown on yeast minimal medium lacking tryptophan (YMM- trp 
medium). Other strains were maintained on yeast minimal medium (YMM) or YMM-AA. The 
test medium which was used for serial dilutions spotting assay was RPMI1640 containing L-
glutamine, but lacking sodium bicarbonate (Invitrogen), buffered to pH 7.0 with 0.165 M MOPS 
(Sigma).  For media preparation see appendix A. 
 
Table 5.1 Strains used in this study 
Candida glabrata strain Strain description Strain source or reference 
ATCC2001 Wild type  www.atcc.org 
HTL reference Control strain of Δbck1and Δmkk2. 
his3∆::FRT leu2∆::FRT trp1∆::NAT1  
(Schwarzmuller et al., 2014) 
Δbck1 BCK1 was replaced with NAT1 marker (Schwarzmuller et al., 2014) 
Δmkk2 MKK2 was replaced with NAT1 marker (Schwarzmuller et al., 2014) 
TG11  The parent strain of TG152. Δtrp1 (a 
derivative of ATCC2001) containing 
pCgACT-P 
(Miyazaki et al., 2010) 
TG152  Δslt2∷HIS3, Δtrp1 containing pCgACT-P (Miyazaki et al., 2010) 
KUE100_chr464 Control strain, CgHIS3 marker was integrated 
into an unrelated locus of chromosome I 
(Ueno et al., 2011) 
KUE10269 
(Cg Δchs3A) 
Δchs3A strain, CHS3A (CAGL0B04389g) was 
replaced with the CgHIS3 marker 
(Ueno et al., 2011) 
KUE10362 (Δchs3B) Δchs3B strain, CHS3B (CAGL0I04840g) was 
replaced with the CgHIS3 marker 
(Ueno et al., 2011) 
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5.2.2 Testing sensitivity of CWI-MAPK mutants to thymoquinone and hydrogen peroxide  
After steam sterilization of RPMI 1640 agar medium (appendix A), the medium was left to cool 
down (~50ºC). Thymoquinone or H2O2 were then added with mixing until the mixture became 
homogenous. Solid media supplemented with TQ or H2O2 were left for about 2 h to dry in the 
dark in a biohazard cabinet before spotting.  Five microliters of 1:10 serial diluted cell 
suspensions were spotted on the agar plates and were left to dry in the dark in a clean biohazard 
cabinet. Plates then were incubated at 30ºC for 2 d. 
 
5.2.3 Observation of TQ’s fluorescence and PI staining 
Candida glabrata ATCC2001 from an overnight YEPD plate was used to inoculate RPMI1640 
liquid medium containing 25, 50 or 100 µg/ml TQ. The working volume was 4 ml in each 50 ml 
centrifuge tube. Cultures were protected from light and incubated at 30ºC with agitation (200 
rpm). Samples of 1 ml were collected by centrifugation and washed with MilliQ water, then the 
cells  were examined with an Epi-fluorescent microscope (Leica DM 2500) using an I3 FLUO- 
Filter cube (Leica; 450-490 nm excitation) or analysed by Flow cytometry using a BD FACS 
Canto™ II equipped with a pacific blue fluorescent filter (351- 450/65 nm excitation and 
emission). For propidium iodide staining, cells were harvested, suspended in 500 µl PBS 
contains 2 µg/ml (PI) and incubated for 15 min at 30°C in the dark. After that cells were 
harvested, washed and resuspended in 500 µl PBS.  Propidium iodide fluorescence was observed 
by using Epi-fluorescent microscope fitted with a TexasRed filter (540 - 580 nm excitation). 
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5.2.4 Qualitative analysis of chitin levels 
Exponential phase cultures of C. glabrata ATCC2001 in YEPD liquid media (5 h incubation 
time at 30°C with agitation at 200 rpm) were washed with RPMI1640 medium followed by 
suspension of the cells in RPMI1640 medium. The initial optical density of these suspensions 
was about 0.2. Five millilitres of the cell suspensions were treated with different concentrations 
of thymoquinone (25 or 50 µg/ml) in 50 ml centrifuge tubes. Solvent controls were also 
included. The cultures were incubated at 30 °C with agitation (200 rpm) and samples were 
collected after 3 or 24 h. Before staining, the optical density (OD600) of different samples was 
adjusted to about 0.2. Then 1 ml samples of cell suspensions were exposed to light for at least 5 
min. The samples were centrifuged and pellets were resuspended in 1 ml of 2.5 µg/ml calcofluor 
white (CFW) (Costa-de-Oliveira et al., 2013). Samples were incubated at room temperature in 
the dark for 15 min. Then they were washed with filtered PBS buffer and analysed by a BD 
FACS Canto™ II flow cytometer equipped with a pacific blue fluorescent filter (351- 450/65 nm 
excitation and emission). 
 
5.2.5 Testing the interaction between thymoquinone and a chitin inhibitor  
Sensitivity of C. glabrata ATCC2001 to nikkomycin Z (Sigma-Aldrich) and thymoquinone was 
examined via checkerboard assay using a standardised broth microdilution assay as defined by 
CLSI (CLSI, 2008) (also see 2.2.1) in a 96 micro-well plate. After incubation for 24 h the wells 
contents were mixed using a pipetting action.  Then 5 µl aliquots from each well were spotted on 
YEPD agar plates. The plates then were incubated for 1-2 d at 30ºC. 
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5.3 Results 
 
5.3.1 Activity of SLT2 is required for hydrogen peroxide resistance but not thymoquinone 
resistance 
The results of the last chapter reported that testing of PKC1 (the upstream kinase of CWI-
MAPK) inhibitor with TQ showed no interaction. To investigate the importance of other 
members of the CWI-MAPK cascade in TQ resistance, mutants of BCK1, MKK2 and SLT2 were 
tested for their susceptibility to TQ. Spotting dilutions of these mutants on RPMI1640 plates 
containing 50 and 100 µg/ml TQ showed no differences compared to their parental strains (Fig. 
5.1). The parental strains were more resistant to TQ than the wild type strain C. glabrata 
ATCC2001. Although TQ caused SLT2 phosphorylation (section 4.3.1) C. glabrata Δslt2 
(TG152) was not sensitive to TQ. This mutant showed a different pattern in its susceptibility to 
hydrogen peroxide. It was more sensitive to hydrogen peroxide than its parental strain (Fig. 5.1). 
These results indicate a difference in the importance of SLT2 activation in cell protection against 
H2O2 and TQ stress. Cells spotted on plates contained 25 µg/ml TQ showed similar growth to 
those which grew on untreated plates. 
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Figure 5.1 Susceptibility of C. glabrata Δbck1, Δmkk2, Δslt2 and their parental strains HTL and TG11 to 
TQ (The two upper panels) and sensitivity of C. glabrata Δslt2  (Cg Δslt2) to hydrogen peroxide (The 
panel at the bottom). 
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5.3.2 Thymoquinone generates a blue fluorescence in the C. glabrata cell wall 
As thymoquinone caused SLT2 activation, the effect of this compound on the cell wall was 
further investigated by examining the interaction between TQ and the cell wall microscopically. 
After incubation of C. glabrata with 25 or 50 µg/ml TQ for at least 9 h in the dark, a blue 
fluorescence was observed surrounding the cells when they were examined microscopically. The 
fluorescence was detectable by flow cytometry (Fig. 5.2 C). Epi-fluorescence microscopy images 
showed more details of the binding site of TQ. The images demonstrate that TQ fluorescence 
was more intense and specific at the bud scars on the cell wall (Fig. 5.2 A).  The emission of blue 
fluorescence was not observable in the whole area of the bud scar but it was specific at rims of 
the bud scars (Fig. 5.2 B). Staining of treated cells (50 µg/ml TQ) with propidium iodide after 9 
h treatment showed loss of cell membrane integrity in some of them. Other cells displayed TQ 
fluorescence whilst keeping their membrane integrity (Fig. 5.3). This confirms that binding of 
TQ to the cell wall leads to cell death.  
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Figure 5.2 Candida glabrata ATCC2001 treated with TQ emits blue fluorescence. A and B epi-fluorescence 
microscopy images of C. glabrata cells after 10 h treatment with 50 µg/ml TQ. The cells were visualized using an 
I3 filter. White arrows indicate TQ fluorescence at the bud scars and specifically at rims of the bud scar. The inset 
in A represents a phase contrast image of the cells, scale bars equal to 5 µm. (C) C. glabrata ATCC2001 cells were 
treated with 50 µg/ml TQ overnight then were analysed by flow cytometry. 
 
                                                    (C) 
                                 TQ fluorescence intensity 
(A)                                                                                        (B) 
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Figure 5.3 Epi-fluorescence microscopy images demonstrate the binding of 50 µg/ml thymoquinone to C. 
glabrata cell wall which leads to  cell death. (A) Bright field, (B) thymoquinone fluorescence 
visualization using an I3 filter, (C) Propidium iodide fluorescence was visualized using a TexasRed filter. 
Scale bars represent 10 µm. 
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5.3.3 Thymoquinone stimulates chitin production 
Chitin distributes over all the cell wall, however Cabib and Arroyo (2013) reviewed several 
studies and concluded that there is more accumulation of chitin at the bud scars (Cabib and 
Arroyo, 2013).  As the fluorescence of TQ was observed at the bud scars, further analysis was 
carried out to determine whether TQ affects chitin production in C. glabrata. Chitin levels were 
analysed qualitatively by use of CFW staining which targets chitin and flow cytometry analysis. 
After 3 h, 6 x 10
6
 cells/ml which were treated with 25 or 50 µg/ml TQ showed no significant 
difference in the median of CFW fluorescent intensity (data not shown).  However after 
overnight incubation of C. glabrata cells with 50 µg/ml TQ, CFW fluorescent intensity was 
increased by 76%, indicating increased chitin (Fig. 5.4). In contrast, cells which were treated 
with 25 µg/ml TQ (sub-inhibitory concentration) did not show any difference from the control 
cells. To avoid the interference between TQ fluorescence and CFW fluorescence, TQ treated 
cells were exposed to light before CFW staining: they showed no TQ fluorescence. 
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Figure 5.4 Thymoquinone induces chitin production in C. glabrata. Untreated cells without calcofluor 
staining (black).  Cells were treated with TQ and stained with calcofluor white (A) 25 µg/ml TQ (red) or 
solvent (green); or (B) 50 µg/ml TQ (blue) and corresponding concentration of solvent (green). Cells 
were treated with TQ for 24 h before analysis. 
 
 
5.3.4  Chitin mutants are more resistant to thymoquinone but not hydrogen peroxide 
An advantage was taken of observing thymoquinone’s fluorescence around the bud scars to 
further investigate the role of chitin in C. glabrata sensitivity to TQ. Chitin synthase III mutants 
have an altered cell wall composition and show a response to TQ stress that is different to their 
parental strain. The susceptibility of two C. glabrata chitin synthase III mutants (CHS3A and 
CHS3B) to TQ was checked by spotting serial dilutions of the cells on RPMI1640 agar medium 
supplemented with TQ. Candida glabrata Δchs3B did not show a significant difference in its 
sensitivity to TQ from the control strain but Δchs3A was TQ resistant. Colonies of the Δch3A 
strain have a dry and rough surface whereas Δchs3B morphology does not differ from the wild 
type, it has shiny and smooth colony surface (Fig. 5.5). The phenotypic characteristics of each 
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strain were also confirmed through personal communication with the provider (Ueno et al., 
2011). In terms of their sensitivity to the known pro-oxidant hydrogen peroxide, both strains 
were the same as the parental strain (Fig. 5.5B). Microscopic examination of Δchs3A showed 
growth defects including formation of aggregates and failure in bud scar septum formation which 
resulted in failure of buds to separate from the mother cell and formation of pseudo-hyphae like 
structures (Fig. 5.6A). These cells were stained by calcofluor to observe clearly the lack of 
separation septum between daughter cells and mothers (Fig. 5.6B). In contrast, C. glabrata 
Δchs3B did not form clumps and it showed normal budding pattern (data not shown).  
 
5.3.5 Chitinase inhibitor antagonise with thymoquinone 
Previous studies demonstrated that Saccharomyces cerevisiae mutants with lowered chitin levels 
show resistance to calcofluor. This compound is supposed to target chitin and compounds that 
inhibit chitin synthase III in vivo reverse calcofluor’s inhibitory effect (Gaughran et al., 1994). 
Therefore a broth micro-dilutions checkerboard assay followed by spotting 5 µl from each 
micro-well was carried out to examine the interaction between TQ and the selective inhibitor of 
chitin synthase III nikkomycin Z. Figure 5.7 demonstrates that the micro-wells which contained 
25 µg/ml TQ with nikkomycin Z concentrations up to 256 µg/ml exhibited enhanced growth. 
This chitin inhibitor rescued C. glabrata from the adverse effect of TQ.   
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Figure 5.5 Sensitivity of C. glabrata CHS3 mutants to TQ and H2O2. (A) Deletion of chs3A but 
not chs3B in C. glabrata resulted in sensitivity to thymoquinone. (B) Both mutants were not 
hydrogen peroxide sensitive. KUE100_chr464 is the control strain. 
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Figure 5.6 Microscopic examination of C. glabrata Δchs3A demonstrate failure in bud scar 
septum formation. (A) Bright field image of C. glabrata Δchs3A, (B) Calcofluor staining of C. 
glabrata Δchs3A observed by utilizing I3filter in epi-fluorescence microscope, (C) Bright field 
image of the control strain (C. glabrata KUE100_chr464). 
(C) 
(A)                                                                             (B) 
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Figure 5.7 Nikkomycin Z rescues C. glabrata from TQ adverse effect. A combination between TQ and 
nikkomycin Z was examined by checkerboard assay in 96 micro-wells plate using C. glabrata 
ATCC2001. The plate was incubated 24 h at 35 ºC then 5 µl from each well were spotted on YEPD plate 
which was incubated for further 24 h and the image was taken. 
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5.4 Discussion 
Thymoquinone and hydrogen peroxide induce oxidative stress in C. glabrata, however part of 
TQ’s mechanism of action differs from H2O2. Although both of them induced SLT2 activation, 
the susceptibility pattern of Δslt2 and Δchs3A to each compound indicated different interaction 
with the cell wall.  
 
5.4.1 Cell wall integrity MAPK and TQ antifungal effect 
Phosphorylation of SLT2 kinase proposed that SLT2 and maybe the upstream kinases are 
required for cell viability upon TQ treatment. Indeed, Candida glabrata Δbck1, Δmkk2 and the 
downstream protein Δslt2 were neither sensitive nor resistant to TQ. In addition, inhibition of 
PKC1 by staurosporine which is known as a PKC1 inhibitor did not enhance TQ’s fungicidal 
effect (section 4.3.5). On the other hand C. glabrata Δslt2 was sensitive to H2O2. Previous 
studies on the sensitivity of S. cerevisiae Δslt2 to H2O2 showed variable data. My results are in 
agreement with the previous findings of Krasely et al., (2006) which reported sensitivity of S. 
cerevisiae Δslt2 to H2O2. In contrast, Vilella et al., (2005) showed no sensitivity of this mutant or 
Δbck1 to H2O2 but Δpkc1 and upstream sensor mutants were sensitive to H2O2. This indicates 
that TQ and H2O2 are different oxidants, acting on different targets in the yeast cells and induce 
cellular responses involving cell wall integrity MAPK activation. According to Vilella et al., 
(2  5) “Hydrogen peroxide is highly diffusible and could enter cells passively and act on 
internal targets”.  Thymoquinone might act on external targets and diffuse inside the cells to 
cause oxidation.  Although TQ induces the phosphorylation of SLT2, the CWI-MAPK module 
seems to be not vital to the cellular response in defence of TQ stress. 
 
Chapter6  
- 167 - 
  
5.4.2 Thymoquinone targets chitin 
 
The observation of blue fluorescence in TQ treated samples and absence of this fluorescence in 
DMSO treated cells was an indicator of TQ fluorescence. A previous study has also reported 
fluorescent emission from TQ and quantitated TQ by HPLC combined with fluorescence 
detectors (Iqbal et al., 2013). Botnick et al., (2012) observed pink fluorescence in longitudinal 
sections of N. sativa seeds under UV or blue light and proposed that the fluorescence is due to 
hydrophobic materials including thymoquinone and thymohydroquinone (Botnick et al., 2012).  
Observation of TQ’s fluorescence binding to dead cells in figure 5.3 suggests a role of TQ as a 
cause of cell death. However, TQ fluorescence was similarly observed on the cell wall of viable 
cells which might create a doubt about the influence of dead cells with TQ. In fact, there are 
several observations support the idea of cell death was caused because of TQ. First, it is known 
that any fungicidal agent will cause the death gradually. The delay in a complete killing in this 
population (Fig. 5.3) can be referred to the relatively high inoculum size (10
6 
cell/ml) which was 
higher than that was used to monitor the fungicidal kinetics of TQ in chapter 2. Moreover, the 
experiment of monitoring the relationship between oxidative stress induction and cell killing by 
TQ in chapter 3 (Fig. 3.4) showed that untreated cells did not show a significant increase in 
intracellular reactive oxygen species generation and death rate, whereas TQ treated cells suffered 
from intracellular oxidative stress and increased death rate. Yet many of TQ treated cells were 
suffering from oxidative stress without showing loss of their membrane integrity. The 
comparison between untreated cells and TQ treated cells indicates the influence of TQ on C. 
glabrata death rate. 
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 In this stage it is not clear if overloading of cell walls by TQ caused the oxidation which led to 
cell death or TQ penetrates into the cells and caused increase in ROS generation regardless of 
TQ’s amount which binds to the cell wall. 
 
Thymoquinone’s fluorescence on the cell wall of C. glabrata was more intense at the bud scars. 
Indeed, the fluorescence was specifically emitted from the rim of bud scars in a similar way to 
the CFW staining pattern (see Fig.2 in (Hausauer et al., 2005). Several studies have concluded 
that more accumulation of chitin occurs at the bud scars (reviewed in (Cabib et al., 2013, Molano 
et al., 1980) ) and CFW has been known to bind chitin in that area and inhibit chitin polymer 
assembly (Roncero et al., 1985). The question is if chitin accumulates at the bud scars, why is 
TQ and CFW fluorescence more intense at the rims and does not cover the whole surface of the 
bud scar?  In S. cerevisiae, chitin is laid down all along the cell wall however it forms mainly 
two structures at the neck between mother cell and the bud, which later becomes the bud scar 
after separation of daughter cell: (i) the chitin ring that forms at budding and (ii) the primary 
septum that forms at cell division. The chitin ring is considerably thick whereas the primary 
septum is very thin and therefore the bud scar shows a raised ring (Cabib et al., 2013, Cabib et 
al., 1971). Thus, the sensitivity of C. glabrata to thymoquinone could be related to chitin. 
Analysing chitin content showed increased levels of chitin in the cells which were treated with 
an inhibitory concentration of TQ but not a sub-inhibitory concentration (Fig. 5.4). Those cells 
which were treated with an inhibitory concentration of TQ should have less budding and 
consequently less chitin accumulated at the bud scars. However those cells seemed to be induced 
to produce more chitin as a response to TQ treatment. Sub-inhibitory concentration of TQ did not 
elevate chitin which means TQ susceptibility was associated with enhancement of chitin levels. 
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Roncero and Duran’s study (1985) demonstrated enhancement in the rate of chitin synthesis in 
Geotrichum lactis after CFW or congo red treatment. In addition they have observed abnormally 
thick septa and incomplete separation of S. cerevisiae buds which were treated with CFW. 
Calcofluor white has been shown to alter the assembly of chitin fibrils in S. cerevisiae and C. 
albicans cells (Elorza et al., 1983). However in my study there was no observation of abnormal 
aggregates resulting from separation defects of C. glabrata buds after TQ treatment. One 
explanation might be that TQ binds to chitin without affecting chitin polymerization or affecting 
the process of septum formation. 
 
Production of excess chitin is a common response to cell wall damage to strengthening the wall 
by the production of excess chitin, initially by the class IV enzymes such as ScCHS3 
and CaCHS3 (Lenardon et al., 2010). Genetic manipulation that leads to depletion of CHS3A 
(but not CHS3B) the major homolog of C. glabrata chitin synthase gene resulted in TQ 
resistance. This protein is required for synthesis of chitin rings at the bud scar but not formation 
of septa (Bulawa et al., 1995), which confirms further the importance of this protein to TQ action 
which was mainly observed at the rings. Saccharomyces cerevisiae chs3 mutants have failure in 
the transport of CHS3 to the cell surface and produce less chitin at the bud ring (reviewed in 
(Lesage et al., 2006). Therefore, mutations in CHS3 or other genes required for CHS3 protein 
function result in resistance to calcofluor, the toxic compound that binds to chitin (Reviewed in 
(Imai et al., 2005). The same principle might be applicable to the observed resistance of C. 
glabrata ∆chs3A to TQ. Candida glabrata Δchs3 strains have been shown to have a thickened 
mannoprotein layer in Δchs3A and a thickened chitin-glucan layer in Δchs3B strain (Uneo et al, 
2011). Uneo et al., (2011) did not demonstrate a difference in chitin levels between Δchs3A and 
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the control strain. Attempts to analyse the amount of chitin levels by flow cytometry in the 
present study to compare it with the parental strain were not successful. When these cells were 
examined microscopically, they showed formation of aggregates due to the lack of budding septa 
(Fig. 5.6) which makes flow cytometry an unsuitable approach to analyse this population. The 
lack of budding septa indicates a decrease in chitin synthesis levels, and probably that is why 
these cells are more resistant to TQ. In contrast, C. glabrata Δchs3A was neither resistant nor 
sensitive to H2O2.  This means the decrease in chitin synthesis did not influence sensitivity of this 
strain to H2O2 maybe because it diffuses at higher rates than TQ. However, the association 
between TQ toxicity, chitin synthesis induction and the antagonism between TQ and the chitin 
inhibitor nikkomycin Z put more emphasis on the necessity of chitin to TQ antifungal property.  
The action of cell wall polysaccharides including β-1,6-glucan and chitin as receptors for 
external materials is widely accepted.  For instance, β-1,6-glucan in Candida boidinii works as 
receptor of  Pichia membranifaciens killer toxin (Santos et al., 2000) and chitin binds to 
calcofluor white stain (Roncero et al., 1985). The present study suggests that chitin might 
facilitate the transport of TQ or work as a receptor of TQ because of the following facts: 
 The toxicity of TQ was associated with an increase in chitin levels, and it is known that 
chitin locates at the cell wall which is the first contact barrier of the yeast cell (Fig. 5.4). 
 The mutant of CHS3A is TQ resistant. This protein is responsible for locating chitin at 
the ring in the bud scar where TQ fluorescence was observed (Fig. 5.6). 
 The mutant of CHS3A was neither sensitive nor resistant to H2O2 which is known as a 
quick diffuser, indicating the importance of chitin to TQ action. 
 Inhibition of chitin production by nikkomycin led to a decrease in the antifungal efficacy 
of TQ ( Fig. 5.7).   
Chapter6  
- 171 - 
  
5.4.3 Chitin, CWI-MAPK and TQ sensitivity 
Activation of the cell wall integrity pathway components is supposed to stimulate cell surface 
transport of CHS3 (Munro et al., 2007). As a result, CWI-MAPK mutants would have less chitin 
and would be resistant to CFW as well as TQ. Candida glabrata Δbck1, Δmkk2 and Δslt2 have 
shown similar growth rates to the wild type when they were treated with CFW (Schwarzmuller et 
al., 2014). This is in agreement with the sensitivity of these mutants to TQ. Indeed a further 
analysis of chitin content in these mutants after TQ treatment might explain further the relation 
between induction of these kinases and cellular response to TQ stress. Cota et al., (2008) showed 
that C. glabrata Δslt2 had a similar amount of chitin to the parent strain but C. glabrata Δslt2 
was not able to enhance its chitin content after caspofungin exposure compared with the parent 
strain; therefore C. glabrata Δslt2 was slightly sensitive to caspofungin (Cota et al., 2008).  
Activation of other signalling pathways which might induce chitin production should not be 
ignored. Intracellular oxidative stress, which can be caused by TQ treatment, induces several 
mitogen activated protein kinase (MAPK) routes in yeast: these include CWI, TOR , HOG and 
RAS-PKA-cAMP (reviewed by (da Silva Dantas et al., 2015, de la Torre-Ruiz et al., 2010). 
Chitin synthesis can be upregulated co-ordinately via the CWI, HOG and Ca
2+
 signalling MAPK 
pathways in Candida albicans. The Ca
2+
-induced upregulation of CHS promoters can be 
independent of the CWI pathway (Munro et al., 2007). Cross-talk between these signalling 
pathways also exists (reviewed by (de la Torre-Ruiz et al., 2010). Therefore, inhibition of CWI-
MAPK components might be compensated by the activity of other signalling pathways.  
However, as mentioned before, further analysis of chitin levels in CWI-MAPK mutants is 
required to confirm that their susceptibility pattern is related to the similar level of chitin 
compared with the control strain. 
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5.5 Conclusion 
In conclusion, it seems that treatment of C. glabrata cells with thymoquinone increases the 
rigidity of the cell wall by increasing chitin levels in a try to overcome TQ’s stress. The increase 
in chitin synthesis might be occurred after stimulation of CWI-MAPK pathway. In addition, the 
resistance of C. glabrata Δchs3A to TQ and the interference between TQ and nikkomycin Z 
indicate an important role of chitin in TQ mechanism of action. 
 
 
Chapter 6: Final conclusions 
 
There are many studies investigating the mechanism of thymoquinone as an anticancer 
compound but, there are no published data on its mechanism of action as an antifungal or even 
an antimicrobial compound.  The present study of thymoquinone’s effect on oxidative status and 
the cell wall integrity pathway in Candida glabrata will advance the understanding of 
thymoquinone tolerance mechanisms and help to develop new approaches to the treatment of 
fungal infections with thymoquinone.  
The antifungal effect of thymoquinone towards C. glabrata, C. krusei and Candida spp. biofilms 
has not been investigated before. Chapter 1 showed that thymoquinone was able to inhibit the 
growth of different Candida species including C. glabrata and C. krusei. In addition, 
thymoquinone showed a fungicidal effect rather than fungistatic effect in a cell-density 
dependent way. In terms of its effect on biofilms, thymoquinone can inhibit the growth of 2 h old 
C. glabrata biofilms by 3 log10 but not mature biofilms. The biofilms were established using a 
polypropylene biofilm reactor (PP reactor) which was developed in this study to mimic the 
Calgary biofilm device. It is a simple, low cost device and provides valid data for studying C. 
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glabrata biofilms and might be useful for other microbial species which produce biofilms.  The 
similarity of biofilms produced at different sites of the PP reactor enables rapid and reproductive 
screening of Candida biofilms for antifungal resistance testing. It can also help to establish 
biofilm models for molecular microbiology investigations. Finally the death caused by 
thymoquinone in C. glabrata seemed to be necrotic death and further investigations to confirm 
this result are recommended. 
 
It has been concluded from testing thymoquinone on mammalian cell lines that thymoquinone 
can act as antioxidant or prooxidant depending on the milieu. The question of whether 
thymoquinone acts as prooxidant or antioxidant in yeast was addressed in chapter 2. The 
obtained data demonstrate that the generation of intracellular oxidative stress is definitely part of 
thymoquinone’s mechanism of action as a fungicidal agent.  Oxidative stress caused by 
thymoquinone led to loss of cell membrane integrity and affected intracellular functions 
including reduction in reduced glutathione amount and reduced mitochondrial membrane 
potential. D-erythroascorbic acid was identified as an important antioxidant in other yeast 
species such as S. cerevisiae and C. albicans. This study identified for the first time the synthesis 
of D-erythroascorbic acid by C. glabrata. Two isolates of the ALO1 gene were cloned and 
sequenced on both strands of DNA, and the sequence of the clone (Cg16a) with less changes is 
shown.  The differences are likely being PCR errors.  Since there was a 2.5 fold increase in 
dehydroascorbate production I assumed the changes did not affect the ALO1 enzyme function.  
The further completion of the study for publication will involve the construction of an ALO1 
disrupting mutant. 
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Overexpressing of D-arabino-1,4-lactone oxidase (ALO1) was demonstrated by measuring a 2.5 
fold increase in D-erythroascorbic acid production in C. glabrata clones. However, the produced 
amount in this study was not enough to significantly alleviate the oxidative stress caused by 
H2O2 or thymoquinone.   
 
As a pro-oxidant, thymoquinone induced the CWI-MAPK cascade. This study hypothesised that 
inhibition of this cascade might weaken C. glabrata cell wall integrity as well as its response to 
the oxidative stress caused by thymoquinone. In fact, utilisation of a PKC1 inhibitor did not 
improve thymoquinone efficacy. Furthermore, the mutants of downstream CWI-MAPK 
components did not show any difference in thymoquinone sensitivity compared with their 
parental strains. That indicates the minor role of this cascade in protection from the 
thymoquinone fungicidal effect. In contrast, the downstream kinase SLT2 was crucial in 
protection against H2O2 toxicity which indicated a different interaction between C. glabrata cells 
and these two pro-oxidants.  
 
This difference was confirmed by discovering the binding of thymoquinone to chitin on the 
surface of C. glabrata cells. The results of chapter 5 describe virtual and genetic evidence to 
support the idea that cell wall chitin plays a role in the interaction between thymoquinone and C. 
glabrata. Observations of thymoquinone fluorescence at the rims of bud scars where more chitin 
is accumulated and induction of chitin synthesis by thymoquinone indicated an interaction 
between TQ and chitin. Moreover, the antagonism between thymoquinone and the chitin 
inhibitor, nikkomycin Z and the resistance of C. glabrata Δchs3A to thymoquinone emphasises 
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the relationship between TQ and chitin. However, it is not clear why it took over 9 h for the TQ 
staining of bud scars to become apparent and further work to clarify this observation is important 
to elucidate further TQ’s mechanism of action as an antifungal agent. 
In conclusion, treatment of C. glabrata with thymoquinone activates the CWI-MAPK cascade 
which leads to an increase in chitin synthesis. As a consequence, the rigidity of the C. glabrata 
cell wall increases to overcome thymoquinone’s stress. On the other hand, there seems to be a 
decrease in the amounts of cellular chitin causing a decrease in TQ’s antifungal effect and 
increased chitin amounts, increasing TQ’s efficacy as antifungal agent. Since the fluorescence of 
TQ needs a long time to be observed at the bud scars, it is not clear whether TQ’s binding to 
chitin at the bud scars contributes to overwhelming of C. glabrata cell wall with TQ, causing an 
oxidative stress and then cell death or TQ might diffuse, causes oxidative stress and binds to the 
cell wall later. The antagonism between chitin inhibitors and thymoquinone should be considered 
in selecting agents for clinically treating Candida infections. In addition, the interaction between 
TQ and chitin might help in development of TQ nanoparticles. 
 
Chapter 4 also showed data on the survival of C. glabrata in water and demonstrated for the first 
time the relationship between cell number and survival rate of this yeast in a hypo-osmotic 
environment which was associated with starvation.  A high cell density of C. glabrata cells 
provides protection towards hypo-osmolarity but not low cell density (<10
5
 cells/ml). In 
addition, dead cells in water do not lyse because of the inflow of water inside the cells but they 
shrink and die via apoptosis. This study also proposed a bio-protection through releasing of 
nutrients from these cells at high density.  Low cell density of C. glabrata can survive at hypo-
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osmotic environment in the presence of osmo-stabiliser or low concentrations of nutrients. Such 
factors might be important to consider in environmental studies which focus on eradication of 
microbial cells (e.g. in water systems).  
 
Cells in water might be a useful model to screen and test CWI-MAPK inhibitors. Compounds 
which inhibit the CWI-MAPK cascade such as staurosporine are toxic in water but higher 
concentrations are needed to become toxic in media. The toxicity of the CWI-MAPK inhibitor 
can be abrogated by an osmo-stabilizer such as sorbitol. Although this study was not able to 
screen novel CWI-MAPK inhibitors due to the limited number of tested compounds, the known 
PKC1 inhibitor staurosporine has supported this hypothesis. 
 
This study also showed for the first time phosphorylation of SLT2 in C. glabrata as a result of  
doxycycline treatment. Doxycycline is used as an inducing agent for some expression systems, 
with the thought that it has no side effect.  However, this unreported side effect should be 
considered when yeast is used as protein expressing system in studies involving doxycycline.
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Appendix A 
A.1 Growth media and general solutions preparation  
Growth media preparation and general solutions’ recipes were prepared following published 
recipes or manufacturer’s guidelines. 
YEPD medium contents (1% yeast extract, 2% bacteriological peptone, 2% dextrose) were 
dissolved in distilled water followed by steam sterilisation. To prepare YEPD solid medium 1.5 
% of bacteriological agar was added. All the components were purchased from Oxoid Ltd or Cell 
Biosciences Pty Ltd. 
Yeast minimal medium (YMM) was prepared by adding 0.67% yeast nitrogen base (with amino 
acids (Sigma-Aldrich)) and 2% dextrose to distilled water. To prepare YMM solid medium 1.8 
% of bacteriological agar was added. This medium lacks uracil. 
 
The yeast minimal medium without amino acids (YMM w/o AA) contains yeast nitrogen base 
without amino acids (Difco) and 2% dextrose. Solid YMM w/o AA was prepared by adding 1.8 
% bacteriological agar. This medium lacks uracil. 
 
RPMI1640 medium 3.04 g (0.165 M) MOPS (Sigma-Aldrich) was added to 1.04 g of RPMI1640 
medium (with glutamine and phenol red, without bicarbonate (Invitrogen)) in  100ml of distilled 
water. The acidity of this medium was adjusted while stirring to pH 7 using 1 mol/L sodium 
hydroxide (CLSI, 2008). This medium was filter sterilised before it was used as a liquid medium. 
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Alternatively RPMI1640 medium supplied with 1.8 % bacteriological agar was steam sterilised 
to prepare RPMI1640 agar plates. 
Phosphate buffer solution (PBS) was prepared by dissolving one tablet (Sigma-Aldrich) in 200 
ml of MilliQ water. The solution was sterilised by autoclave and was filtered through 0.22 µm 
filter (Millex) prior flow cytometry experiments. 
TAE Buffer  0.04M Tris- acetate, 0.001 EDTA and the acidity was adjusted to 8.3. 
 
A.2 Yeast strains maintaining  
Candida cryogenic stocks were stored at -80 ºC in YEPD medium with 25 % sterilised glycerol 
and streaked onto YEPD plates as working stocks. The working stocks were stored at 4ºC and 
replaced at most after two months. Before each experiment candida from working stocks were 
sub-cultured twice onto YEPD plates or selective medium with overnight incubation at 30 ºC. 
Candida glabrata ura3 HM100 mutant cryogenic stocks were stored at -80 ºC in yeast minimal 
medium lacking uracil (YMM-ura3) without amino acids and plated onto the same medium.  
Escherichia coli DH5α and E. coli HHT2 were stored in Luria-Bertani LB medium with 20% 
sterilised glycerol at -80 ºC. To prepare working stocks, cells were streaked from -80ºC onto the 
same LB agar and incubated overnight at 37 ºC. Cultures for plasmid transformation and 
selection were grown in LB contain 100 µg/ml of penicillin.  
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A.3 Antimicrobial agents used in this study 
The antifungal agents including caspofungin stocks were dissolved in sterilised MilliQ water and 
stored at -20 ºC.  Nikkomycin and doxycycline were dissolved in sterilised RPMI1640 medium 
at the time of use. Fluconazole was dissolved in Dimethyl sulfoxide (DMSO) and used 
immediately.  
Stausporine stocks of 1 mg/ml were prepared in ethanol and stored at -20 °C. Sorafenib and 
XMD8-92 (Santa Cruz, USA) stocks were prepared freshly in DMSO. 
Thymoquinone stocks were prepared by dissolving thymoquinone in DMSO at concentration of 
20 mg/ml and usually were used immediately or stored into Eppendorf tubes at -20 ºC for not 
longer than two weeks. Before use, TQ stocks of 20 mg/ml were diluted 1:10 and further 1:2.5 in 
RPMI 1640 before adding equal volume of RPMI 1640 to make serial dilutions. 
 
 A.4 General procedures 
All the practical operations were carried out aseptically on clean bench wiped with 70% ethanol. 
Work was kept near from flaming Bunsen burner or in a biohazard cabinet wiped with ethanol 
and exposed to UV-light for at least 20 min.  Most of the reagents, media and consumables (e.g. 
tips) were steam sterilised at 121ºC for 15 min.   
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A.5 Spotting of yeast on agar plates 
Serial dilutions of 1:10 were done in 96 micro-plates by picking up some of yeast colony from 
overnight plate using tooth picks. The biomass was suspended in the first well followed by serial 
dilutions. The medium was used for serial dilutions was same as the agar plates. Immediately 
after the serial dilutions or after overnight incubation 5 µl from each well were spotted on the 
agar plates and left to dry in a biohazard cabinet. 
 
A.6 Microscopy 
Epi-fluorescence microscope  (Leica DM2500, Germany) was used to visualise fluorescent stains 
and Differential interference contrast (DIC) or the bright field . Electronic Images were captured 
using a DFC310 FX Leica camera and processed using the Leica Application Suite (LAS, V4.3, 
Switzerland). This microscope was equipped with three filter cubes: Filter cube A (UV 
excitation) is 340-380 nm, Filter cube I3 (blue excitation between 450-490 nm), GFP filter 
(excitation 469 nm), Texas Red filter (Excitation 559 nm). 
 
A.7 Flow cytometry 
FACS Canto II flow cytometer (BD Biosciences, Becton-Dickinson, Franklin Lakes, USA) flow 
cytometer equipped Different laser filters was utilised to obtain flow cytometry data. The filters 
which were used are: 
 Pacific Blue™, 45 /5  filter (351-450/65nm Excitation max – Emission max). 
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 AmCyan, 525/20 filter (458-489 nm Excitation max –Emission max). 
 PerCP-Cy™5.5, 695/4  filter (482/695 nm Excitation max –Emission max). 
 FITC, 530/30 filter (494/519 nm Excitation max –Emission max). 
 
Ten thousand cells were collected at the most of experiments and data files were saved as FCS3, 
then were analysed whether by  Flowing software which was created by Perttu Terho (Cell 
Imaging core, Turku Centre for Biotechnology, Finland) or trial version of WEASEL
TM
 software 
(WEHI, Australia).   
 
